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Abstract:  
The lamina is a cage-like structure, composed of lamins, found underneath the 
inner nuclear membrane (INM). In mammals, Lamins are type V intermediate 
filaments. Three genes encode seven different lamin proteins. These genes are 
LMNA, LMNB1 and LMNB2. Lamins are classified into A- and B-types. A-type 
lamins, Lamin A, Lamin C, Lamin Aδ10 and Lamin C2, are mainly expressed in 
differentiated tissues. All encodes by the LMNA gene and products of alternative 
splicing. Recent studies have shown the expression of Lamin A/C in colon crypt 
epithelia cells. This expression was greater in differentiated epithelial and stem 
cells than in the proliferation zone. Since 1999, mutations in LMNA have been 
shown to cause several different inherited diseases in muscle, fat, bone, skin and 
nerve tissues. LAP2α is one of the strong binding partners to Lamin A/C. LAP2α 
has a specific function as a non-membrane protein associated with the 
nucleoskeleton and may help to organize higher order chromatin structure by 
interacting with Lamin A/C.  
    
To understand more about Lamin A/C and LAP2α in colon epithelial development, 
a Yeast 2-hybrid screen was used to look for novel protein interactions to Lamin 
A/C and/or LAP2a. It was found Cytochrome c oxidase subunit II (Cox2) is a 
putative binding partner to Lamin A/C and LAP2 α. Cox2 is encoded by the 
mitochondrial genome and imported into complex IV (COX) of the mitochondrial 
respiratory chain (MRC). The majority of mitochondrial proteins are encoded by 
nuclear DNA. However, 13 essential subunits of the MRC are encoded by mtDNA. 
The MRC is composed of five multi-subunit complexes (I-V). MRC is implicated in 
ATP generation and is involved in apoptosis in response to different stimuli. 
Deficiency in COX in colon cancer cells results in resistance to apoptosis and 
increases in reactive oxygen species (ROS). Biochemical assays like Co-
immunopreciptation (IP) and western blot (WB) and Immuno-gold labeling (TEM) 
were used.  IP confirmed the putative interaction of Cox2 to Lamin A/C and LAP2 
α. WB showed the expression of lamin A/C and LAP2α in the mitochondrial and 
nuclear fractions but not in cytosol. TEM is alternative method showed the 
distribution of lamin A/C and LAP2α in the nucleus and mitochondria. 
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Chapter 1: Introduction 
 
 
1.1 Nuclear biology in health and diseases: 
 
 
1.1.1 The nuclear envelope.  
 
In higher eukaryotic cells, the nucleus is a complex organelle which contains a 
majority of the genetic information and is the site of DNA replication, RNA 
transcription and processing, and ribosome assembly. It is surrounded by the 
nuclear envelope (NE) which separates the nuclear content from the cytoplasm. 
The NE is composed of three parts: the nuclear membranes (inner, outer, and 
pore) the nuclear pore complexes (NPCs), and the nuclear lamina (Figure 1.1) 
(Broers et al., 2006). The outer nuclear membrane (ONM) is continuous with the 
rough endoplasmic reticulum (ER). However the inner nuclear membrane (INM) is 
linked to the nuclear lamina by integral membrane proteins termed nuclear 
envelope transmembrane proteins (NETs) and lipid modifications. The luminal 
space is the space between INM and ONM which is about 100nm in width. The 
NPCs are composed of multiple proteins that form a complex. In vertebrates, the 
NPC is ~120 MDa protein complex made of ~30 different proteins. The NPCs 
regulate the passage of macromolecules in and out of nucleus (Goldberg, 2004). 
The nuclear lamina is a fibrous meshwork composed of type V intermediate 
filament proteins termed lamins (Muchir and Worman, 2004). 
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For many years, the NE was thought to function mainly as an architectural 
stabilizer for the nucleus, participating in assembly and disassembly processes 
during mitosis and to separate the DNA from the cytoplasm. However, recent 
findings demonstrate that NE proteins are involved in fundamental nuclear 
functions, such as gene regulation and DNA replication, and that inherited or de 
novo mutations in NETs cause human diseases. If the mutations are in INM or 
NPC proteins the diseases are termed “nuclear envelopathies”, whereas if the 
mutations are in lamins then the diseases are termed “laminopathies”. These 
finding emphasize the  importance of understanding the function of this cellular 
domain, in both physiological and pathological states (Somech et al., 2005a). 
 
 
Figure 1.1: Model of the location of nuclear lamins and their interaction with nearby localized 
proteins. Lamins bind directly to lamina-associated proteins (LBR, LAP2, emerin, MAN1, nesprins-1 and -
2), but also to BAF, Rb, SREBP1, histone proteins, and DNA, and thereby mediate association with a scala of 
interacting structural proteins, including SUN1, actin, and possibly tubulin and intermediate filament proteins. 
Question marks indicate suggested but not yet proven interactions (Broers et al., 2006). 
INM
ONM
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1.1.2 Intermediate filaments and the nuclear lamina. 
 
The nuclear lamina is a cage-like structure found underneath the INM and is 
composed of lamins. The lamina is interconnected with integral membrane proteins 
and NPCs and together these interactions constrain nuclear size and shape (Moir 
et al., 2000a; Hutchison, 2002; Herrmann and Foisner, 2003; Hutchison and 
Worman, 2004).  
 
In mammals, the cell cytoskeleton is composed of three main parts: microtubules, 
actin filaments and intermediate filaments (IF). The intermediate filament super 
gene family comprising of more than 70 genes are divided into six groups, five of 
which (I-IV & VI) are cytoplasmic. The acidified and basic keratins (type I and II) 
are expressed in epithelial cells. The type III IFs are: vimentin that is expressed in 
mesenchymal cells, desmin which is expressed in muscle cells, glial fibrillary acidic 
protein (GFAP) which is expressed in glia and astrocytes and peripherin which is 
expressed in neurons of peripheral nervous system. The type IV neurofilament 
triplet proteins which are NF-L, NF-M, and NF-H and α-internexin are expressed in 
neurons of the central nervous system. Lamins make up group (V) of the IF family 
(Strnad et al., 2008). The main functions of IFs are to maintain cell integrity and 
shape. 
 
The nuclear lamins have the typical domain structure of the cytoplasmic IFs. All IF 
proteins have four central rod domains (α-helical-coiled-coil dimerization domain 
1A, 1B, 2A and 2B), consisting of a heptad repeat which is characteristic of 
proteins forming an α-helix structure. They are separated by flexible linker regions 
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and flanked by N-terminal (head) and C-terminal (tail) globular domains of variable 
size. The major differences between lamins and cytoplasmic IFs in the protein 
structure are, IFs have an α-helix pre-coil domain (PCD) just before 1A of α-helix 
coiled-coil domain which is probably not involved in coiled-coil formation. However 
in lamins the head domain is ~47 amino acid shorter; there is a six heptad 
extension within coil 1B; the globular tail domain is longer and possesses a 
Nuclear-localization signal sequences (NLS) and carboxyl terminal tail CaaX motif 
which is the target for carboxyl methylation, farnesylation and proteolytic cleavage 
(Figure 1.2) (Herrmann et al., 2007). Lamins like cytoplasmic IFs assemble into 
polymeric structures that are resistant to solubilization under a variety of conditions 
(Moir et al., 2000a).  
Figure 1.2: Structural model of cytoplasmic and nuclear intermediate filament protein dimers. 
Modelling of the human vimentin and the lamin A dimers, on the basis of structural data and structure 
prediction, revealed that the central α-helicalrod domain of the individual molecules is subdivided into the 
coil segments 1A, 1B, 2A, 2B1 and 2B2. The vimentin coil 1A ispreceded by an α-helical pre-coil domain 
(PCD), which is probably not engaged in coiled-coil formation. Linker segments that connect the individual 
α-helical segments are indicated: L1, L12 and L2. Left-handed coiled-coil segments are shown in green. 
Regions that are predicted to form nearly parallel α-helical bundles as well as the so-called stutter (stu) region 
in the heptad repeat pattern are represented in yellow. Non- α-helical linkers are shown in grey. The non- α-
helical N- (head) and C-terminal (tail) domains are coloured blue and red, respectively. Parts of the α-helical 
coiled coils of vimentin and lamin A have been solved by X-ray crystallography9. The structure of the 
immunoglobulin-fold domain in the tail domain of lamin A (red wide arrows) has been solved both by X-ray 
crystallography and by NMR9. The numbers in brackets refer to the number of amino acids in each respective 
domain. Scale bar, 5 nm. NLS, nuclear localization signal (Herrmann et al., 2007). 
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1.1.3.  Nuclear Lamins. 
 
 
1.1.3.1 Lamin structure. 
 
In mammals, three genes encode seven different lamins protein. These genes are 
LMNA, LMNB1, and LMNB2 (Hutchison, 2002). Lamin proteins are classified into 
A-type and B-type lamins.  
 
B-type lamins are expressed in all cells and are essential for cell survival (Harborth 
et al., 2001). There are three different B-type lamin proteins. Lamin B1 is encoded 
by the LMNB1 gene, Lamin B2 and B3 are encoded by alternatively spliced 
LMNB2.  Lamin B1 and B2 are expressed in most cells, while Lamin B3 is 
expressed in germ cells (spermatocytes and oocytes) possibly reflecting the 
distinct organization of nuclei of these cells (Bridger et al., 2007).  
 
A-type lamins (Lamin A, Lamin C, Lamin Aδ10, and Lamin C2) are mainly 
expressed in differentiated tissues (Hutchison et al., 2001). Lamin C2 is expressed 
in germ cells (spermatocytes and oocytes) possibly reflecting the distinct 
organization of nuclei of these cells (Bridger et al., 2007).  Lamin Aδ10 is an 
alternative lamin protein that is expressed in tumor and several normal cell types 
(Machiels et al., 1996).  
 
B-type lamins are acidic and A-Type lamins are basic as demonstrated by 
isoelectric focusing in conventional two dimensional polyacrylamide gel 
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electrophoresis (Lehner et al., 1986). All lamins contain a carboxyl-terminal CaaX 
motif except lamin C, (“C” is cysteine, “a” is commonly an aliphatic amino acid, and 
“X” can be different amino acids). The CaaX sequence in prelamin A is CSIM and 
in lamin B1 is CAIM (Stewart et al., 2007). Lamin A and C proteins are identical for 
the first 566 amino acids but are distinct at their carboxy-terminal ends. Lamin C 
has six unique carboxy-terminal amino acids (Lin and Worman, 1993).  
 
  
1.1.3.2 Lamin translation and post translational modifications. 
 
Prelamin A is the precursor to mature lamin A. Prelamin A undergoes specific post 
translational processing to produce mature lamin A. This process starts by adding 
farnesyl lipid to the cysteine of the caboxy-terminal CaaX box of the protein by a 
cytosolic enzyme protein farnesyltranssferase. Subsequently, the last three amino 
acids of the protein –aaX are clipped off by RCE1 and ZMPSTE24. This will be 
followed by a methylation step via methyltransferase ICMT. These three 
modifications render the carboxyl-terminal domain of lamin A, B1 and B2 more 
hydrophobic, and this hydrophobicity could facilitate lamins to associate in INM 
(Young et al., 2006). The post translational processing of B type lamin proteins 
follows the same steps of prelamin A (Rusinol and Sinensky, 2006; Stewart et al., 
2007). The only difference in post translational processing is that prelamin A 
expose to a second endoproteolatic cleavage by ZMPSTE24. This process is 
ended by clipping off the last 15 amino acids including the farnesyled methylated 
cysteine which will release mature lamin A (Figure 1.3A). This process occurs 30-
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60 minutes after assembly into nuclear lamina (Bergo et al., 2002; Pendas et al., 
2002). 
  
 
Figure 1.3A: The maturation step of Lamin A posttranslation in normal cells (Young et al., 2006). 
  
 
Mutation in this cleavage site leads to accumulation of permanently isoprenalyted 
lamin A that cause progeria (Young et al., 2006). Lamin C lacks the CaaX motif 
and is never undergoes post-translation process (Figure 1.3B) (Hutchison et al., 
2001). But it still be found at the NE, which may show the post translation process 
is not essential for NE localization (Goldberg et al., 2008a).   
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Figure 1.3B: Schematic representation of somatic cell lamins. Coloured rectangles represent α-helical coiled-
coil domains; B-type lamins are shaded in green, and A-type lamins are shaded in red. The blue shaded 
NLS=nuclear localization signal sequence; CaaX is the site for carboxy methylation, prenylation and 
proteolytic cleavage. Coloured regions in the C-terminal tail domains show the major sites of amino acid 
residue variation among the lamin subtypes (Hutchison et al., 2001). 
 
 
1.1.3.3 Lamin polymer assembly. 
 
In somatic cells lamina structure is more complex because of its interactions with 
intranuclear structures proteins. Because of this it is difficult to access and to judge 
the relevance of in vitro structures (Goldberg et al., 2008a). An intermediate 
approach has been taken to study lamina structure in vitro using Xenopus oocytes. 
Accumulated evidence helped investigators to imagine three steps for the 
assembly of lamina structure.  The first evidence showed the in-vitro assembly of 
B-type lamin to form a 10-13nm diameters filament was performed in  Xenopus 
oocytes (Aebi et al., 1986). However, in vitro experiments showed A-type lamin 
form a thicker (>13nm) diameter structure (Quinlan et al., 1995)(Goldberg et al., 
2008b).  Lamin assembly was studied using EM analysis of purified recombinant 
wild-type and mutant lamin and chemical cross-linking within the native lamina  
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(Stuurman et al., 1998). These studies suggested that lamin assembly in-vitro 
involved lateral interaction via coiled-coil associations of α-helical rod domains of 
two lamin chains to form homodimers.  
 
It was also suggested that lamins interact longitudinally to form head-to-tail 
polymers. Several studies on the mutant Drosophilla lamins have shown that 
amino acid residue of N-terminal end of coil 1A associated with the amino acid 
residues of C-terminal end of coil 2A, that suggest the head-to-tail polymerization 
(Heitlinger et al., 1991; Moir et al., 1991). 
 
A model was suggested to explain how tetramers of B-type lamin form. This model 
showed that beside the lateral interaction of two lamin chains and head-to-tail 
polymerization (see above), B-type lamins are involved in N-N half anti-parallel 
tetramer structure of two polymers. This model was based on studies confirmed 
the binding of LAP2β with coil 1B of B-type lamins (Yang et al., 1997a, 1997b; 
Mical and Monteiro, 1998; Gant et al., 1999). Moreover the implication of LBR as 
an isoperen receptor, after confirmed binding CaaX motife to LBR (Mical and 
Monteiro, 1998).   
 
A cartoon model was developed to show how a 2D lamina array forms in the INM 
(Figure 1.4). Since A-type lamins are not expressed in embryonic cells, it was 
proposed that the B-type lamin is the base of lamina structure. It was demonstrated 
that a tetramer of B-type lamin anchors to the NE by interacting with NETs such as 
LBR and LAP2β (Yang et al., 1997b, 1997a).   
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Figure 1.4: Cartoon showing the constrained polymerisation of B-type lamin filaments at the INM. Tethering 
of B-type lamins to the INM in this model is through association with LAP2 through coil 1b and through an 
isoprene receptor (possibly LBR). Lamin B dimers form NN half-staggered anti-parallel associations to make 
tetramers and head-to-tail associations to form higher-order structures such asproto-filaments (Hutchison et 
al., 2001). 
 
 
Several experiments showed the aggregation of A-type lamin in the nucleoplasm in 
the B-type lamin null cells (Dyer et al., 1999). But, how A-type lamin interacts with 
B-type lamin is a big issue that needs to be investigated.  
 
Several studies implicated lamin A in anchoring lamin C into the NE. In cancer cell 
lines that do not express lamin A, lamin C was located in the nucleolus instead of 
the NE (Vaughan et al., 2000; Venables et al., 2000). A cartoon model was 
developed to demonstrate how lamin A/C tetramer associate with B-type lamin 
dimers through anti-parallel associations at the NE (Figure 1.5) (Hutchison et al., 
2001). 
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Figure 1.5: Incorporation and stabilisation of A-type lamins at the INM. A-type lamin tetramers are 
incorporated into the INM by head-to-tail and anti-parallel associations with B-type lamin filaments. 
Recruitment of these lamins to the INM leads to further recruitment of emerin and LAP1C from the ONM/ER 
to the INM, stabilising the A-type lamins. ‘Lamina’ indicates where lamin filaments are assembling. 
 
 
1.1.3.4 Lamins in mitotic disassembly and assembly. 
 
During interphase, it was believed that the nuclear lamins have important roles in 
the NE integrity and chromatin organization. At mitosis a complete disassembly 
and reassembly of the NE occurs (Vaillant and Paulin-Levasseur, 2008). 
Disassembly of nucleus was classified into three main independent steps: 
chromosome condensation, nuclear lamina depolymerization, and nuclear 
envelope breakdown (NEBD) (Newport and Spann, 1987). NEBD would define the 
end of prophase and the beginning of prometaphase (Vaillant and Paulin-
Levasseur, 2008). Disassembly of nuclear lamina correlates with its 
hyperphosphorylation (see below). It was also believed that number of integral and 
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peripheral NE proteins, including LBR, LAP2α and LAP2β are involved in 
hyperphosphorylation by cyclin B and cdk during prophase (Dechat et al., 1998). It 
was thought that phosphorylation step is important to abolish the structural protein-
protein integrity of the NE, and to promote membrane release from chromatin 
(Vaillant and Paulin-Levasseur, 2008). The release of NPCs was implicated in 
nuclear disassembly, leading to a fenestration of the NE before NEBD (Collas, 
1998). 
 
At the G2/M transition, the localization and attachment of dynein to NE has been 
shown (Busson et al., 1998; Salina et al., 2002). It was speculated that dynein 
binds with NPC proteins which could serve as an attachment site for microtubules 
(Daigle et al., 2001; Salina et al., 2002). At the end of prophase and beginning of 
prometaphase microtubules bind to the nuclear membrane via dynein/dynactin and 
NPC proteins and tear away the membrane fragments out of the nucleus to 
generate NEBD. After NEBD, microtubules would stay attached to NPC and dynein 
and pull NE fragments away from the chromosome surface towards the 
centrosomes (Beaudouin et al., 2002). The timing of disassembly of A- type and B-
type lamins are different. A-type lamin are released to the nucleoplasm in early 
prophase before B-type lamin (Georgatos et al., 1997). It was shown that B-type 
lamins solubilized rapidly within 5-10mins after NEBD. A kinetics experiments were 
performed on NE proteins dispersion including LBR, LAP2β, POM121 and Lamin B 
correlated to NEBD. The results demonstrate that all NE proteins tested except for 
LBR were dispersed only after NEBD. All three NE proteins were equilibrated with 
ER except B-type lamin appeared to be soluble in the cytoplasm (Ellenberg et al., 
1997; Daigle et al., 2001; Beaudouin et al., 2002). A-type lamins completely 
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solubulized during mitosis (Gerace and Blobel, 1980). Several key elements that 
control G2 to metaphase in the eukaryotic cell cycle have been found. Among 
these is the protein complex of cdc2 kinases that is composed of at least two 
subuints: p34cdc2 the 34 Kd product of the cdc2/cdc28 gene, and a 45-62 Kd 
protein known as cyclin B (Norbury and Nurse, 1989). The relationship between 
cdc2 and nuclear lamins were subjected for further studies. It was demonstrated 
that both chicken lamins B1 and B2 were phosphorylated by purified cdc2 kinase in 
vitro. It was confirmed that the sites of phosphorylation in vitro is the same one in 
vivo. This study was able to identify one of the M-phase specific phosphoacceptor 
sites of cdc2 kinase as an evolutionarily conserved serine residue in the N-terminal 
head domain of all lamins. Protein kinase A and C are among several lamin kinase 
proteins that have been implicated in lamins phosphorylation (Collas et al., 1997). 
Binding of lamin A with PKA was identified and occurs through both the V5 region 
and a portion of the C2 region of the kinase (Martelli et al., 2002). Down-regulation 
of PKA has been implicated in lamina disassembly (Lamb et al., 1991). At 
interphase, PKC has been implicated in phosphorylation of chicken lamin B2, a 
process thought to regulate lamin import into the nucleus (Hennekes et al., 1993).  
  
At the end of mitosis, the NE proteins reassemble around chromatin to rebuild the 
nucleus structure (Gant and Wilson, 1997). Immunodepletion of lamins using 
antibodies in Xenopus nuclear assembly extracts did not affect nuclear envelop 
formation (Meier et al., 1991), the nuclei have a full membrane structure. This 
suggested that lamins do not have an important role in rebuilding the nuclear 
envelop but may they have critical roles in its function. However, one study showed 
NPC clustering and small nuclei in immunodepletion of lamin B3 in Xenopus 
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extracts (Goldberg et al., 1995). A different study showed that lamins start to 
assemble after the nuclear membranes have formed (Wiese et al., 1997).  Lamin 
polymerization appears to be necessary for the growth of the nucleus and the 
maintenance of nuclear shape during interphase (Moir et al., 2000a).  
 
 
1.1.3.5 Lamina functions in health and disease. 
 
To understand the function of lamins in health and disease, we need to understand 
their structure at the gene and protein level. For over a decade, the investigators 
have focused on two areas; the role of lamins as building blocks and transcriptional 
regulators. 
 
Since 1999, mutations in LMNA have been shown to cause several different 
inherited diseases; in muscle, fat, bone, skin and nerve. These observations have 
forced cell biologists to consider the nuclear lamina in a new light (Worman and 
Courvalin, 2002, , 2004). ~220 mutations have been discovered in LMNA  
(Gruenbaum et al., 2005), which are linked to at least 12 diseases, including 
Hutchinson-Gilford progeria, striated muscle diseases including muscular 
dystrophies and dilated cardiomyopathies, lipodystrophies affecting adipose tissue 
deposition and a peripheral neuropathy (Stewart et al., 2007) a database of nuclear 
envelopathies can be found at http://www.umd.be/.  
 
As B-type lamins are essential for cell survival, loss of either lamin B1 or B2 is 
lethal to dividing cells (Harborth et al., 2001). However, a duplication of lamin B1 
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gene was reported to be associated with the neurodegenerative disease 
autosomal-dominant leukodystrophy that is caused by myelin loss in the central 
nervous system (Padiath et al., 2006). Recently, 3 rare mutations in lamin B2 
genes were reported in patients with acquired partial lipodystrophy (APL). Two of 
these mutations result in amino acid substitutions. As there were no associations of 
these mutations in other APL patients, the relationship of these mutations to this 
disease is not yet understood (Hegele et al., 2006). 
 
Accumulation of different studies reported mutations in A-Type lamins. How 
mutations in A-type lamin proteins that are expressed in virtually all somatic cells 
cause different tissue-specific diseases were not understood yet. Therefore, 
several investigators in this field have converged on two types of hypothesis: gene 
expression and mechanical stress (Worman and Courvalin, 2004). 
 
The gene expression hypothesis states that A-type lamins are considered to be 
essential in maintaining tissue-specific expression of certain genes. Thus, a 
pathogenic mechanism of some laminopathy diseases might be a change in gene 
expression caused by mutations in lamin A /C (Worman and Courvalin, 2002). 
 
The mechanical stress hypothesis states that mutations in lamins A/C weaken the 
structural integrity of an integrated nucleocytoplasmic skeletal network (Worman 
and Courvalin, 2002). This weakness seems to be involved in physical damage to 
cells and tissues (Hutchison and Worman, 2004).  
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1.1.3.5.1 LMNA Mutations. 
 
Mutations in A-type lamins were sub-classified into primary and secondary 
laminopathy diseases. The primary is the mutations in the LMNA. The secondary is 
the mutations in the enzyme (ZMPSTE24) that is involved in the posttranscriptional 
processing of lamin A /C. 
 
Primary laminopathies affecting striated muscle: Numerous different mutations 
along LMNA which are mainly heterozygous substitutions were identified in the 
autosomal dominant form of Emery-Dreifuss Muscular Dystrophy (AD-EDMD) that 
are associated with clinical and biological features of early contractures of ankles, 
elbows and cervical spine, slow progressive humero-peroneal muscle weakness 
and wasting, and cardiac conduction defects and dysrhythmia in adult (Bonne et 
al., 1999). Similar mutations were associated with limb-girdle muscular dystrophy 
type 1B (LGMD 1B), and associated with clinical and biological features of slow 
progressive proximal muscle weakness and wasting and frequent conduction 
defects (Muchir et al., 2000). LMNA mutations were also identified in dilated 
cardiomyopathy with conduction system defects (DCM-CD), and associated with 
clinical and biological features of cardiac failure, cardiac conduction and rhythm 
disturbances and dilated cardiomyopathy (Fatkin et al., 1999). 
 
Primary laminopathy affecting axonal myelination: Homozygous R298C 
substitution mutation in the rod domain of lamin A was identified in Charcot-Marie-
Tooth axoanal neuropathy type 2B1 (CMT 2B1), and associated with clinical and 
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biological features of absent deep-tendon reflexes, distal amyotrophy and loss of 
large myelinated nerve fibers (De Sandre-Giovannoli et al., 2002). 
 
Primary laminopathies affecting adipose and skeletal tissue: A heterozygous 
substitution mutation on codon R482G was reported in familial partial lipodystrophy 
of the dunnigan type (FPLD2), and associated with clinical and biological feature of 
loss of subcutaneous white adipose tissue in limbs and trunk and accumulation in 
face, neck and abdominal regions that begin at puberty which may not be 
recognized in children (Shackleton et al., 2000). Several heterozygous substitution 
mutations at codon 482 (R482W/Q/L) were identified. Other mutations like: G465D, 
K486N, R582H and R584H were also associated with FPLD (Vigouroux and 
Capeau, 2005). Heterozygous C591F and R439C substitution missense mutations 
were also reported in FPLD2 patients (Araujo-Vilar et al., 2008; Verstraeten et al., 
2009) respectively. Homozygous mutation R527H or A529V was identified in 
Mandibulo-Acral Dysplasia (MAD) and associated with clinical and biological 
features of the metabolic and fat depot, osteolytic lesions, and skeletal 
abnormalities of craniofacial region and clavicles, insulin resistance and 
hypertriglyceridermia (Simha et al., 2003). A unique LMNA mutation (G602S) was 
reported in a nonobese 24-yr-old woman. This mutation was associated with 
polycystic ovary syndrome that including severe hyperandrogenism, acanthosis 
nigricans, and type A insulin resistance (Young et al., 2005). Restrictive 
dermopathy (RD) is a rare disorder mainly associated by growth retardation, tight 
and rigid skin with erosions, prominent superficial vasculature and epidermal 
hyperkeratosis, sparse or absent eyelash and eyebrow, multiple joint contractures 
and an early neonatal lethal within the first week of life. It is caused by a 
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heterozygous mutation in the LMNA gene, that leads to form in-frame encoding 
resulting a truncated prelamin A (Navarro et al., 2004). Lethal fetal akinesia, one 
case was found with a homozygous LMNA nonsense mutation (Y259X). It was 
associated with a lethal phenotype including dismaturity, facial dismorphism with 
retrognathia, severe contractures of the fingers and the toes and severe 
generalized muscular dystrophy (Mounkes et al., 2003).  
 
Primary laminopathies and progeroid syndromes: A heterozygous substitution 
mutation G608G that produces a truncated prelamin A or a homozygous 
substitution mutation K542N were identified in Hutchinson-Gilford Progeria (HGPS) 
and associated with clinical and biological features of generalized severe growth 
retardation, loss of subcutaneous fat (lipoatrophy), reduction in bone density 
(osteodystplasia), poor muscle development and artherosclerosis. The average 
age of death in this disease is 12-15 years because of artheroslerosis resulting 
myocardial infarction (Sarkar and Shinton, 2001). 
 
A second mutation that causes premature aging is Werner’s syndrome. It is an 
autosomal recessive mutation in WRN gene, which is one of RecQ DNA helicase-
exonuclease that unwinds DNA and cleaves nucleotides from DNA termini. The 
disease associated with early-onset cataracts, arthrosclerosis, type-II diabetes, 
premature graying and loss of hair, cancer, death in the late 40’s from myocardial 
fraction. 83% 0f Werner’s patients have defects in the WRN locus, a few of them 
do not. However, mutations in LMNA were found in 15% of the Werner’s patients 
(Stewart et al., 2007).   
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Secondary laminopathies affecting skeletal muscle or skin tissue:  
Heterozygous mutations were identified in the ZMPSTE24 gene that encodes the 
protease involved in posttranslational process to produce mature lamin A. These 
mutations were found in Mandibulo-Acral Dystrophy (MAD) and restrictive 
dermopathy (RD) patients, and associated with exact MAD’s clinical and biological 
features or with tight and rigid skin with epidermal hyperkeratosis, pulmonary 
hypoplasia, joint contractures and early neonatal mortality in the first week 
(Donadille et al., 2005). Mutations in ZMPSTE24 were reported in neonates 
associated with RD symptoms. Accumulation of prelamin A and complete absence 
of ZMPSTE24 and mature lamin A were found in these patients (Navarro et al., 
2005). 
 
 
1.1.3.5.2 Cancer development. 
 
The expression levels of lamins have been correlated with tumors. Down regulated 
expression of lamin A/C have been associated with different cancers, such as 
lymphoma and leukemia  (Agrelo et al., 2005), lung cancer (Broers et al., 1993) 
and colon cancer which suggested that down regulation of lamin in colon cancer 
could be a biological marker of malignancy (Moss et al., 1999). One study in 
colorectal cancer showed that the expression of A-type lamin in tumors leads to a 
more aggressive form. Lamin A expression was associated with high motility, loss 
of cell adhesion which become more invasive and a stem cell-like phenotype (Willis 
et al., 2008). The expression of A-type and B-type lamins were investigated in skin 
normal and tumor tissue. It was concluded that down expression of lamin A is 
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correlated to rapid growth within the tumor, while down regulated expression of 
lamin C is correlated with slow growth within the tumor. These findings suggest 
that lamin A has a negative influence on cell proliferation (Venables et al., 2001; 
Tilli et al., 2003). 
 
 
1.1.3.5.3  DNA replication. 
 
It has been reported that lamins are not only found in the NE or nucleoplasm but 
they are located at sites of DNA synthesis. The first reports that implicated lamins 
in DNA replication was when small nuclei that failed to replicate DNA were 
assembled in lamin depleted Xenopus egg  extracts (Newport et al., 1990; Meier et 
al., 1991). It was also shown that lamin B1 binds to DNA and histones (Taniura et 
al., 1995). Two further studies demonstrated that disruption of lamina structure in 
nuclei affects the initiation phase but not the elongation phase of DNA replication. 
These results were performed when two constructs of GST-lamin mutant fusion 
proteins were used as a dominant negative protein in Xenopus egg extracts (Ellis 
et al., 1997; Izumi et al., 2000). It was also shown that complexes of nuclear 
proteins like LAP2β and HA95 have important roles in the initiation but not 
elongation phase of DNA replication. It was found that this complex protects the 
initiation protein cdc6 from destruction by the proteasome (Martins et al., 2003). As 
B-type lamins bind to LAP2β, it is thought that B-type lamins may tether the 
complex of LAP2β/ HA95 to the NE to stabilize cdc6 (Broers et al., 2006). 
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1.1.3.5.4  RNA transcription. 
 
Both A-type and B-type lamins have important functions in transcription regulation. 
Several experiments have been designed to investigate the exact role of B-type 
lamins in gene expression. RNAi knockdown of either lamin B1 or lamin B2 in 
cultured cells inhibited cell growth and promoted apoptosis, which suggested both 
lamin B1 and B2 genes are important for gene expression (Harborth et al., 2001). It 
was also found that B-type lamins bind to RNA polymerase II, which implicated B-
type lamins in RNA synthesis (Spann et al., 2002). In mammalian cells, recent 
studies show low expression of lamin B1 but not lamin A/C has a critical role in 
RNA synthesis, which was associated with morphological changes in nuclear 
compartments, nuclei and nuclear speckles. These results elucidated that lamin B1 
is important to maintain RNA synthesis (Tang et al., 2008). 
 
A-type lamins can move between the NE and nuclear bodies so may have positive 
and negative influences on gene expression, while B-type lamins are located in the 
NE only which suggested they may have a specific effect on gene silencing 
(Hutchison, 2002). There is also strong evidence that A-type lamins have roles in 
RNA transcription regulations and processing. It has been reported that four 
different transcription regulators can bind strongly to A-type lamins: the kruppel-like 
protein (MOK2), the sterol response element-binding protein (SREBP1), 
Retinoblastoma (Rb) and c-Fos (Ozaki et al., 1994; Dreuillet et al., 2002; Lloyd et 
al., 2002; Ivorra et al., 2006).  
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On the other hand the influences of A-type lamins were not clear; some studies 
show that lamin A was not crucial in gene expression but other show that lamin A 
has role in gene expression (Wilson et al., 2001). In fact, the binding of 
transcription regulators may explain their influences on gene expression at 
transcriptional or post-transcriptional level (Hutchison, 2002).    
 
 
1.1.3.5.5  Nuclear envelope shape and size. 
 
A-type lamins have a role in determining the nuclear shape. Alteration in nuclear 
morphology has been reported in fibroblasts from patients with lamin A/C 
mutations (Vigouroux et al., 2001).  The same phenomena was seen in cell lines 
knocked down using siRNA for Lmn-1 in C.elegans (Liu et al., 2000). Small nuclei 
were formed in the presence of dominant negative lamin mutants in Xenopus eggs 
extract (Spann et al., 1997). Many experiments have revealed the role of lamins in 
resisting deformation of the nuclear envelope, green fluorescent protein (GFP)-
lamin was used to look for lamina assembly properties of living cells. The 
experiment showed that the original shape of the NE was quickly restored (Broers 
et al., 1997; Moir et al., 2000b). In fact the presence of lamins helps the nucleus to 
take its shape, size and the strength of the nuclear envelope (Hutchison, 2002).  
 
One of the important functions of the lamina is anchoring the nuclear envelope’s 
elements to the right position. B-type lamin was confirmed to interact to nuclear-
pore protein nucleoprotein 153 (Nup153): when lamina assembly is prevented in 
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Xenopus egg extract using a dominant negative lamin mutant, Nup153 did not 
incorporate into NPCs (Smythe et al., 2000). 
 
 
1.1.3.5.6  Cytoskeleton organization. 
 
Growing evidence demonstrate the links between the lamina and the cytoskeleton. 
These links were through the interaction of nuclear lamins with proteins located at 
the INM and ONM to join the lamina with the cytoskeleton (Broers et al., 2006). 
 
A complex of proteins was found at the INM and ONM. Three SUN domain 
proteins called UNC-83, UNC-84 and SUN1 were found located at the INM and 
ONM in C. elegans (Starr et al., 2001; Lee et al., 2002; Malone et al., 2003). A 
putative interactions between UNC-84 and SUN1 to lamin A were found, this 
demonstrates the localization of both of them at the INM. Two additional protein 
ZYG-12 and ANC-1 are anchored to the ONM by SUN1 and UNC-84 respectively 
(Malone et al., 1999; Starr and Han, 2002). ZYG-12 is a microtubule binding 
protein. ANC-1 is a homolog of nesprin-1 which interacts with the actin 
cytoskeleton. These findings emphasise that the tethering of UNC-84 and SUN1 by 
lamins will maintain two independent protein complexes at the ONM which interact 
with microtubules and the microtubule organization center (MTOC).  
 
Further studies were done on the mammalian cells which concluded that a family 
of proteins homologous to ANC-1 termed nesprin-1 and 2 are localized at the NE 
(Mislow et al., 2002; Libotte et al., 2005; Zhang et al., 2005). It was found that 
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nesprin-1 interacts with emerin and lamin A in vitro (Mislow et al., 2002). Nesprin-1 
interaction to actin bundling protein was also found in vivo and in vitro 
(Padmakumar et al., 2004). Several studies also showed the interaction of nesprin-
2 to lamin A/C and emerin. These studies suggested that a complex of nesprin-2 
and lamin A/C is necessary for anchoring emerin to the INM, whereas dominant 
mutants of nesprin-2 showed mislocalization of emerin to the ER (Libotte et al., 
2005). However, different studies showed that A-type lamins are not involved in 
anchoring nesprin-1 or 2 into the NE. These studies showed SUN1 interacts to 
nesprin-1 and 2. Moreover, small interfering (si)RNA knockdown of SUN1 leads to 
mislocalization of nesprin-2 (Padmakumar et al., 2005). The third member of 
nesprin family nesprin-3 was identified. It’s interaction to lamin A was confirmed. It 
has also been reported to interact to IFs (Wilhelmsen et al., 2005). These finding 
may implicate A-type lamin in maintaining three independent protein complexes at 
ONM by interconnecting the microtubules, MTOC or actin and IFs to NE. 
 
A study showed that lack of A-type lamin disrupts a macromolecular complex that 
spans the nuclear envelop and connects the nucleoskeleton to cytoskeleton (Crisp 
et al., 2006). A recent study showed that lamin A/C deficiency induced significant 
separations of the MTOC from the nuclear envelope. In addition, the elasticity and 
viscosity of the cytoplasm in Lmna-/- cells were reduced; the same results were 
found when either actin filaments or microtubule networks were disassembled in 
wild-type cells. Investigators implicated the mechanical properties of cytoskeleton 
and cytoskeleton-based processes, including cell motility, coupled MTOC and 
nuclear dynamics, and cell polarization depend on the integrity of the nuclear 
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lamina which may explain the connection between the nucleus and cytoskeleton 
(Lee et al., 2007). 
 
One more study implicated B-type lamins in nuclear dynamics and in anchoring the 
nucleus to the cytoskeleton. By using time-lapse video-microscope, investigators 
were able to show the nuclear rotation in laminB1-/- cells verses wild-type fibroblast. 
The rotation involved the nuclear interior as well as the nuclear envelope. This 
rotation was eliminated by expressing lamin B1 in the cell (Ji et al., 2007).  
 
Figure 1.6: Regions in A-type lamins to which partners bind (Zastrow et al., 2004). 
Regions in lamins A andC to which partners bind. Thestructural domains (head, rod,tail) of prelamin A are 
shown.Exons 1-12 encoding residues 1-664 are numbered; the last residue encoded by each exon (except 
exon 11) is given above. The Ig-fold domain, which includes exons 8 and 9, is shaded gray. Residues 1-566 of 
lamin A and lamin C are identical. Unique lamin C tail residues 567-572 are produced by alternative mRNA 
splicing; thus the extreme C-terminal regions of lamins A and C may have distinct binding properties. The 
zigzag represents the farnesyl moiety on prelamin A; the farnesylated C-terminal peptide is normally removed 
by proteolytic cleavage after residue 646 (bold; dotted line) togenerate mature lamin A. Colored bars indicate 
the region(s) in lamins A and C required for each named partner to bind, as detailed in Table 1 (e.g. actin can 
bind two different regions in the tail). For partners with question marks, the binding region in lamin A/C is 
unmapped. Based on current incomplete knowledge, interactions were loosely color-coded (top to bottom) as 
blue (architectural), orange (chromatin), yellow (gene regulation), pink (signaling) and green (unknown). 
Some partners (e.g. BAF) will continue to defy categorization until more is known about their functions. 
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1.1.4 Lamin A Binding Partners. 
 
To understand more about the function of the lamina we need to know more about 
the proteins that binding to lamins. Some studies showed A-type lamins bind to 
other proteins, some of them showed in two-hybrid assays and in vitro, but in vivo 
significances remain untested.  
 
These proteins were classified into four groups; some of these proteins are linked 
in different function. Architectural partners are LAP1, Nesprin 1α, LAP2α, Actin and 
Lamin B. Chromatin partners are Histone, and BAF. Gene regulatory partners are 
BAF, SREBP1a, SREBP1c, MOK2, LAP2α and Retinoblastoma (Rb). Signaling 
partners are E1B 19K, 12(S)-lipoxygenase and PKCα. Some of them have 
unknown function like NARF (Figure 1.6) (Zastrow et al., 2004).  
 
A recent proteomics analysis suggests that as many as eighty transmembrane 
proteins are localized to the INM in interphase cells (Schirmer et al., 2003). Only a 
few of these proteins have been characterized in detail as interaction with nuclear 
lamina (Figure 1.1) (Broers et al., 2006).   
 
It was suggested that BAF may be function as a modulator of cell proliferation by 
influencing S-phase progression. Because, many nuclear proteins do not exist in 
unicellular eukaryotics but they do in multicellular metazoan including C. elegans. It 
was thought that in multicellular organisms, BAF through it’s interaction with 
nuclear envelope proteins may regulate DNA synthesis and/or cell proliferation in 
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particular cells to produce specific type of tissues and organs (Haraguchi et al., 
2007). 
 
 
1.1.4.1 Lamina-associated polypeptide 2 (LAP2). 
 
LAP2 (also called thymopoietein) is a family of alternatively spliced proteins 
derived from a single gene. Three isoforms (lap2-α,β,γ) have been identified in 
humans at the protein and mRNA level (Harris et al., 1994). Seven isoforms (lap2-
α,β,β’,γ,δ,ε,ζ) were identified in mouse (Berger et al., 1996). 
 
  
1.1.4.1.1 LAP2 isoforms structure. 
 
LAP2β is a type II NET containing a N-terminal nucleoplasmic domain, a single 
transmembrane region, C-terminal domain located in the luminal space between 
INM and ONM (Dechat et al., 2000) and N-terminal domain sharing a common 
structure motif of an 40 aa which is found in all LAP2, Emerin, and MANI proteins 
and called (LEM domain) (Lin et al., 2000). LAP2-γ,δ and ε are slightly shorter than 
LAP2β, but they are very closely related in structure. They only lack a short region 
of 109, 72, and 40 amino acids respectively. LAP2ζ and LAP2α don’t contain a 
potential transmembrane region. LAP2ζ represent the first 219 N-terminal residues 
of LAP2β and five additional C-terminal amino acids.  LAP2α is different in the 
structural and function compared with other LAP2 isoforms. It shares only 187 
amino acids at the N-terminal, but contains a unique C-terminal of 506 amino acids 
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(Foisner, 2003). The following figure shows the different LAP2 isoforms and  how 
they attached to the INM (Dechat et al., 2000) (Figure 1.7).  LAP2 α and β have 
been shown to be resistant to NE treatment with Triton X100 and high salt 
suggesting that they make a very tightly complex associated with the Lamina 
(Dechat et al., 1998).    
 
 
Figure 1.7: This figure shows us the matching between different LAP-2 isoforms and their structures 
(Dechat et al., 2000). 
  
 
1.1.4.1.2 LAP-2 α and β function. 
 
Studies have shown that LAP2α assembles around chromosomes earlier than 
LAP2β, suggesting that it is the first protein among the NE/nucleoskeleton 
components to associate with chromosomes during NE assembly (Foisner, 2003).  
 
The unique C-terminus of LAP2α may add a specific function as a non-membrane 
protein associated with the nucleoskeleton and may help to organize higher order 
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chromatin structure by interacting with Lamin A/C (Dechat et al., 2000) . LAP2α is 
one of the binding partners of Lamin A/C, which also bind strongly to pocket C and 
weakly to pocket B of retinoblastoma protein (Rb) (Markiewicz et al., 2002). Four 
possibilities were suggested to explain how Lamin A/C-LAP2α complexes regulate 
Rb (Dorner et al., 2006): first,  LAP2α may regulate Rb phosphorylation by 
preferential binding to Rb phosphorylated on serine 780 which is the first serine to 
be targeted during the G1-S phase. The interaction of lamin A/C-LAP2α with Rb 
may delay the phosphorylation of Rb and leads to stop Rb function. Second, Lamin 
A/C-LAP2α may recruit regulatory proteins to the Rb complex. Third, Lamin A/C-
LAP2α may recruit Rb-E2F complexes to subnuclear compartment or chromatin 
regions. Fourth, the interaction of Lamin A/C-LAP2α complexes with Rb may 
stabilize the Rb protein. In Lmna-/- fibroblasts Rb protein was destabilized by 
proteasomal degradation (Johnson et al., 2004). The function of LAP2α in cell 
cycle progression and differentiation was studied. A decrease in expression of 
LAP2α negatively affects growth arrest response of fibroblast to serum starvation. 
Increased LAP2α expression delays the transition from G1 to S phase. This 
function of LAP2α in the cell cycle requires Rb and involves regulation of the 
activity of E2F transcription factors (Dorner et al., 2006). When LAP2α was 
immunoprecipitated from nuclear fractions, lamins A/C and hypophosphorylated Rb 
were co-precipitated efficiently (Markiewicz et al., 2002). This study confirmed the 
importance of Lamin A/C-LAP2α complexes to anchor Rb protein to the nucleus.  
 
Other studies showed that entry of HDFs into G0 is correlated with low expression 
of LAP2α. HDFs Lamin A/C null cells result in LAP2α aggregates, which is 
correlated with cell cycle arrest (Pekovic et al., 2007). However, embryonic 
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fibroblast from a lmna-/- mouse (MEFs) display a rapid growth phenotype (Johnson 
et al., 2004).  One author justified the difference in LAP2α function. HDFs are able 
to respond to stimuli by inducing a checkpoint arrest, while this checkpoint in cell 
lines like MEFs or transformed cell lines does not exist (Pekovic et al., 2007). 
 
LAP2β has the ability to bind to Lamin B via specific Lamin B binding domain 
(Furukawa and Kondo, 1998). LEM domain was found to bind not only to lamins 
but to BAF as well (Segura-Totten and Wilson, 2004; Gruenbaum et al., 2005). The 
interaction of HA95 with LAP2β was reported via two distinct domains. This 
association was implicated in regulating the initiation phase of DNA replicating after 
the association was disrupted (Martins et al., 2003). There was also found to be a 
strong interaction between LAP2β and the transcriptional repressors germ cell less 
(GCL) (Nili et al., 2001), and histone deacetylase 3 (HDAC3) resulting in the latter 
case in deacetylation of histone 4 (Somech et al., 2005b). One study has been 
shown that under certain unknown physiological conditions, NE proteins such as 
LAP2β and LBR are involved in the modification of the chromatin in order to induce 
gene silencing. To understand how this is happened, investigators have suggested 
that two complexes are formed and anchored at NE. One complex is LAP2β 
recruits the enzyme (HDAC3) while the other complex is LBR recruits the 
substrates (histone H3/H4) (Shaklai et al., 2007).  
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1.1.4.2 MAN1 and Lamins. 
 
MAN1 is one of INM proteins with two transmembrane spanning domains and N- 
and C- terminal nucleoplasmic domains. It share a ~40 amino acids residue 
conserved domain with LAP2 and emerin termed a LEM domain (Lin et al., 2000). 
Beside the interaction between MAN1 and lamin A, it was shown that MAN1 
interacted with certain transcription factors. Recent studies show the interaction 
between Smad4 transcription factor and MAN1 (Bengtsson, 2007; Cohen et al., 
2007). It was shown that MANI functions as an antagonist to transforming growth 
factor-β (TGFβ) and bone morphgenic protein (BMP). Smads4 are crucial 
regulators of TGFβ and BMP. Activation of TGFβ and BMP lead to phosphorylation 
to receptor-mediated R-smads which will be oligomerized with Smads4, 
subsequently translocated to the nucleus where they bind to DNA and regulate 
transcription (Bengtsson, 2007). It was thought that MAN1 acts as a nuclear 
scavenger, sequestering R-smads that illegitimated enter the nucleus (Heessen 
and Fornerod, 2007). It also interacts with several transcription factors including 
GCL, the BCL2-associated transcription factor (BTF) and BAF, although the 
function of these interactions are not yet understood (Heessen and Fornerod, 
2007). 
 
    
1.1.4.3 Emerin and Lamins. 
 
Emerin is a type II integral membrane protein of the inner nuclear membrane 
(INM). It is a 254-residue (34 kda) protein encoded by the EMD gene located on 
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the human X-chromosome (Yorifuji et al., 1997; Gruenbaum et al., 2005). It 
contains an ~40-residue motif at N-terminus termed the LEM domain (Lin et al., 
2000), which is homologous to LAP2 and MAN1 proteins. Second homology 
between emerin and LAP2β have been reported at the transmembrane domain 
(Foisner and Gerace, 1993). It has also been found that emerin has 2 functional 
domains, LEM and the central domains. These let investigators suggest that 
emerin may have additional functional domains which bind to different partners 
related to diseases (Lee et al., 2001). The interaction of emerin to lamin A by the 
central domain of emerin and to lamin B was confirmed (Fairley et al., 1999; 
Clements et al., 2000). The interaction of emerin to barrier autointegration factor 
(BAF) by the LEM domain has also been confirmed (Lee et al., 2001). It was also 
found that the interaction of emerin to cytoskeleton organization through direct 
binding to α and β actin or indirect binding through its association with nesprin 1 
and 2 (Mislow et al., 2002; Lattanzi et al., 2003; Libotte et al., 2005). Emerin 
through its interaction to β-catenin was implicated in preventing nuclear 
accumulation of β-catenin which leads to inhibit its transcriptional activity 
(Markiewicz et al., 2006). The localization of emerin at the INM is critical for its 
function, since a mutation that inhibits emerin to reach its position at nuclear rim 
causes disease (Fairley et al., 1999). The known disease caused by mutations in 
EMD is the X-linked form of EDMD (X-Linked EDMD) (Gruenbaum et al., 2005).  
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1.2 Mitochondria. 
 
Mitochondria are central organelles in the cell that have a critical function, 
producing cellular energy ATP and acting as signaling organelles. Mitochondria are 
the same size as an E. coli bacterium, which is 1-2um in length and 0.1-0.5um 
width. Mitochondria occupy up to 25% of the volume of the cytoplasm. The main 
function of mitochondria is producing energy (ATP) via aerobic metabolism that will 
be utilized for cell activity (Figure 1.8).  
 
Division of mitochondria in the cell is not coupled to the division of the cell. 
Mitochondria grow by the incorporation of proteins and lipid that are localized in the 
mitochondrial membranes. It increases in size, then one or more daughters pinch 
off in a similar to the way to bacterial cell growth and division (van der Bliek, 2000).  
 
 
Figure 1.8: A three dimension diagram of mitochondria [From Lodih H. Molecular Cell Biology, 4th 
edition, p. 622]. 
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1.2.1 Mitochondrial structure. 
 
Mitochondria are unique in their double genetic origin; proteins are encoded via 
nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). They contain two 
membranes mitochondrial outer membrane (MOM) and mitochondrial inner 
membrane (MIM), which are separated by an intermembrane space. Inside the 
MIM there is the matrix (Figure 1.8). 
 
The MOM is composed of about half lipid and half protein which let molecules 
move across easily. It contains mitochondrial porin a transmembrane channel 
protein that allows molecules to pass through if it has a molecular weight less than 
10 kDa. 
 
The MIM is composed of about 20 percent lipid and 80 percent proteins and is 
much less permeable than the outer membrane. The surface area of the MIM 
increases by infoldings (cristae). In the MIM there are  the proteins of mitochondrial 
respiratory chain (MRC), transport proteins important in importing or exporting 
molecules like ADP, P, Fatty acid, and pyruvate or a shuttle protein that transports 
electrons from the cytosol to matrix to reduce NAD+ to NADH and FAD to FADH2 
(Figure 1.9). 
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Figure 1.9: ATP generation. Electrons donated from NADH and FADH2 through (ETC) of 
complex I and II respectively. Then the electrons pass from complex I, II, III to cytochrome c which 
will move to complex IV. Associate to transfer electrons the protons will across the inner membrane 
through complex I, III and IV which will create an intermembrane potential ∆ψ. The gradient of 
protons dissipate by reenter of protons to the matrix through complex V (Madamanchi and Runge, 
2007). 
 
 
1.2.2 Mitochondrial genome and the genetic code. 
 
The matrix is the place where the mitochondrial genome is located and the proteins 
are encoded. Each mitochondrion contains 5 to 10 copies of mtDNA. Thus the total 
amount of mtDNA is depend on the number of mitochondria in the cell, the number 
of mtDNA and the size of mtDNA per mitochondria (Wallace, 1999). 
 
Human mtDNA is a circular molecule that contain 16,569 base pairs which is self 
replicating and present in multiple copies in the mitochondrial matrix (Madamanchi 
and Runge, 2007) (Figure 1.10). The mitochondrial genome has been fully 
sequenced. In-side this genome there are thirteen sequences that start with ATG 
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(methionine) codon and end with stop codon. They are long enough to encode a 
molecule of polypeptide more than fifty amino acids. MtDNA lack introns and long 
non-coding sequences. Unlike the nuclear genome, mtDNA is continuously 
replicated, independently of the cell cycle (Bogenhagen and Clayton, 1977). The 
only polymerase that is required for mtDNA replication in human is poly-γ (Kaguni, 
2004). poly-γ 195 kDa heterotrimer compose of catalytic subunit (p140, coded by 
POLG on chromosome 15q25), and two identical accessory subunit (p55, coded by 
POLG2 on chromosome 17q) (Longley et al., 1998).  
 
 
 
 
Figure 1.10: Human Mt.DNA encodes 37 genes (13 polypeptides, 22 tRNAs, and 2 rRNAs). 
Each mitochondrial contains of several circular DNA bound to the inner membrane at the matrix 
side. The 13 proteins that encode of Mt.DNA are involve in different subunit of mitochondria 
respiratory chain complex as follow: 7 polypeptides of 43 subunit of complex 1 (NADH 
dehydrogenase), 1 of 11 subunits of complex III, 3 of 13 subunits of complex IV, and 2 of 16 
subunits of complex V(Madamanchi and Runge, 2007). 
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1.2.3 Synthesis and targeting protein to mitochondria. 
 
The majority of mitochondrial proteins are encoded by the nuclear genome (nDNA) 
and transported into mitochondria. MtDNA encode; thirteen essential subunits of 
mitochondrial respiratory chain (MRC), two ribosomal RNA (rRNAs), and twenty 
two transfer RNA (tRNAs). MtDNA transcribe and translate within mitochondria 
(Attardi and Schatz, 1988). 
 
As far as is known, mitochondria have their own transcription-translation 
machinery. All RNA transcripts of mtDNA and their translated products remain in 
the mitochondria. All of mitochondria proteins that are encoded by mtDNA are 
synthesized on mitochondrial rRNA, and all of tRNA used for protein synthesis in 
mitochondria are encoded from mtDNA. However, the genetic codes that are used 
in mtDNA are different from nDNA. UGA is used as a stop codon in the nDNA but 
is read as tryptophan in the mtDNA. AGA and AGG are codons for arginine in 
nDNA but they are stop codons in mtDNA (Fox, 1979). 
   
Mitochondrial proteins that are encoded by the nuclear genome are translated in 
the cytosol and transferred to mitochondria. These proteins should contain a 
specific sequence at the N-terminus called the mitochondrial targeting sequence 
(MTS). By using gene engineering techniques, the MTS of alcohol dehydrogenase 
was fused to the N-terminal of such protein that usually localize in the cytosol like 
dihydrofolate reductase which then re-localized in mitochondria. Mutation in the 
MTS of these proteins stopped their localization into the matrix and increased their 
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accumulation in the cytosol (Rassow et al., 1990), which illustrated the importance 
of MTS to import these proteins into mitochondria (Figure 1.11). 
  
 
Figure 1.11: Uptake targeting sequences of imported mitochondrial proteins. All proteins encoded by 
cytosolic machinery and transfer into mitochondria has a unique precursor allow them to import and 
localized in specific area of the mitochondria [From Lodish H. Molecular Cell Biology, 4th edition, p. 622]. 
  
 
Two mechanisms are involved in importing proteins into mitochondria. These 
mechanisms involve two cytoplasmic chaperones which are cytosolic Hsc70 (Fan 
et al., 2006) and mitochondrial-import stimulation factor (MSF) (Komiya et al., 
1997). The proteins that synthesize in the cytosol and transfer into mitochondria 
need to bind to a specific receptor on the MOM. These receptor proteins are able 
to recognize MTS at the N-terminus of the protein that should be moved into 
mitochondria.  
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The main function of chaperones is to prevent the targeted proteins from 
aggregation and is to bind them to one of the receptor that found on the MOM 
(MOM-R). These receptors will recognize the MTS domain on the targeted 
proteins. This process needs ATP to be complete (Figure 1.12).  
 
So, after the proteins are synthesized, they will bind to one of the chaperone 
proteins. The protein that binds to MSF travels and binds to a set of MOM-R called 
Tom70/Tom37. Then, this protein releases from MSF and binds to a second set of 
MOM-R called Tom20/Tom22. The protein that binds to cytosolic Hsc70 travels 
directly to MOM and binds to Tom20/Tom22. After this protein is bound to 
Tom20/Tom22, it was suggested that this receptor has a mechanism to pass this 
protein through the channel at the MOM that called Tom40. These channels are 
1.5 to 2.5 nm wide that allow non-aggregated proteins to pass through to the 
intermediate space. If the protein is to be located in the matrix, it needs to proceed 
through an additional channel located on MIM that is composed of different trans-
membrane proteins called Tim44, Tim23 and Tim17 (Figure 1.12) (Komiya et al., 
1997; Fan et al., 2006).  
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Figure 1.12: The pathway of protein import into mitochondrial matrix. Such protein encoded in 
cytoplasim bind to a specific carrier, that bind to the target sequences of that protein or to the whole protein 
sequences which need energy to keep them on the such receptors on the mitochondrial outer membrane. 
[From Lodish H. Molecular Cell Biology, 4th edition, p. 622]. 
 
 
As far it was known, the imported protein must fold back once it has reached its 
final location. This procedure must be in the right manner to maturate/activate the 
target protein. Once the protein has entered the matrix, it binds to one of 
mitochondrial chaperone proteins like Matrix Hsc70 (mhsc 70) which locates close 
to the MIM channel. This step is to prevent protein aggregation or incorrect 
association within or between polypeptide chains during protein folding process. 
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Accumulated studies showed that different proteins use different strategies for 
folding in the matrix. Most of these proteins are folded without assistance, while 
some proteins need the assistance of matrix chaperones like Hsc60 (Figure 1.13) 
(Rospert et al., 1996).  
 
 
   
Figure 1-13: Model for folding pathway for some of imported protein to matrix, rhodanacse (Rospert et 
al., 1996).   
 
 
1.2.4 The mitochondrial functions. 
 
The main function of mitochondria is to produce ATP that will be used for the cell’s 
mechanisms. Mitochondria are also implicated in cell signaling, inherited diseases, 
apoptosis and cancer. 
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1.2.4.1 Mitochondrial function in health. 
 
Biologists noticed that mitochondrial morphology may change during their functions 
in health and disease. Increases in matrix volume are reported during ATP 
production (Halestrap, 1989; Lim et al., 2002), ROS production (Garlid et al., 
2003), and apoptosis (Holmuhamedov et al., 1998; Gogvadze et al., 2004). The 
fabulous functions of mitochondria balance between the utilization and/or releasing 
of NO, H2O2, O-2 through ATP generation and redox system. This function 
responds to the needs of cell for proliferation, differentiation and apoptosis 
pathways in health and diseases (Huang et al., 2000; Wang et al., 2000). 
 
 
1.2.4.1.1 ATP generation: 
 
The most important function of mitochondria is ATP generation. The MIM and the 
matrix are the main part of mitochondria where most of the ATP producing 
reactions take place. The MIM with so many infoldings provide sufficient surface 
area for the reaction of MRC to occur.  
 
The main fuels for ATP synthesis are fatty acids and glucose. 36 ATP molecules 
result from the complete aerobic degradation of glucose to CO2 and H2O. The 
glucose degradation process goes through two stages, the initial stage occurs in 
the cytosol (glycolysis). The terminal stages including oxidation and 
phosphorylation occur inside the mitochondrial matrix and cristae. 
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After, the glucose and fatty acid move across the cell membrane, the initial part of 
ATP generation will start. Inside the cytosol glycolysis of glucose starts to produce 
a little amount of ATP and converts one molecule of glucose to two molecules of 
pyruvate. A set of 10 enzyme reactions are involved in the glycolysis pathway. 
During this reaction the cell will lose two molecules of ATP and gain four molecules 
which will gain in the end two molecules of ATP and pyruvate.  
 
The pyruvates need to react with coenzyme A (CoA) in order to be transport from 
the cytosol across the mitochondrial membranes to the matrix. This reaction 
produces CO2 and intermediate acetyl CoA, and is catalyzed by pyruvate 
dehydrogenase. This reaction is highly exogenic and irreversable. Pyruvate 
dehydrogenase is located in the mitochondrial matrix, and is composed of three 
different proteins that form a complex of multi-enzyme.  
 
Acetyl CoA is generated from pyruvate and is important in the oxidation of fatty 
acids and many amino acids. It is important in numerous biosynthetic reactions, 
such as transfer of acetyl groups to lysine residues in histone proteins and to the 
N-termini of other proteins.  
 
The oxidation of acetyl CoA through the citric acid cycle or krebs cycle will produce 
CO2, and the coenzymes (NADH, FADH2). Electrons are donated from NADH and 
FADH2 to oxygen through an electrons transport chain (ETC) consisting of 
complexe I (NADH dehydrogenase), II (succinate_ubiquinone oxidase) of MRC. 
The electrons then pass on to ubiquinol via coenzyme Q. The electrons pass to 
complex III (ubiquinol_cytochrome oxidoreductase), which in turn to cytochrom c. 
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Then move to complex IV (cytochrom c oxidase ‘COX’). The movements of 
electrons will be associated with pumping of protons across MIM which will create 
a mitochondrial membrane potential ∆ψ. Then the protons will influx back into the 
matrix through complex V of MRC (complex F0-F1) where the ATP will be 
produced by adding a phosphate group to ADP (Madamanchi and Runge, 2007) 
(Figure 1.9). ATP is then exchanged with cytosolic ADP through adenine 
nucleotide translocase (ANT).  
 
 
1.2.4.1.2 Nitric oxide productions. 
 
Nitric oxide (NO) is a free radical which functions as an intracellular and an 
intercellular messenger in regulating cell O2 uptake and ATP production. 
Mitochondria were implicated in producing NO from arginine, NADH and O2 by 
nitric oxide synthase (NOS)  (Alderton et al., 2001).  
 
Recently, different investigations showed that different isoforms of NOS are 
expressed in different tissue. In rat four isoforms of NOS were found. These 
isoforms were classified according to the tissue-type [neuronal (NOS I or nNOS0, 
inducible (NOS II), endothelial (NOS III) and mitochondrial (mNOS)] (Ghafourifar 
and Richter, 1997; Giulivi et al., 1998). It was found that mNOS is nNOS 
translocated into mitochondria. mNOS bind to mitochondrial PDZ domain of COX 
(Persichini et al., 2005; Franco et al., 2006). NOS I and III are constitutively 
expressed (Lamas et al., 1992; Christopherson and Bredt, 1997). However, NOS II 
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expression is regulated by inflammatory stimuli like TNFα, IFNγ, and LPS (Taylor 
and Geller, 2000).  
 
NO has been implicated in mitochondrial activities. Prolonged NO affects 
mitochondrial functions which may explain the link between NO, ROS and ATP 
production (Huang et al., 2000). NO via high affinity binding to COX has a critical 
role on MRC activity, (Boveris et al., 1999). NO binds to Cu2+ B center of COX 
leading to inhibited electron transfer to O2 and reduces mitochondrial O2 uptakes. 
Different studies showed the effect of NO on MRC, in rat heart, skeletal muscle, 
liver and synaptosome mitochondria (Cleeter et al., 1994; Brown, 1995; Poderoso 
et al., 1996; Boveris et al., 1999). Different studies showed the implication of NO in 
cell processes. It was reported that the utilization of NO is associated with 
production of H2O2 and superoxide (Poderoso et al., 1996; Cadenas et al., 2000). 
In a different approach, high expression of mNOS was implicated in releasing 
cytochrome c from mitochondria to the cytoplasm and initiating apoptosis 
(Ghafourifar and Richter, 1999). The modulations in the NO concentration in 
mitochondria were linked to modulations in H2O2 and superoxide. At low NO 
concentrations the inhibition of COX will be low which increase O2 consumption 
and ATP generation which will reduce superoxide and H2O2. Otherwise, at high 
concentrations of NO there is a block of COX consequently there is a block of 
complexes I, II, and III, which will lead to increase in superoxide and H2O2  
(Carreras and Poderoso, 2007).       
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1.2.4.1.3 Mitochondria and Reactive Oxygen Species productions.  
 
Reactive Oxygen Species (ROS) are a wide range of molecules that have 
important signaling functions. Free radicals are chemical species composed of one 
or more unpaired electrons. Hydrogen atoms have one unpaired electron while 
most metal ions, nitric oxide, and oxygen have two unpaired electrons (Halliwell, 
1991). The unpaired electrons in the oxygen molecule react to make partially 
reduced highly reactive species that are classified as ROS including, superoxide 
O2-, hydrogen peroxide (H2O2), hydroxyl radical, and peroxynitrite (Fruehauf and 
Meyskens, 2007). The system of various enzymes including, mitochondrial 
transport chains, cytochrome P450, lipoxygenase, cyclogenase, the NADH oxidase 
complex, xanthine oxidase, and peroxisoms are involved in production of ROS 
from free radicals (Inoue et al., 2003).  
 
Over a decade, investigators have sought to understand how and why ROS is 
produced in cells. Scientists in this field elucidated two factors that cause ROS 
production which are: 1) when mitochondria do not produce ATP, this correlates 
with a high proton motive force (∆P) and a reduced coenzyme Q (CoQ) pool, 2) 
when there becomes a high NADH/NAD+ ratio. But, in the normal mitochondria 
that are producing ATP the ROS level will be low, low proton motive force (∆P) and 
normal NADH/NAD+ ratio (Murphy, 2009). 
 
ROS was involved in several cell processes including redox system, apoptosis and 
mitochondria dysfunctions which will be explained below (Figure 1.14) (Murphy, 
2009). 
47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Overview of mitochondrial ROS production 
ROS production by mitochondria can lead to oxidative damage to mitochondrial proteins, membranes and 
DNA, impairing the ability of mitochondria to synthesize ATP and to carry out their wide range of metabolic 
functions, including the tricarboxylic acid cycle, fatty acid oxidation, the urea cycle, amino acid metabolism, 
haem synthesis and FeS centre assembly that are central to the normal operation of most cells. Mitochondrial 
oxidative damage can also increase the tendency of mitochondria to release intermembrane space proteins 
such as cytochrome c (cyt c ) to the cytosol by mitochondrial outer membrane permeabilization (MOMP) and 
thereby activate the cell’s apoptotic machinery. In addition, mitochondrial ROS production leads to induction 
of the mitochondrial permeability transition pore (PTP), which renders the inner membrane permeable to 
small molecules in situations such as ischaemia/reperfusion injury. Consequently, it is unsurprising that 
mitochondrial oxidative damage contributes to a wide range of pathologies. In addition, mitochondrial ROS 
may act as a modulatable redox signal, reversibly affecting the activity of a range of functions in the 
mitochondria, cytosol and nucleus (Murphy, 2009).  
 
 
 
 
 
48 
 
1.2.4.1.4 Mitochondria and Redox balance system. 
 
Redox process is the balance between oxidization and reduction reactions within 
the cell that takes place mainly inside mitochondria. It was found that redox has an 
important role in the regulation of cell signaling, including kinase and phosphatase 
activity and gene expression (Sen, 2000; Thannickal and Fanburg, 2000; Biswas et 
al., 2006).  
 
Redox balance is maintained via various enzymes (superoxide dismutase (SOD) 
glutathione peroxidase and glutathione reductase). Two different SODs were found 
in mitochondria. Manganese form (Mn-SOD) which is localized in the mitochondrial 
matrix or copper zinc form (Cu,Zn-SOD) which is localized in the mitochondrial 
intermembrane space.  
 
SOD converts superoxide to hydrogen peroxide then to water via catalyses 
glutathione peroxidase coupled with glutathione reductase. There are varieties of 
scavengers including glutaredoxin, and thioredoxin coupled to thioredoxin 
reductase that use glutathione (GSH) as a substrate. GSH has a main role in  
maintaining redox homeostasis (Schafer and Buettner, 2001). 
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1.2.4.1.5 Mitochondria and Cell death pathways (Necrosis and 
Apoptosis). 
 
Mitochondria play very important roles in cell death pathways. A balance between 
cell death and cell proliferation is essential for the development and maintenance 
of multicellular organisms.  
  
Cell death divides into two main pathways namely apoptosis and necrosis. 
Necrosis occurs in response to infection while apoptosis occurs in normal tissue. 
Both pathways of cell death involve mitochondria (Fink and Cookson, 2005).  
 
Necrosis is the un-controlled cell death program that leads to cellular break-up and 
irreversible damage. Necrosis results in the release of inflammatory cytokines such 
as TNF-α, giving rise to subsequent tissue damage.  
 
Apoptosis is a controlled programmed cell death which occurs via signalling 
pathways that at certain steps is a reversible process (Fadeel and Orrenius, 2005). 
Apoptosis is important in physiological process throughout cell life, development 
and maintenance of multi-cellular organism. Two major initiating pathways trigger 
apoptosis, inner / intrinsic / mitochondrial and outer / extrinsic / mitochondrial 
pathways (Petak and Houghton, 2001; Green and Kroemer, 2004; Thorburn, 
2004). Defects in apoptosis are linked to dysfunction of mitochondria. Defects in 
apoptosis may cause various diseases, such as tumors, autoimmune and 
neurodegenerative disorders. 
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The factors that initiate the intrinsic pathway include chemical and physical injuries 
(e.g. UV radiation, heat shock, osmotic shock, hypoxia), over expression of 
oncogenes and tumor suppressor genes (e.g. c-Myc, c-Fos, p53, PTEN), DNA 
damage, cytoskeleton structure disruption, growth factor / cytokine deprivation and 
accumulation of misfolded proteins (Klener et al., 2006). All of the above lead to 
mitochondrial outer membrane permeablization (MOMP) and increased production 
of ROS, resulting in release of cytochrome c and other pro-apoptotic molecules 
such as AIF (apoptosis-inducing factor), Smac/DIABLO (second mitochondria-
derived activator of caspase/direct IAP-binding protein) and endunuclease G to the 
cytoplasm (Susin et al., 1999; Du et al., 2000). In response to different stress 
stimuli at the mitochondria, a pro-apoptotic Bcl-2 members Bax/Bak form oligomers 
and react to MOM to make pores which increase MOM permeabilization. This 
permiblization will increase Cytochrome c accumulation in the cytoplasm which 
initiates the apoptotic pathway (Green and Kroemer, 2004). Studies showed that in 
response to specific stimulation, Ca2+ is released from the ER and accumulates in 
the mitochondria. This accumulation was associated with ROS production and 
opening of the mitochondrial permeablility transition (MPT) which was the cause of 
mitochondrial membrane dissipation, MOMP and releasing of pro-apoptotic 
molecules from mitochondria to cytoplasm (Brookes and Darley-Usmar, 2004). 
  
Outer / extrinsic / mitochondria-mediated pathway starts when one of TNF super-
family ligand binds to TNF receptor (TNF-R). This binding initiates the formation of 
a higher order complex at the intra cellular ligands of TNF-R. This formation helps 
the interaction of procaspase 8 with 10, that resulting in activation of caspase 3, 
Bid cleavage and Bax/Bak activation. Then Bax/Bak involved mitochondria by 
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causing MOM permeabilization and release of cytochrom c to the cytoplasm  to 
increase in the induction of caspase 3 (Chinnaiyan et al., 1996a; Chinnaiyan et al., 
1996b; Kischkel et al., 2001). 
 
 
1.2.4.2 Mitochondrial dysfunction. 
 
Organ systems such as brain, heart, liver etc that have high ATP demands are 
most likely to be affected by mitochondrial dysfunction. 
 
 
1.2.4.2.1 Reactive Oxygen Species and mitochondrial dysfunction.  
 
 
1.2.4.2.1.1 ROS and Atherosclerosis: 
 
Atherosclerosis is a vascular disease that causes death. The endothelium regulate 
the passage of macromolecules to tissue is a major target of oxidant stress (Faraci 
and Heistad, 1998). Most of the cell types including the endothelium are able to 
synthesize, store and release ROS in response to stimuli. Oxidant stress plays 
important role in the pathophysiology of several vascular diseases. MtDNA lacks 
protective histone and repair machinery found in the nuclear genome, which make 
It vulnerable for ROS damage (Clayton et al., 1974; Yakes and Van Houten, 1997; 
Souza-Pinto et al., 1999). Accumulation of oxidative damage to mitochondrial 
proteins lead to mitochondrial dysfunction that is associated with atherosclerosis 
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(Madamanchi and Runge, 2007). Accumulation of oxidant stress involves in: 1) 
interfering in nitric oxide (NO) function and endothelial relaxation; 2) increasing 
endothelial permeability and promoting leukocyte adhesion; 3) leading to alteration 
in endothelial signal transduction and blood flow (Lum and Roebuck, 2001).  
 
 
1.2.4.2.1.2 ROS and Dyslipidemia. 
 
Mitochondria play an important role in oxidizing Low Density Lipoproteins (oxLDL). 
OxLDL has been implicated in the induction of apoptosis in the endothelial layer of 
the effected vessel in the atherosclerotic patient (Hessler et al., 1979; Alcouffe et 
al., 1999). This process involves two special calcium-dependent pathways. One is 
mediated by activation of the cysteine protease calpain and release of tBid, a 
truncated form of Bcl2 family member Bid which will result to release of cytochrome 
c into the cytosol and induction/activation of caspase 3. The second pathway is 
mediated by activation of apoptotosis-inducing factor cytochrome c and AIF (Vindis 
et al., 2005).  
 
 
1.2.4.2.1.3 ROS and Hypertension. 
 
Mitochondria also play an important role in high blood pressure. Mitochondrial ATP 
deficiency leads to arterial hypertension (Postnov Iu, 2001) and it was also shown 
that a mutation in mitochondrial tRNA is associated with hypertension (Wilson et 
al., 2004). 
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1.2.4.2.1.4 ROS and Diabetes. 
 
Mitochondrial superoxide levels increase in diabetic patients from two different 
stimulators (Insulin-resistance or hyperglycemia). Insulin resistance is associated 
with type II diabetes (Bonora et al., 1998). Hyperglycemia was reported in diabetic 
patients (DeFronzo et al., 1989). Hyperglycemia was also associated in different 
diseases like vascular damage. It was found that hyperglycemia induces 
superoxide in mitochondria that causes cell apoptosis and cell damage (Nishikawa 
et al., 2000; Du et al., 2003). Increase in superoxide will activate PKC and 
advanced glycation end (AGE), which in turn activates  nuclear factor kB (NF kB) 
(Nishikawa et al., 2000). 
 
 
1.2.4.2.1.5 ROS and Aging. 
 
Mitochondrial oxidation is a major contributor to aging (Ames and Liu, 2004). 
Mitochondrial respiratory and ATP generation dysfunction, ROS production, 
mtDNA damage and accumulation of mutations in mtDNA are all linked to aging 
(Harman, 1972; Trounce et al., 1989; Cortopassi et al., 1992; Hsieh et al., 1994; 
Goodell and Cortopassi, 1998). Loss of mitochondria in the endothelial layer of 
cerebrovascular are also linked with aging because this leads to cerebral blood 
flow that cause cerebrovascular disfunction (Zhu et al., 2007).  
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1.2.4.2.1.6 ROS and Carcinogenesis. 
 
The most vulnerable target genome is mtDNA. ROS arising from mtDNA mutations 
are involved in carcinogenesis and malignant transformation (Singh, 2006; Valko et 
al., 2006). MtDNA alterations were suggested to be a main cause of cancer 
(Jeronimo et al., 2001; Kagan and Srivastava, 2005). MtDNA mutations are ten 
times higher than nuclear DNA in some cancers (Verma et al., 2003). ROS 
mediates DNA damage. For example, hydroxyl radicals react with pyrimidines, 
purines, and chromatin proteins which result in base modifications, genomic 
instability, and altered gene expression. The main sources of pathological forms of 
ROS are chronic inflammation secondary to infections or chronic irritants. Defects 
in NOS and mtNOS have also been reported during tumor formation (Galli et al., 
2003).  
 
Cancer cell has special cell death program called autophagy. Autophagy doesn’t 
require activation of caspases (Gozuacik and Kimchi, 2004). Cancer cell use 
autophagy to survive nutrient limitation and low oxygen environments and may 
help cancer cells from ionizing radiation by removing damaged elements (Paglin et 
al., 2001).  
 
Tumors can survive in hypoxic environments. Studies showed that HIF1 (Hypoxia-
inducible factor-1) act as a regulator of the hypoxic response (Jiang et al., 1996; 
Huang et al., 1998; Maxwell et al., 1999). HIF1 is a heterodimer comprising HIF-1α 
and HIF-1β. HIF1α and HIF-1β translocate to the nucleus to associate with other 
proteins to initiate the transcription of more than 70 genes. HIF-1α is constitutively 
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expressed, but under normal conditions has a very short half life <5 min. 
Hydroxylation of HIF-1α proline residues by prolal 4-hydoxulases (PHD) that use 2-
oxoglutarates and O2 as substrates, marking HIF-1α for rapid degradation by the 
proteasome (Schofield and Ratcliffe, 2004; Semenza, 2004). Recent evidence 
implicated various oxygen species like H2O2 in promoting HIF1α stabilization by 
inhibiting (PHD) activity and nitric oxide (Metzen et al., 2003; Bell et al., 2005; 
Wallace, 2005). Increased HIF1α half life was associated with transcription of 
target genes that were involved in maintaining cell growth in low oxygen 
environments (Semenza et al., 2006). In low oxygen environments mitochondrial 
superoxide accumulates and converts to H2O2 by Mn-SOD or Cu, Zn-SOD. Then, 
H2O2 effluxes into the cytosol that leads to inhibit PHD activity. This inhibition in 
PHD activity allows HIF1α to accumulate and dimerize with HIF1β and translocate 
into nucleus where it modulates the expression of target genes (Semenza et al., 
2006).  
 
 
1.2.4.2.2 Neurodegenerative disorder and mitochondrial dysfunction. 
 
1.2.4.2.2.1 Alzheimer’s disease. 
 
Alzheimer’s disease (AD) is one of the neurodegenerative disease of the central 
nervous system that results in dementia (Selkoe, 2001). Intracellular neurofibrillary 
tangles and extracellular senile plaques in the neocortex, hippocampus and other 
subcortical region in the brains are involved and essential for cognitive function 
(Mattson, 2004). 
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There is strong evidence showing increased levels of oxidative stress in AD (Zhu et 
al., 2005). It was reported that AD-samples have a decline in polyunsaturated fatty 
acid (Lovell et al., 1998) and increase in lipid peroxidase (Smith et al., 1996; Sayre 
et al., 1997). Protein, DNA and RNA oxidation was also linked to alzheimer’s 
diseases (Mecocci et al., 1994; Smith et al., 1995; Nunomura et al., 1999; 
Nunomura et al., 2004). Lower plasma antioxidant and alteration in the activity of 
antioxidant enzymes are associated at early stage of AD (Riviere et al., 1998; 
Bourdel-Marchasson et al., 2001).  
 
Amyloid β-peptide (Aβ) is not synthesized in neurons but is abundant in the 
endothelial layer of blood vessels which explain the link between the blood brain 
barrier (BBB) and the AD. Aβ interacts on endothelial cells to produce free 
superoxide radicals that lead to oxidation and lipid peroxidation (Thomas et al., 
1996). In AD patients, it was reported that Aβ released from the blood vessels 
accumulates in neurons causing mitochondrial dysfunction and neuronal apoptosis 
(Kawai et al., 1990; Alavi et al., 1998; Kalaria, 1999). Neuronal death in AD 
patients is associated with Aβ deposition that results in oxidative stress and 
apoptosis (Colurso et al., 2003). Deposition of Aβ, a 39-43 amino acid peptide 
derived by cleavage of the amyloid precursor protein (APP) is associated with 
plaque formation. Aβ fragment leads to inhibit the activity of cytochrome c oxidase, 
pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, electron transport via 
mitochondrial respiratory complexes, and elevate Ca2+. Aβ fragments in aqueous 
solution may also generate free radical peptides (Hensley et al., 1994). Different 
Aβ deposition molecules were used in vitro to establish the link between the 
depositions with different mitochondrial dysfunction phenomena. Aβ (25-35) and 
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Aβ (1-42) cause reduction in mitochondrial membrane potential (Abramov et al., 
2004). Aβ (1-42) via p53 cause release of cytochrome c which results in apoptosis 
in human neurons (Zhang et al., 2002). Whereas, Aβ (25-35) limits its affects in 
reduction in ATP generation via inhibition in complex I of mitochondrial respiratory 
complex (Casley et al., 2002). From these studies, it seems that increases in the 
level of Aβ is a major factor in AD, and has important roles in controlling apoptosis 
in neuronal cell (Takuma et al., 2005).  
 
  
1.2.4.2.2.2 Parkinson Disease (PD). 
 
PD is an age-related chronic neurodegenerative disorder characterized by 
progressive resting tremor, rigidity, bradykinesia, gait disturbance, postural 
instability and dementia (Mandemakers et al., 2007). Mitochondrial dysfunction has 
been linked to PD for many years. PD-like symptoms have been observed upon 
exposure to MPTP(1-methl-4-pheyl-1,2,3,6-tetrahydopyridine) a product of heroin 
(Langston et al., 1983). MPTP enters dopaminergic neurons via the dopamine 
transporter and inhibits complex I of the mitochondrial respiratory chain which 
results in increased oxidative stress, elevated intracellular Ca2+ level and 
decreased ATP production which all contribute to PD-like symptoms (Vila and 
Przedborski, 2003). A similar effect has been shown on rodents treated with 
rotenone a complex I inhibitor (Sherer et al., 2003).  
 
Several studies showed mutations in mtDNA or nuclear-encoded mtDNA 
polymerase showed PD like symptoms (van der Walt et al., 2003; Autere et al., 
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2004; Pyle et al., 2005). Other studies also showed that mtDNA polymorphisms 
and haplotypes are also associated with PD, mutation in nuclear-encoded mtDNA 
polymerase-G (POLG) cause PD-like symptoms (Luoma et al., 2004; Pagnamenta 
et al., 2006).  
 
Other genes also have critical roles in PD. Parkin functions as an E3 uniquitin 
ligase (Shimura et al., 2000) catalyzing the ubiquitylation of damaged proteins that 
lead to their degradation by the 26S proteasome (Ciechanover, 1998). The 
mechanism of parkin in regulating mitochondrial function is not yet understood, but 
there is a link between parkin and mitochondrial function showed in a different 
study. Parkin null Drosophila (park25) has reduced life spans, excessive apoptosis, 
flight muscle degeneration and male sterility. Microscopic images showed swollen 
and severe disruption of mitochondria (Greene et al., 2003). Loss of parkin in mice 
results in an increase in dopamine levels and reduction in the synaptic excitability 
in straitum (Goldberg et al., 2003). PINK1 (encoding the PTEN induced putative 
kinase 1) has specific functions in protecting the cell from mitochondrial induced 
apoptosis (Petit et al., 2005). Homozygous mutations of PINK1 in primary fibroblast 
of patients was associated with increasing lipid peroxidation and expression of 
mitochondrial superoxide dismutase which explained the link between PINK, 
mitochondrial function and PD (Hoepken et al., 2007).  
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1.2.4.2.2.3 Mitochondrial dynamics and neuronal disorder. 
 
Mitochondria are dynamic organelles that undergo continuous cycles of fusion and 
fission. The balance between the fusion and fission not only play important roles in 
the morphology of mitochondria but has important roles in mitochondrial function 
(Chan, 2006).  
 
Dynamin-related protein (Drp1) and fission1 (Fis1) are proteins involved in 
mediating mitochondrial fission. Fis1 is anchored to the mitochondrial outer 
membrane (MOM) by a hydrophobic domain with two tandem tetratrico-peptide 
repeat motifs facing the cytosol, which mediate protein-protein interactions 
between Fis1 and other proteins (Suzuki et al., 2003; Dohm et al., 2004). Fis1 is 
thought to be a receptor for Drp1. Drp1 is a large cytosolic GTPase which 
translocates to the mitochondria where it is implicated in fission (Smirnova et al., 
2001). The mitochondrial protein 18 (MTP18) and Ganglioside-induced 
differentiation associated protein 1 (GDAP1) have also been implicated in 
mitochondrial fission (Niemann et al., 2005; Tondera et al., 2005).  
 
The dynamin-family members, optic atrophy 1 (OPA1) and mitofusins (MFN1 and 
2) are involved in mitochondrial fusion. MFN1 and 2 are anchored to MOM which 
forms homo and hetero-complexes with each other. Their N-terminal GTPase 
domain is required for fusion and is oriented towards the cytosol. Their C-terminal 
coiled-coiled domain also faces the cytosol and coordinates the docking of 
mitochondria to one another through antiparallel binding to the C-terminal of MFN1 
or 2 molecules on adjacent mitochondria (Koshiba et al., 2004). OPA1 is a large 
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GTPase located on the mitochondrial inner membrane (MIM) facing the 
intermediate space (IMS). At least eight isoforms have been identified. Their role in 
mitochondrial fusion is not fully understood yet (Delettre et al., 2000). They localize 
in the IMS of mitochondria and tight association with MIM was found (Olichon et 
al., 2002; Cereghetti and Scorrano, 2006). The interaction of OPA1 with MFN1 was 
found and may explain the main function of this interaction in coordinating the 
fusion reaction of the outer and inner membrane (Cipolat et al., 2004). These 
proteins are involved in localization as well as fusion of mitochondria. Over 
expression of MFN1 in neuronal primary cell culture decreased the localization of 
mitochondria to dendritic spines, whereas over expression of dynamin-1-like 
(Dnm1l or Drpl) resulted in relocalization of mitochondria to dendritic spines and is 
involved in mitochondrial fission (Li et al., 2004). Coiled-coil protein Milton (Stowers 
et al., 2002) and rho-related GTPase dMiro (Guo et al., 2005) are implicated in 
moving mitochondria along microtubules. 
 
Mutations in the proteins that are involved in mitochondrial dynamics cause 
neurodegenerative diseases (Mandemakers et al., 2007). Mutations in GDAP1 
cause Charcot-Marie-Tooth (CMT) type 4A, a severe autosomal recessive form of 
neuropathy associated with either demyelinating or axonal phenotypes. It was 
suggested that CMT4A disease is in fact a mitochondrial disorders caused by 
mutations in nuclear genes. This study postulates that GDAP1 may be related to 
the maintenance of the mitochondrial network (Pedrola et al., 2005). Mutation in 
human mitofusin-2 (MFN2) occurs in Charcot-Marie-Tooth neuropathy type 2A 
disease (Zuchner et al., 2004). Optic atrophy 1 (OPA1) is another protein that 
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involved in mitochondrial dynamics. Mutation in the gene that encodes OPA1 is a 
major cause of blindness (Delettre et al., 2000).  
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1.3 The aim of this work. 
 
LAP2α is one of the strongest interacting nuclear proteins that interact with Lamin 
A/C. The nucleoplasmic complexes of Lamin A/C/LAP2α are implicated in cell 
pathways by interacting with a tumor suppressor retinoblastoma (Rb), regulating 
the expression of Rb-E2F-dependent target genes and differentiation. Mutations in 
LMNA cause a heterogeneous group of inherited human disease called 
laminopathies, which affect different tissues, including cardiomyopathy. Mutations 
in LAP2α have been identified and linked to cardiomyopathy as well. To 
understand more about Lamin A/C and LAP2α in cancer, it was suggested to start 
searching for a novel protein partner binding to Lamin A/C and/or LAP2α in colon 
tissue and their function in cancer development. 
 
Chapter 3 describes the generation of bait gene of lamin A/C and LAP2α, by 
cloning the full length of each one in frame with the Gal-4 DNA binding domain of 
the yeast expression vector (pGBKT7), in order to carry out yeast two hybrid 
screens to detect interactions. The generation of a cDNA library from normal 
human colon RNA, and clone them in the frame with the activating domain of yeast 
expression vector (pGADT7). Mating bait constructs to cDNA constructs resulted 
about 1000 positive colonies of lamin A/C and 40 positive colonies of LAP2α. Then 
simple bioinformatics analyses were applied on both of them which resulted in 
hundreds of hypothetical genes including cytochrome c oxidase subunit II (Cox2). 
Interestingly, Cox2 is an mtDNA encoded protein and associated in building 
complex IV of the mitochondrial respiratory chain (COX). Evidence implicated COX 
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in cancer. Because of this, it was interesting to understand this interaction in a 
colorectal cancer cell lines. 
 
Chapter 4 focuses on the confirmation part. As the yeast 2-hybdrid system showed 
the in vivo binding between proteins encoded through the expression vector. In 
addition of the check point through the assay, it was important to think about an 
alternative method to confirm any outcome results. In-vitro biochemical assays 
were used to do so; western blots were performed from HT29 cell line fractions. 
These experiments were subjected for antibodies to Rb and LAP2β to check if the 
fractions are clear of cross contamination. Then the blots were subjected to probe 
by anti-lamin B antibody to answer the question of the possibility of a lamina 
structure in mitochondria as in the nucleus.  
 
Chapter 5 uses alternative techniques to confirm these findings. Transmission 
Electron Microscopy (TEM) was used on different cell types. Cryo-sections of HT29 
cells were labeled with different antibodies to lamin A, LAP2α and Cox2. To 
address if the results that were found in chapters 3&4 are not specific for colon 
tissue, new sections from different cell lines such as Normal Human Fibroblast 
(NHF), fibrosarcoma and brain cancer cells were labeled with anti-lamin A 
antibodies all of which showed the same phenomena. To address why lamin A/C 
are localized in mitochondria, functional assays such as Reactive Oxygen Species 
(ROS), mitochondrial mass and Cox2 protein expression were suggested in lamin 
null cells versus normal and nuclear protein null cell lines including Lamin-/-, NHF, 
LBR-/-, LBR-/+ and Emerin-/-.  
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Chapter 2: Materials and Methods 
 
 
2.1 General Chemicals. 
 
Unless otherwise stated, all general chemicals used in this work are from Sigma-
Aldrich Company Ltd; BDH Laboratory Supplies (AnalaR  or  Molecular grade). All 
microbiological growth media was from DIFCO.   
 
 
2.2 Tissue and cell culture.  
 
 
2.2.a Normal Human Colon Tissue. 
 
Human colon tissue was supplied to the laboratory after surgical procedure. One-
centimeter squares were cut from the sample of normal human colon tissue found 
adjacent to the carcinoma. The tissue was washed three times with sterile RNAse 
free PBS (see Appendix I). The sample was incubated overnight at 4oC in 1 mg/ml 
Dispase (GIBCO) in RNAse-free PBS. The following day, under 20X magnification 
and sterile conditions the epithelial layer was teased from muscle and 
subsequently used for total RNA extraction. 
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2.2.b Cell lines. 
 
Human Colon carcinoma cell lines (HT29), Fibro sarcoma (US913T), Lamin B 
receptor heterozygote (LBR-/+), Lamin B receptor homozygote (LBR-/-), Emerin-/- 
(KK), Lamin A/C null (Lamin A/C-/-) and Normal Human Fibroblast (NHF) were 
found in lab’s liquid nitrogen. Brain cancer cell line (U373) was a gift from Prof. Roy 
Quinlan. Cells were cultured in 25 ml or 75 ml tissue culture flasks under the 
following conditions:- HT29 cells were grown in McCoy’s 5A medium (Sigma) 
supplemented with 10% Foetal Bovine Serum (FBS), 2mM L-Glutamine, 100 
units/ml Penicillin and 100 units/ml Streptomycin (Invitrogen). U373, US913T, LBR-
/+, LBR-/-, KK, Lamin A/C-/- and NHF cell lines were grown in DMEM (Invitrogen)  
supplemented with 10% FBS, 2mM L-Glutamine, 100 units/ml Penicillin and 100 
units/ml Streptomycin.  
 
All cultures were maintained in a humidified incubator at 37oC and 5% CO2. Cells 
were maintained twice a week or when they became 80% confluent. Cells were 
washed twice with phosphate buffered saline (PBS)  and detached in the presence 
of 0.25% trypsin, 0.5mM EDTA in PBS at 37oC for 2-4 min, then cells were split 1:3 
or 1:4 in fresh medium and incubated for a further three or four days.    
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2.3       DNA and RNA preparation: 
 
 
2.3.a Total RNA extraction. 
 
Trizol reagent (Invitrogen) was used to extract total RNA from colon epithelial layer 
which was prepared from 1 cm2 of normal colon tissue (see section 2.2.a). One-
centimeter squares of tissue were homogenized in 10ml of Trizol using a glass-
Teflon homogenizer. After 5 minutes incubation at RT 2ml of Chloroform was 
added, followed by vigorous shaking for 30secs. The sample was then centrifuged 
at 12000g for 15min at 4oC. For the precipitation step, the upper aqueous layer 
was transferred into a new sterile tube. Then 5ml of isopropyl alcohol was added 
and mixed by vortexing for 10secs. The mixture was then incubated at RT for 
30min, centrifuged at 12000g for 10min at 4oC. After decanting the supernatant, 
RNA pellet was washed twice with cold 75% ethanol as follows. 3ml of cold 75% 
ethanol was added to the pellet, vortexed then centrifuged for 5min at 12000g at 
4oC. After decanting the last washing buffer, RNA pellet was dried by standing it at 
RT for 30min, and then finally re-suspended in a minimal amount of RNAse free 
water. The sample of RNA was stored at -70oC. The sample of RNA was quantified 
as described in section (2.4.a), and run in 1.2% agarose to determine the quality 
and purity of RNA as described in section (2.5.a). 
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2.3.b Poly A+ mRNA extraction. 
 
Poly A+ mRNA was purified from 300ug of total RNA extracted from colon tissue 
by using a Poly A+ mRNA extraction kit (Qiagen). The kit was used as described in 
the manufacture’s instructions. The sample of Poly A+ mRNA was quantified using 
the RiboGreen method (see section 2.4.b). 
 
 
2.3.c Plasmid DNA mini-preparation. 
 
Positive bacterial colonies were inoculated into 7 or 10ml of selective media and 
then incubated with shaking overnight at 37oC. Two aliquots of 700ul of bacteria 
culture were used for glycerol stock by adding 300ul of 100% sterile glycerol, 
vortex, and stored in -70oC for further need. The cultures were then centrifuged at 
3000rpm for 5min at 4oC. By using the Wizard® Plus SV Miniprep DNA Purification 
System (Promega), the plasmid DNA was prepared as described in manufacturer’s 
instructions. DNA was quantified as described in section (2.4.c).  The plasmid DNA 
was stored at -20oC. The sample of DNA was determined as described in section 
(2.5.b). 
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2.4 Nucleic Acid Quantitation. 
 
 
2.4.a Total RNA quantitation. 
 
2ul of RNA sample was mixed with 98ul of RNAse free water and the optical 
density at 260nm and 280nm determined. An optical density of 1 at 260nm is 
equivalent to 40ug/ml. 
 
 
2.4.b Poly A+ mRNA quantitation. 
 
RiboGreen RNA quantitation Reagents (Molecular Probes) was used to measure 
the concentration of poly A+ mRNA. The kit was used as described in the 
manufactures instructions. 
 
  
2.4.c DNA quantitation.    
 
2ul of DNA sample was mixed in 98ul of RNAse free water and the optical density 
at 260nm and 280nm determined. An optical density of 1 at 260nm is equivalent to 
50ug/ml. 
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2.5 Nucleic Acid purity analysis. 
 
 
2.5.a RNA quality and purity analysis. 
 
The quality and purity of RNA extraction was determined by gel electrophoreses. 
1.2% agarose gels were prepared as follows:- 1.2g of agarose (Sigma) and 79ml of 
RNAse free water were microwaved for 1-2 minutes then allowed to stand at RT for  
10min to cool down.  Then 10ml of 10 x MOPs  (Chemicon) and 11ml of 37% 
formaldehyde (Sigma) were added to make the final concentrations of MOPs 1X 
and formaldehyde 4%. Running buffer was 1 x MOPs in RNAse free water. 
Samples were prepared as followed:- after quantitation, 5ug of RNA was mixed 
with 15ul of RNA Gel Loading Buffer (Sigma) and made up to 30ul with RNAse free 
water. The samples were denatured at 65oC for 10min followed by 2min in ice. The 
gel was run at 80 Volts for 3-5 hours. RNA marker (Sigma) was used as a 
standard. Good quality RNA should show clean bands without signs of degradation 
between 4 kb and 2 kb, representing 28S and 18S rRNA respectively.. 
 
 
2.5.b DNA quality and purity Analysis. 
 
TAE agarose gel electrophoreses was the standard method used to check DNA 
purity and quality. Agarose concentration depends on the expected size of the 
DNA. 1 - 1.5 % agarose gels were prepared as follows:- 1 - 1.5 grams of agarose 
was mixed with 100 ml 1 X TAE, microwaved for 2 min then allowed to cool down 
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at RT for 10 minutes. Then 10ul of 1mg/ml  ethidium bromide was added before 
pouring the gel. Running Buffer was 1 x TAE. Samples were prepared as follows:- 
5ul of DNA  were mixed with 3ul of 10 x Blue Juice-loading Buffer  (Invitrogen) and 
made up to 30ul with  1 x TAE. The gel was electrophoresed at 100 volts for 1-2 
hours. A 1 kb DNA Ladder (Invitrogen) 0.5 ug/lane was used as a standard. 
 
 
2.6 First strand cDNA generation. 
 
Purified human colon total RNA sample was used to generate the 1st cDNA by 
using Avian Myeloblastosis Virus reverse transcriptase (AMV-RT). The method 
was as described by Invitrogen. 5ug of RNA was mixed with 1ul oligo dt20 (50uM), 
2ul dNTP mix (10mM) and then made up to 12ul with RNAse free water. The mixed 
was denaturized at 65oC for 5 minutes and then placed on ice. To the mix 4ul of 5x 
cDNA Synthesis buffer,1ul of 0.1M DTT, 1ul of RNase 40 U/ul, 1ul of RNAse free 
water and 1ul of Cloned AMV RT 15 U/ul. The reaction was incubated for 45min at 
50oC, followed by 30min at 55oC, and finally 5min at 85oC to stop the reaction. 
 
 
2.7 Polymerase Chain Reaction. 
 
All of the PCR reagents were purchased from Invitrogen. PCR master mixes were 
prepared fresh in a total volume of 25ul as follows:- 2.5ul of 10X PCR Buffer, 
0.75ul of 50mM MgCl2, 0.5ul of 10 mM dNTPs mix, 1.25ul of 10uM of upper and 
lower primers(Sigma), 1ul of 1 unit/ul of Platinum Taq polymerase and made upto 
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24ul with RNAse free water then 1ul of 200ng/ul cDNA or 2ul of plasmid DNA was 
added. 
 
Different PCR programs were used. [LD-PCR, denaturation 95oC for 30secs, then 
30 cycles of: denaturation 95oC for 15secs, annealing 65oC for 3min, followed by 
long polymerization at 65oC for 30min]. [Gene specific RT-PCR, denaturation at 
95oC for 5min, then 30 cycles of; denaturation at 95oC for 40secs, annealing at 
58oC for 3min, polymerization at 72oC for 2min, followed by a further 
polymerization at 72oC for 10min]. [Colony PCR program, denaturation at 95oC for 
10min, then 25 cycles of; denaturation at 95oC for 30secs, annealing at 55oC for 
1min, polymerization at 72oC for 2min, followed by a further polymerization at 72oC 
for 20min]. 
 
 
2.8 Phenol: Chloroform extraction and Ethanol precipitation. 
 
 
2.8.a Phenol: Chloroform extraction. 
 
An equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) (Sigma) was 
added to the reaction. The mixture was vortexed then centrifuged at high speed at 
4oC for 5min. The aqueous layer was transferred to a fresh tube and re-extracted 
with an equal volume of chloroform and centrifuged as above. The aqueous layer 
was then transferred to a fresh tube for the ethanol precipitation step. 
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2.8.b Ethanol precipitation. 
 
One tenth volume of 3M sodium acetate pH5.5 was diluted in three volume of 
100% ethanol, this was then added to the reaction, mixed well and left at -70oC for 
at least 30min or on dry ice for 10min. The mixture was centrifuged at high speed 
at 4oC for 15min. The pellet was washed twice with cold 70% ethanol. The pellet 
was dried at RT for 30min and re-suspended in a minimal amount of RNAse free 
water. The sample was stored at -20oC. 
 
 
2.9 Gel extraction and purification. 
 
The qiagen gel extraction and purification kit was used as described in the 
manufactures instruction. DNA samples were electrophoresis in 0.9% TAE agarose 
gel. The correct bands were excised using a sterile scalpel and transferred into 
1.5ml eppendorf tube. The volume of the slice was calculated by weighting. 
 
 
2.10 Transformation into E.coli. 
 
Ligation mixes were transformated into E.coli DH5α chemically competent cells 
(see Appendix III). 2 ul of ligation mix was added to 50 ul of DH5α and incubated 
on ice for 30min. After a heat shock at 42oC for 2min followed by 2min on ice, 
250ul of S.O.C media was added (see appendix II). The cells were incubated at 
37oC for 1 hour with agitation at 225 rpm. 30ul aliquots were spread onto LB-agar 
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supplemented with appropriate antibiotics (see appendix II). Plates were 
incubated overnights at 37oC. 
 
Single colonies were selected for inoculating overnight cultures of LB-media (see 
Appendix II) containing antibiotics. Plasmid DNA was purified as described in   
section (2.3.c). The correct colonies were identified by using colony-PCR followed 
by DNA sequences and restriction analysis. Colony-PCR was performed by using 
T7 primers and a gene specific primers and 2ul of DNA plasmid, 5ul was sent for 
DNA sequence. Restriction analysis was performed using specific enzymes 
selected to cut internal to the insert and one in the vector to give ~ 75 % of the 
predicted insert size. In the case of incorrect orientation a fragment, 25% of the 
predicted insert sizes will results. 
 
 
 2.11 Yeast two-hybrid system. 
 
 
2.11.a  The principle. 
 
The Matchmaker Library Construction and Screening Kit  (BD Biosciences) was 
used to screen for  novel proteins that bind to Lamin A/C and/or LAP2α. 
 
The principle of this method is to express a full length cDNA of a gene of interest 
known as `bait` fused in-frame to the yeast Gal4 DNA-binding domain (DNA-BD). 
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This is co-expressed with a cDNA library fused in-frame to the yeast Gal4 
activating domain (AD). 
 
If there is an in-vivo interaction between one of the cDNA library expressed 
proteins and the bait fusion protein then this will allow interaction of the Gal4 DNA-
BD with the Gal upstream activating sequence (AD). This interaction will activate 
the expression of reporter genes. Yeast strain AH109 has four reporter genes 
(ADE2, HIS3, MEL1, and LacZ) under the control of Gal Upstream Activating 
Sequences (Gal-UAS) and TATA boxes.  This will allow yeast colonies to grow on 
Minimal SD Agar –ADE, and –HIS3 (see Appendix II). The positive colonies will 
also generate a blue colony color on SD -ADE, -HIS + X-α-Gal, because of the 
activation of MEL1 that encodes α-galactosidase.  
 
 
2.11.b  Construction of  `bait` vectors. 
 
 
2.11.b.1 Primer design. 
 
The primers that have been used to generate the bait gene were selected and 
checked using the Vector NTI software. For both Lamin A/C and LAP2α, the entire 
coding sequence was to be fused in-frame to the Gal4 DNA BD. The 5’ end of the 
5’ forward primer begins at the ATG start codon and the 5’ end  of the 3’ reverse 
primer begins just before the stop codon. Selected restriction sites were then 
added to the 5’ end of each primer. The predicted PCR product when cloned into 
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pGBKT7 will create an in-frame fusion with the gal DNA BD. The PCR product was 
initially cloned into TOPO(TA)pCR2.1 (Invitrogen) and then subcloned into 
pGBKT7. 
 
The primers were reconstituted in 100ul of RNAse free water and primer stock of 
10mM concentration have been made and stored at -20oC until be used for PCR 
reaction. 
 
 
2.11.b.2 Cloning into TOPO-TA-pCR2.1. 
 
The `bait` gene cDNA was prepared by RT-PCR (see section 2.6), from RNA 
extracted from colon tissue (see section 2.3.a). PCR primers were designed using 
the bioinformatics and gene engineering software Vector NTI (see section 
2.11.b.1). PCR primers were designed not to include the  stop codon so that  when  
sub-cloned  into pGBKT7 it creates an in-frame fusion to Gal4 DNA-BD. In addition 
this set of PCR primers contained specific restriction sites that facilitate sub-cloning 
into pGBKT7 (see below). PCR reactions in a total volume of 25ul  were set up as 
described  in section (2.7).  
 
The PCR products were electropheresed in 1% TAE agarose gel. The correct band 
was excised and purified (see section 2.9). The purified PCR product was used for 
cloning into TOPO-TA-pCR2.1 (Invitrogen). A ratio of 3:1 insert to vector was 
mixed with 1ul Salt provided with the kit in a 0.2ml tube and kept at RT for ligation 
for 20min. The ligation mix was used for transformation into DH5α chemically 
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competent E.coli (see Appendix III). 2ul of ligation mix was used for 
transformation as described in section (2.10). 30ul aliquots were spread on LB-
agar contained 50ug/ml of Kanamycin (see appendix II). Plates were incubated 
overnight at 37oC. 
 
Single colonies were selected for inoculating overnight cultures of LB-media (see 
Appendix II) with 50ug/ml Kanamycin. Plasmid DNA was purified as described in   
section (2.3.c). Colony-PCR was performed to check for clones with the correct 
orientation (section 2.10). 
 
 
2.11.b.3 Sub-Cloning into pGBKT7. 
 
pGBKT7 is a yeast expression vector that has the Gal4 DNA-Binding Domain at 
the 5’ prime end of the multi cloning site (MCS). This vector needs to be prepared 
for ligation with the prepared insert. 20ug of plasmid DNA of a correct clone (see 
section 2.11.b.2) was digested with specific restriction enzymes that excise the 
PCR product from TA vector at the sites of the  5’ and 3`  primers. The digested 
DNA was electrophoresis in 1 x TAE agarose for 2 hours. The PCR insert band 
was excised and purified as described in section (2.9).  
 
16ug of pGBKT7 was digested with 16 units of the relevant enzymes (Promega). 
These were mixed in an eppendorf tube, the correct buffer was added and made 
up to 100ul with RNAse free water and then incubated at the recommended 
temperature for 1 hour. 
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The digested DNA was then dephosphorylated as follows:- 5ul of Calf Intestinal 
Alkaline Phosphatase (CIAP) was added with 10ul of 10x dephosphorylation buffer  
(Invitrogen) and then incubated at 37oC for 30 min. Followed with incubation at 
85oC to stop the reaction. Then the plasmid DNA was cleaned out of restriction 
enzymes by using phenol: chloroform extraction followed ethanol precipitation as 
described in section (2.8).  The following formula was used to calculate how match 
of insert need to be mixed with 100ng/ul of vector to get a ratio of 3:1 insert: vector.  
100ng vector X z Kb insert / y Kb vector X 3/1= v (ug of insert the equal 3x of 
100ng of vector). After calculation 2ul of 100ng/ul of digested vector and 2ul of 
100ng/ul of prepared insert mixed with 1x ligase buffer and 1 unit of T4 DNA ligase  
(Invitrogen) incubated at 14oC overnight. 2ul  of ligation mixture was used for 
transformation as described in section (2.10). 30ul of transformed cells were 
spread on LB-agar containing  50ug/ml of Kanamycin (see appendix II). Plates 
were incubated overnight at 37oC. Single colonies were selected for inoculating 
overnight cultures of LB-media (see Appendix II) with 50ug/ml Kanamycin. 
Plasmid DNA was purified as described in   section (2.3.c). Colony-PCR, restriction 
digestion and sequencing were used to check for the correct clones.  
 
 
2.11.b.4 Test the bait gene for transcriptional activation. 
 
As described in the principle of the yeast two hybrid system above, `bait` 
sequences are  expressed proteins fused to the Gal 4 BD. These alone should not 
activate transcription of the reporter genes in yeast strains AH109 or Y187. 
However, some times the `bait` gene or part of its sequence has a transcription 
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factor-like domain which will activate the transcription of the reporter genes even in 
the absent of an interacting partner. For this reason we need to test the bait gene 
for autonomous activation of transcription before starting the search for novel 
protein interactions. The cloned bait gene and empty control vector (pGBKT7) were 
transformed into AH109, and Y187 yeast strains (see appendix III). The 
transformed cells were spread on the following media: SD/-Trp/X-α-gal, SD/-His/-
Trp/ X-α-gal, and SD/-Ade/-Trp/ X-α-gal. These plates were incubated at 30oC for 
3-5 days or until the colonies appeared. If the `bait` gene is inactive as a 
transcriptional activator, we should see white colonies only on SD/-Trp/ X-α-gal 
plates for both the empty control vector and the bait gene construction. If the `bait` 
gene is an active transcriptional factor, then blue colonies will appear on all of the 
plates but not on the empty control vector cells. If these colonies appear on all 
plates except the SD/-Ade then this background growth could be eliminated by 
adding 3-AT to the media. If however, they grow even on SD/-Ade then a new bait 
gene construct, lacking the transcription activating sequences would have to be 
made.  
 
 
2.11.b.5 Test the bait gene for toxicity. 
 
It is possible that some of the bait gene constructions are toxic in  yeast. They will 
grow on selective plates but have weak growth in selective liquid media. To check 
this, the growth of cells with the empty control vector was compared with cells with 
the bait gene construct after overnight culture in selective liquid media. If the cells 
had comparable growth, then they can be processed to mate them with cDNA 
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library. If however, the growth was slower than 5 colonies were picked from 
selective plates and mixed with 1ml of 0.5 x YPDA media and then spread on five 
SD/-Trp plate. After colonies will appear, they were harvested in 5 ml of 0.5 YPDA 
and the number of yeast cells determined. If this was >1x109cells/ml then they can 
be used for mating to cDNA library (see below). 
 
 
2.11.c  Construction of a  cDNA Library into pGADT7. 
 
2.11.c.1 Generation of cDNA. 
 
First strand synthesis was achieved by taking 4ul (0.1 ug) of human colon Poly A+ 
mRNA (25 ng / ul) and treating it with PowerScript Reverse Transcriptase (BD 
Bioscience). The primer was CDSIII oligo-dt provided with the kit. This primer has 
oligo-dt and a unique sequence at the 5’ end called CDSIII which matches with the 
3’end of the MCS in pGADT7. In most cases the first strand cDNA will terminate 
with CCC, the BD Smart III oligonucleotides were used prime synthesis of the 
second strand. BD smart III has unique sequences at the 5’end that match with the 
5’end of the MCS in the pGADT7 and GGG at the 3’end. After this step we have 
cDNA Library from poly A+mRNA that starts with BD Smart III and end with CDSIII.  
 
This library was now amplified by LD-PCR using the advantage-2 PCR kit (BD 
Biosciences) as follows: 2ul of the cDNA library, 80ul DD-water, 10ul of 10 x BD 
Advantage-2 PCR Buffer, 2ul of 50 x dNTP Mix, 2ul of 5’ PCR primer and 3’ PCR 
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primer, 2ul of 50x BD Advantage-2 Polymerase Mix. The PCR program was used 
as described in section (2.7).  
 
The cDNA was size fractionated after LD-PCR by using BD CHROMA spin 
Columns TE-400 which is included in the kit. These are packed with resins that 
fractionate molecules based on size. This column selects DNA molecules >200 bp. 
By following the manufacturer’s instructions, the LD-PCR products were purified 
and concentrated into 20ul of elution buffer. 
 
 
2.11.c.2 Construction the LD-PCR product with pGADT7 into Yeast. 
 
Co-transformation of yeast with purified LD-PCR product cDNA and Sma I 
linearized pGADT7-Rec allows in-vivo recombination of the two to yield a complete 
Gal4 AD expression library.  
 
Yeast strain AH109 was made competent as described in (Appendix III). 20ul of 
the purified LD-PCR was mixed with 6ul of pGADT7-Rec (0.5ug/ul) and 20ul of 
denatured Herring testes carrier DNA (10mg/ml) this was added to 600ul 
competent yeast cells. The contents were gently mixed and then 2.5ml PEG/LiAc 
was added (see Appendix I). The cells were mixed and incubated at 30oC for 45 
min. The cells were gently mixed every 10-15min. 160ul DMSO (Sigma) was 
added, mixed, and then the cells placed at 42oC for 20min. The cells were gently 
mixed every 10 min. The cells were then centrifuged at 700xg for 5min. The 
supernatant were discarded and the pellet re-suspend in 3ml of YPD-Plus Liquid 
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Medium provided in the kit. The cells were then incubated at 30oC with shaking for 
90min. After that the cells were centrifuged at 700xg for 5min. The supernatant 
was discarded and the cell pellet re-suspended in 30ml of 0.9% NaCl solution (see 
appendix I). 
 
The transformed cells were spread on 180 SD/-Leu plates of 150mm diameter 
200ul/plate. For calculation of the transformation efficiency, 1:100, 1:1000, and 
1:10,000 dilutions of transformed cells were spread onto 100mm SD/-Leu plate as 
100 ul/plate.  The plates were then incubated at 30oC for 3-6 days or until colonies 
appeared. 
 
After colonies were appeared, they were harvested as follows:-  the plates were 
chilled at 4oC for 4 hours. Batches of plates were taken and placed on ice, 5 ml of 
freezing medium (see appendix II) was added to each plate. Using glass beads 
the colonies were gently scraped and pooled into a sterile flask. 2ml aliquots were 
stored at -80oc.   
 
 
2.11.d  Yeast two hybrid screening. 
 
 
2.11.d.1 Mating Bait-gene constructs into the cDNA library. 
 
On the day of mating, `bait` construction transformed Y187 cells and a 2ml aliquot 
of  cDNA library AH109 cells were counted using a hemocytometer. Both cell types 
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were mixed in equal numbers in a sterile two liter flask, then 45ml of 2X YPDA/Kan 
(50 ug/ml) was added. The mixture was incubated at 30oC for 20-24 hours with 
gently agitation at 50 rpm. After 20 hours one drop of mating mixture was tested 
under a phase-contrast microscope at 400 x powers for zygote formation this 
typically has a three-lobed shape, the lobes representing the two haploid parents 
and the third lobe the budding diploid cell. If at 20 hours incubation zygotes were 
present in the culture the cells were incubated four hours more. Then a further drop 
was checked again to determine if more than 90% of the cells had separated as 
single diploid cells. At this point, the cells were transferred to two 50ml falcon tubes 
(25ml of culture/tube) then centrifuged at 1000xg for 10min. Meanwhile, the 2-liter 
culture flask was rinsed twice with 50ml of 0.5x YPDA/Kan (50ug/ml). This was 
centrifuge of as before and all of the pellets combined and resuspended  in 10ml of 
0.5 ml YPDA/Kan. 
 
The cells suspension were plated on 150mm diameter SD/-Trp/-Leu/-His/-Ade 
plate, and 200 ul/plate, incubated at 30oC until colonies appeared. For calculation 
of  the mating efficiency, the cells suspension were diluted 1:10, 1:100, 1:1000 and 
1:10,000 and spread  on 100mm diameter selective agar: SD/-Leu, SD/-Trp, and 
SD/-Leu/-Trip at 100ul/plate. After few days incubation at 30oC colonies were 
appeared. Colonies from the experimented plates were re-streaked on SD/-Trp/-
Leu/-His/-Ade/x-α-gal. This step is to reduce the background and to test for MEL1 
expression. The mating efficiency was calculated as in formula 2 (Table 2.1).  
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Table 2.1 Formula.  
 
 
Formula No 1: 
To quantify nucleic acids. 
(OD260 X DF X N)/ 1000= concentration  ug/ul 
N; is a constant concentration at 1 OD260  for RNA 40ug/ml, for DNA 50ug/ml for  
ss DNA 30ug/ml.    DF; Dilution Factor of the sample.  
____________________________________________________________________
Formula No 2:  
Yeast mating efficiency. 
1. Count the colonies (cfu*) on the SD/-Trp; SD/-Leu; and SD/-Trp/-Leu in  
   plates that have 30-300 cfu.        
2. Calculate the viable cfu/ml on each type of SD medium: 
(Cfu / Vol.plated (ml)) x dilution factor=  viable cfu/ml 
cfu/ml on SD/-Trp     = Viable AH109 cells.  
cfu/ml on SD/-Leu     = Viable Y187  cells. 
cfu/ml on SD/-Trp/-Leu= Viable diploids. 
3. The strain with the lower viability is the “limiting partner”. In this protocol, the 
          AH109 [library] strain is the ‘limiting partner”. 
4.      Calculate the mating efficiency (% Diploid): 
(cfu/ml of diploids) / (cfu/ml of limiting partner) x 100 = % Diploid  
       If the mating efficiency was <2%, the protocol was repeated. 
*Colony Formation Units (cfu). 
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2.12  DNA sequencing and Bioinformatics analysis. 
 
 
2.12.a  DNA sequencing of yeast two-hybrid colonies.. 
 
Positive colonies were incubated at 30oc overnight in SD –Trp/-Leu selective 
media. Colony PCR was performed by mixing 5ul of overnight culture with 45ul of 
PCR master mix (see section 2.7), using the pGADKT7-LD-insert forward and 
reverse primers. The PCR program used as described in section (2.7). 5ul of the 
PCR product was electrophoresed in 1% agarose gels and 5ul was sent, with 
pGADKT7-LD-insert forward and reverse primers to the DNA sequencing core 
facility. 
 
 
2.12.b  Bioinformatics and sequences analysis. 
 
Invitrogen Vector NTI bioinformatics software was used for sequence compilation 
and editing. Raw sequence files were imported into Vector NTI using the contig 
express feature. Sequence files were corrected of mismatches. Any mismatches 
edited by viewing the relevant chromatogram. Sequence files were then assembled 
into contigs. Each contig was then screened for open reading frames (ORFs). 
Suitable ORFs were then screened against the human EST databases using a 
BLASTN search engine. 
 
 
85 
 
Table 2.2 Primers design sequences. 
 
 
 
 
Gene 
 
Accession 
Number 
Primer direction 
5’-------------3’ 
Start Primer sequences Product 
size (bp) 
Lamin A/C NM_170707 
Sfil 170707 forward 
 
Sall 170707 reverse 
 
213 
 
2204 
 
TCTGGCCATGGAGGCCATGGAGACCCCG 
 
GTTGTCGACCATGATGCTGCAGTT 
 
1992 
LAP2α NM_U09086 
Sma l- U09086 
forward 
 
Sall U09086 reverse 
 
205 
 
2286 
 
CCAGCCCGGGGATGCCGGAGTTCCTGGAA 
 
 
CAGAGTCGACGTGTTTATTTCCACGCTT 
 
 
2082 
 
pGADKT7 
 
AD –
expression 
vector 
 
 
AD LD-Insert Seq 
forward primer 
AD LD-Insert Seq 
reverse Primer 
 
1858 
 
 
2175 
 
CTATTCGATGATGAAGATACCCCACCAAAC
C 
GTGAACTTGCGGGATTTTTCAGTATCTACG
ATT 
 
β actin NM_001101 
 
Sense 
 
Anti-Sense 
 
257 
 
1090 
 
GGCACCACACCTTCTACAATGAGC 
 
CGTCATACTCCTGCTTGCTGATCCAC 
834 
Contig5/ 
Cox2 
________ 
            Sense 
 
Anti-Sense 
__ 
 
__ 
 
ATGGCACATGCAGCGCAAG  
 
GTTTAGACGTCCGGGAATTG 
 
~500 
LAP2α 
Seq8 
________ 
Sense 
 
Anti-Sense 
___ 
 
___ 
TTACGCTCTTATGGCCATGGAG 
 
CCCCGACCCGCATCTCTTTC 
~500 
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2.13 Protein Analysis. 
 
 
2.13.1  Protein extraction. 
 
2.13.1.1 Total cell extract. 
 
Cell lines cultured as described in section (2.2b). On the day of experiment, the cell 
monolayer were washed twice with cold PBS then harvested with a cell scraper 
and centrifuged at 1000 rpm for 5 minutes at 4oC. The cell pellet was re-suspended 
in 0.5 ml/flask of hypotonic solution (see Appendix I) containing 0.5 mM DTT, 1x 
of Protease Inhibitor (Sigma) and 50u/ml DNAse1 (Sigma). The cell suspension 
were incubated on ice for ~20 min followed with vortex every. The total extract was 
subjected for protein measurements see section 2.13.3. 
 
 
2.13.1.2 Cell fractionation. 
 
Cell lines cultured as described in section (2.2b). On the day of experiment, the cell 
monolayer were washed twice with cold PBS then harvested with a cell scraper 
and centrifuged at 252g for 5 minutes at 4oC. The cell pellets were re-suspended in 
0.5 ml/flask of hypotonic solution (see Appendix I) containing 0.5 mM DTT and 1x 
of Protease Inhibitor (Sigma). The cell suspension were incubated on ice for 15min 
then harvested by homogenization. The nuclear pellet was isolated from the 
suspension by centrifugation at 1000g for 5 minutes at 4oC. This step was 
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repeated to remove any nuclear contamination from the sample. The supernatant 
was then used for mitochondrial extraction by centrifugation 13552g for 20 min at 
4oC. The nuclear pellets were combined and re-suspended in 500ul of Hypertonic 
solution (see Appendix I) with 0.5mM DTT and 1x Protease Inhibitor and incubate 
on ice for 10 min then centrifuged at 21918g for 5min at 4oC. The supernatant was 
either transferred into a dialysis tube to incubate in 1 liter cold PBS in magnetic stir 
at 4oC room for co-immunoprecipitation or transferred into new tube and stored at -
20oC until used. The mitochondrial pellet was washed three times, in each time it 
was re-suspended in 300ul of hypotonic solution followed by centrifugation 13552g 
for 20 min at 4oC. Then the mitochondrial pellet was solubilized in 200ul of NP-40 
(see appendix I) plus 0.5mM DTT and 1x Protease Inhibitor and stored at -20oC 
until used. The post-mitochondrial supernatant was centrifuged at 469280g for 1 
hour at 4oC for isolation of the cytosolic fraction. The pellet was washed once in 
cold PBS and re-suspended in 200ul of NP-40 and stored at -20oC until used. 
 
 
2.13.2  Co-Immunoprecipitation. 
 
For each immunoprecipitation 50ul of Dynabeads coated with sheep anti-mouse 
IgG antibodies (Invitrogen) was washed three times with 500ul cold PBS-1% BSA. 
Each aliquot of Dynabeads was then incubated with 50ul of diluted specific 
antibody (see Table 2.3), and incubated with low speed agitation overnight at 4oC. 
The following day, the incubated beads were washed twice in PBS-0.1% Triton x-
100 for cross linking. Fractioned proteins extractions (see section 2.13.1.2) were 
measured by using the BCA as described in section (2.13.3). 100 ug of dialyzed 
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nuclear extract or mitochondrial extract were mixed with the beads and agitated at 
low speed for 4 hours at 4oC. The beads were then centrifuged at 12000g for 1 min 
at 4oC. The supernatant was precipitated with an equal volume of cold Methanol: 
Acetone 1:1 and incubated at -20oC for 15 minutes. The precipitated was collected 
by centrifugation at 12000g for 5 minutes then washed two times with cold PBS- 
0.1 % Triton x-100. Finally, the pellet was re-suspended in 50ul of 2x sample buffer 
and denaturated at 95oC for 3 minutes then placed on ice. This was labeled as the 
unbound (S) fraction. The beads were washed twice in cold PBS- 0.1% Triton x-
100 by using the magnetic rack. The beads were resuspended in 50ul of 2x sample 
buffer and denaturated at 95oC for 3 minutes then placed on ice. This was labeled 
as the bound (IP) fraction. 10 ul of each sample were resolved using 10 or 12 % 
one dimensional SDS-PAGE (See below).  
 
 
2.13.3  Protein concentration determination. 
 
Protein quantification was determined by use of the BCA Protein Assay Kit 
(Pierce). 5 mg/ml of Bovine Serum albumin in 1 x Laemmli Sample Buffer was 
prepared (see Appendix I). Stock Standards of 0, 0.1, 0.25, 0.5, 1, 1.5, and 2 
mg/ml BSA were prepared from this by dilution in 1 x Laemmli sample buffer and 
stored at 4oC until used. On the day of assay, 10ul of each standard was mixed 
with 40ul of DD-water, and 2ul of sample extracts with 48ul of DD-water. Then 1/50 
dilution of reagent b to reagent A was prepared. 950ul of diluted reagent B and A 
were added on each tube and incubated at 37oC for 20 min. The optical density of 
each sample at 545 nm was now determined. 
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2.13.4   SDS-PAGE. 
 
SDS-PAGE gels were prepared using the Bio-Rad mini-gel apparatus. 10 or 12% 
of resolving was made as described in (Appendix II.8.I). Stacking gel was made 
as described in (Appendix II.8.II). Samples were run at 100 V for about 2 hours 
(when the loading dye reach of the gel) in 1X running buffer as described in 
(Appendix I).  
 
 
2.13.5  Immunoblotting. 
 
Nitrocellulose membrane (Protran, grade BA85, Schleider and Schuell BioScience) 
was cut same size of the gel and soacked in 1X transfer solution (see Appendix I). 
The resolving gel was laid on the membrane and the two sandwiched between one 
layer of 3MM filter paper and sponge. The apparatus was assembled and ran at 
100 V for 1.5 hours at RT using ice pack to cool the transfer buffer. The 
nitrocellulose membrane was stained with Pounco dye to check the transfer 
quality. The membrane was washed in 2x TBST (see Appendix I) and blocked in 
blocking buffer (5% Milk powder w/v 2x TBST) for 1-2 hours at room temperature. 
After blocking, the membrane was incubated in exact dilution of primary antibody in 
1 Milk powder w/v 2x TBST (see Table 2.3) for 2 hours at RT or overnight at 4oC 
room with shaking. After primary antibody incubation the membrane was washed 3 
times at RT, 15 min each, in 2x TBST. Then the membrane was incubated with a 
1/2000 dilution of secondary – HRP antibody in 1% Milk powder w/v 2x TBST (see 
Table 2.3) for 1 hour at RT with shaking. The membrane was washed 3 times at 
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RT, 15 min each, in 2x TBST. The nitrocellulose membrane was then exposed to 
1:1 mix of ECLTM Western Blotting Reagents 1 and 2 (Amersham Biosciences, 
Buckinghamshire, UK) for 1-4 minutes and immunoreactivity was measured by 
detecting the chemiluminescence on HyperfilmTM ECL (Amersham Biosciences). 
The film was developed in a compact X4 Automatic X-ray Film Processor (Xograph 
Imaging System Ltd) or by recording the signal in a Fuji film imagining camera. 
 
Then by using ImageJ software, selected images were opened. After the image 
was inverted, a box was draw around the biggest band. Then, the mean of the 
histogram of background alone and the band was taken. The mean of band was 
subtracted from the mean of background. As the band represents the expression 
level of the protein in the amount of protein was loaded on the gel, not from the 
total amount of protein in the fraction. So, the dilution factor was used to calculate 
the amount of the protein expression in the sample. Because the nuclear pellets 
were re-suspended in 500ul and both of cytosol and mitochondrial pellets were re-
suspended in 200ul, so the dilution factor is 2.5 between nuclear and other 
fractions. Because of that the mean histogram of nuclear band will multiply by 2.5.    
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Table 2.3 Primary and secondary antibodies used and their dilutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WB-western blot, IP-immunoprecipitation, EM-electron microscope, HRP-Horse-radish peroxidase. 
Primary 
Antibodies Target Type Reference 
 
WB 
 
IP EM 
              
IF 
Jol2 Lamin A/C tail Mouse- M In house 
 
1:200 
 
1:10 - 
              
1:50 
R-Lamin A Lamin A Rabbit-R Sigma 
 
- 
 
- 1:600 
              
1:500 
M-Lamin A/C Lamin A/C Mouse-M Santa Cruz 
 
- 
 
- 1:10 
              
- 
M-Lamin A Lamin A Mouse-M Novus 
 
- 
 
- 1:5 
              
- 
 
LAP15 
 
LAP2α 
 
Mouse- M Gift from Dr. Foisner 
 
1:100 
 
1:10 1:50 
              
1:100 
R-LAP2α LAP2α Rabbit-R ImmuQuest 
 
1:1000 
 
- 1:300 
              
1:500 
 
LAP17 
 
LAP2β 
 
Mouse- M Gift from Dr. Foisner 
 
1:10 
 
- - 
              
- 
 
IF-8 
 
Retinoblastoma 
 
Mouse- M In house 
 
1:100 
 
- - 
              
- 
 
Mt.COX2 
 
Cytochrom C 
Oxidase 
 
Mouse- M Invitrogen 
 
1:500 
 
1:100 1:50 
              
1:300 
Lamin B B1 and B2 Mouse-M ImmuQuest 1:50 - - 
              
- 
Lamin B2 B2 Mouse-M Abcam - - 1:50 
              
- 
Β-Actin AC-40 Mouse-M Sigma 1:1000 - - 
              
- 
Secondary 
Antibodies Target Type Reference 
 
WB 
 
IP EM 
              
- 
Donkey anti-
Mouse 
Mouse primary 
antibodies HRP Stratech 
 
1:2000 
 
- - 
              
- 
Donkey anti-
Rabbit 
Rabbit primary 
antibodies HRP Stratech 
 
1:2000 
 
- - 
              
- 
Goat anti-
mouse IgG 
Mouse primary 
antibodies 
Gold 5, 10 
or 20 nm British Biocell International  - - 1:20 
              
- 
Goat anti- 
Rabbit IgG 
Rabbit primary 
antibodies 
Gold 5, 10 
or 20 nm British Biocell International  - - 1:20 
              
- 
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2.14 Transmission Electron Microscope (TEM). 
 
Cells were grown in 100mm culture dishes. Media was replaced with 3mls of new 
growth media one day before fixation. On the day of fixation, medium was replaced 
with 3mls of double strength fixation buffer (see Appendix I) mixed gently and 
quickly for 2mins. Then fixation was replaced with 3mls of single strength fixation 
buffer (see Appendix I) for 2 hours at room temperature. Cells were washed three 
times with PBS-0.1% glycine 15mins each time. Cells were incubated with 3mls of 
PBS-1% glycine at 37oC for 10mins. Cells were scraped from dish and centrifuged 
down at 200g for 5mins. Cells pellets were re-suspended in 5mls of PBS-10% 
gelatin and incubated at 37oC for 10mins. Cells were re-centrifuged down and 
incubated on ice for gelatin sets. The tips of the eppendorf tube containing cells 
were cut off by using a razor blade. By using 2.3M sucrose as a lubricant the tip of 
the eppendorf tube was cut half, and the separated of the cell pellet. Small blocks 
of cell pellets was prepared in pyramids (1x1x1mm) and stored in 2.3M sucrose at 
4oC until the cryosectioning was prepared. The cryosection was then fixed on 
grids. The grids were put on cold 2%gelatin and melted under a lamp. Grids were 
incubated on the melted gelatin at 37oC for 30mins. The grids were rinsed 5 times 
with PBS-0.1% glycine 1min each, then one time with PBS-1%FBS for 3mins. 
Then 5 droplets of specific antibody concentration in PBS-1%FBS was added for 
one hour at room temperature or over night at 4oC. Grids were rinsed 4 times with 
PBS-1%FBS 2min each. Then the grids were rinsed 3 times with PBS, followed 
with 4 times washing with PBS 2mins each. The grids were incubated in stabilizer 
PBS-1% gluteraldehyde for 5mins. The grids were washed 10 times with distilled 
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water 1min each. The grids were rinsed quickly with two drops of cold MC/UA pH4 
on ice, followed with 5mins incubation with fresh drops of cold MC/UA pH4 on ice. 
The grids were let for air dry for 10mins and kept until used. 
 
 
2.15 Gold particles count and analysis.  
 
Image Processing and Analysis in Java software (ImageJ software) was 
downloaded free from web site. The scale was set on each opened image 
according to the scale bar provided with the image. In order to quantify the density 
of labeling of A-type lamins at the NE, a region was defined that enclosed the NE 
and the gold labels that were associated with it. In case of B-type lamins and 
LAP2α, because they express all over the nucleus, the size of the whole nucleus 
was taken. In case of Cox2, because there were no gold particles in the nucleus, 
the size of the whole nucleus was taken. The size of the whole mitochondria was 
taken for each labeling. The size of cytoplasm was taken by subtracting the size of 
the whole nucleus and mitochondria of each image. After that the gold labels were 
counted on each selected cell compartments. By using excel, a chart was draw to 
represent the value of the density of gold labeling expressed as the mean + SD (n= 
30 images, 10 images of each cell pellet). At least ten images per cell 
compartments were analyzed. The average of the gold labeling was divided by the 
average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2. Significance was calculated using the Student t-
test P < 0.05 which Comparing mitochondria or nucleus to cytosol. 
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2.16 Reactive Oxygen Species (ROS) measurement. 
 
To measure ROS, CM-H2DCFDA (Molecular Probes, Invitrogen) was used. The 
dye makes covalent binding to mitochondrial inner membrane. Fluorescent will 
generate when the acetate groups remove by oxidation.  
 
Cell lines were seeded in a density of 5X104 cell/well of 12 well plate. Cells were 
grown for 48 hours. Then, cells in particular wells were treated for 12 hours by 1% 
DMSO (-ve control to show that DMSO that used for solving the reagent and dye 
has no affect on the ROS production) and for 12 hours by 5uM Valinomycin (+ve 
control and to show that the protocol is working). At the day of measurement, cells 
were washed once with PBS and incubated with 10mM CM-H2DCFDA in DMEM-
Low glucose Phenol red free and serum free (DMEM-PR-FBS) for 45 minutes at 
37oC incubator. Then, cells were trypsinized and centrifuged down at 1000 rpm for 
5 minutes at 4oC. The cell pellet was re-suspended in 1ml of DMEM-PR followed 
by flow cytometry (FACS) FL1.  
 
Flow cytometric analyses were carried out using Coulter® EPICS XL-MCLTM Flow 
Cytometer (Beckman Coulter, Inc., Fullerton, CA) installed with System IITM version 
3.0 software.  
 
The template page was set with 4 histograms. One for forward scatter (FS) and 
side scatter (SS), one for Filter 1 (FL1) green filter and event, one for filter 2 (FL2) 
red filter and the last one was FL1 and FL2 X and Y axis respectively. Then, the 
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parameter was set for FS and SS of the light as cells pass through laser by using 
cell suspension without dye (no green fluorescence), where the peak of the cell 
population will be close to zero for both filters. The counter was set for 10,000 
events. 
 
FlowJo was used to analysis the FACS data. The median of FL1 value of wild-type 
was made 100% as a basal level. Then the FL1 values of other samples were 
calculated based on this. The experiments repeated at least three times. The chart 
representing the percentage of the ROS level as the mean + SD (n= 3). 
 
 
2.17 Mitochondria mass measurement. 
 
To monitor the mitochondrial mass of specific cells, fluorescent dye 10-n-nonyl-
acridine orange (NAO; Molecular Probes, Eugene, Oreg., USA) was used. This 
dye binds specifically to the negatively charged cardiolipin (diphosphatidylglycerol) 
in the mitochondrial inner membrane independently of the membrane potential.  
 
On the day of the experiment, Cells were trypsinized and counted. Then 200,000 
cells were re-suspended in 1 ml of DMEM no serum containing 10uM NAO. After 
incubation for 10 minutes at 37°C in the dark, cells were centrifuged at 1600rpm 
2min and supernatant discarded. The cell pellet was re-suspended in 3ml of 
DMEM without serum. Then, Cell were analyzed by flow cytometry and green 
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fluorescence was recorded FL1, using the same parameter that mentioned in 
section 2.16. 
 
FlowJo was used to analysis the FACS data. The median of FL1 value of wild-type 
was made 100% as a basal level. Then the FL1 values of other samples were 
calculated based on this. The experiments repeated at least three times. The chart 
representing the percentage of the mitochondrial mass as the mean + SD (n= 3). 
 
 
2.18 Immunofluorecscence (Confolcal). 
 
HT29 cell line was seeded at an density of 4x105 cells/ml. 500ul of cells were 
loaded/well on 24 tissue culture well plats. Each well contains 1x13mm diameter 
glass cover slips pre-autoclaved. Cells were grown overnight, replaced with phenol 
free medium contains 500nM MitoTracker Red CMXRos probe (Invetrogen M7511) 
and incubated for 30 minutes at cell culture incubator. Then cells were washed 
three times in 1x PBS pH 7.4, followed by fixation in pre-warmed at 37oC and fresh 
made 3.7% Para-formaldehyde in PBS pH 7.4 for about 12 minutes at RT with 
shaking. Permeablization step in 0.5 % triton X-100 in PBS for 5 minutes and 
followed with three times washing in PBS 5 minutes each at RT and shaking. 
Cover slips were then blocked in 1%  New Born Serum in PBS (NCS-PBS) for 30 
minutes at RT. Cover slips were washed twice in PBS and kept at 4oC or used 
immediately. 
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Cells were stained single with primary antibodies (50 ul/cover slip) for one hour at 
RT in humidified condition (Table 2.3). Followed by washing three times in PBS 
and dried on tissue by touching the cover slip at 45o angle. Fluoescein (FITC)- 
conjucated IgG secondary antibodies were used in 1:50 dilution and incubated for 
one hour at RT in humidified condition. Cover slips were washed three times in 
PBS and dried. Cover slips were mounted in Mowiol mounting media containing 
2.5 % DABCO and 1 ug/ml DAPI. 
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Chapter 3: Yeast 2-Hybrid analysis of proteins binding to Lamin 
A/C and LAP2α. 
  
 
3.1 Introduction. 
 
3.1.1 Lamin A/C binding protein. 
 
Many studies have shown that there are hierarchies of lamin-lamin associations at 
the Inner Nuclear Membrane (INM) to form the nuclear lamina. After the lamina has 
formed, it will interact with integral proteins of the INM to determine the size and 
shape of the nucleus and aid the distribution of nuclear pore complexes (NPC), as 
well as other more poorly defined functions. 
 
To understand the function of the lamina we need to know more about the proteins 
that bind to lamins. Studies in-vitro and two-hybrid assays have shown that  A-type 
lamins bind to other proteins, but the in-vivo significances remain untested  see 
Table 1 in (Zastrow et al., 2004), which have been classified according to their 
function when interacting with A-type lamins.  
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3.1.2 Colon Crypt development. 
 
A cross-section of the colon shows that it is composed of three main layers. The 
mucosa is composed of epithelial cells, 90% of these are found in crypts and the 
remaining 10% found in the flat surface. There is a sub-mucosa and two layers of 
smooth muscle. The mucosal crypt has stem and proliferating precursor cells 
occupy the  bottom two thirds, whereas differentiated cells occupying the top third 
and the flat surface epithelial layer  (Kirchhoff and Geibel, 2006; Prendergast et al., 
1996). The main functions of the colon crypts are to absorb and secrete fluid to 
maintain normal salt and water homeostasis (Kirchhoff and Geibel, 2006).  
 
 
3.1.3 Lamin A/C expression in Colon Crypt. 
 
Recent studies have shown the expression of Lamin A/C and Lamin B1 in the crypt 
epithelia cells. The expression of Lamin A/C is greater in differentiated epithelia 
and stem cells than in the proliferation zone. This expression is decreased in 
colonic adenocarcinoma tissues as well as at an intermediate stage of neoplasm in 
the same organ. This phenomena may be because of contamination of non-
epithelial cells in cancer sections, or it could be due to aberrant cytoplasm but 
there is no  explanation as to why this is happening (Moss et al., 1999). However, 
one author linked the expression of lamin A/C in colorectal cancer (CRC) in 
promoting the reorganization of the cytoskeleton (Willis et al., 2008), whereas 
lamin A/C expression in CRC promoted invasiveness through up-regulation in the 
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expression of the actin-bundling protein (T-plastin), which down regulated the cell 
adhesion molecule (E-cadherin). 
 
 
3.1.4 LAP2α expression in Colon Crypt. 
 
There are no studies showing LAP2α expression in the crypt of normal human 
colon tissue. There has been only one study showing the over expression of 
LAP2α in different cancer tissues from larynx, lung, stomach, breast, and colon. 
This expression is under the control of the E2F transcription factor (Parise et al., 
2006). 
 
 
3.2 The aim of this study. 
 
As described above LAP2α is one of the strongest binding partners to Lamin A. In 
this chapter we would like to understand more about the role of Lamin A/C and 
LAP2α in controlling cellular function in colon tissue. To do so, we need to search 
for novel protein binding partners to Lamin A/C and/or LAP2α. In this chapter we 
describe the search for these binding partners using the yeast two-hybrid assay. 
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3.3 Results: 
 
3.3.1 cDNA library construction and cloning into the Gal4-Activating Domain 
vector. 
 
A cDNA library of colon epithelia is not available commercially therefore we had to 
construct our own. Total human RNA was extracted from 1cm2 of the epithelial 
layer of normal human colon (sections 2.2.a, 2.3.a). Quality of the RNA extraction 
was checked by electrophoresis run in a 1.2% formaldehyde agarose gel (Figure 
3.2.a). β-actin PCR was performed on 0.5ug of total RNA to check for DNA 
contamination (Figure 3.2b). Poly A+ mRNA was purified from 300ug of total RNA 
(section 2.3.b) and after quantification (section 2.4.b) 100ng of poly A+ mRNA 
was used to generate the cDNA library (section 2.11.c.1). LD-PCR was used to 
amplify a selection of cDNAs ranging from 300 to 3000 bp in length (section 
2.11.c.1) and Figure 3.2c. The purified LD-PCR products were ultimately cloned 
into pGADT7 before transformation into yeast strain AH109 (section 2.11.c.2) and 
Figure 3.5.a.  
 
 
3.3.2 Lamin A/C-Gal4 DNA Binding Domain Construction. 
 
In the databases there are different variants of lamin A/C mRNA sequence. The 
one that was used in this study is Lamin A/C transcription variant 1 with accession 
no. NM_170707. The full length of the lamin A coding sequence was required. 
Primer design was described in section 2.11.b.1. The PCR primers must not 
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generate a stop codon when ultimately sub-cloned into pGBKT7 where it will be 
fused to the Gal4 DNA-BD. Both PCR primers have specific restriction enzyme 
sites at the 5’ ends which are not in the MCS of TOPO-TA pCR2.1 intermediate 
vector, that will allow later in sub-cloning into pGBKT7. The SfiI-170707 forward 
primer is 28 nucleotides in length; 3 nucleotides as cozak plus a 13 nucleotide SfiI 
site plus 12 nucleotides which are gene specific from the ATG start codon at 
mRNA sequence position 213 (see Table 2.2). The Sall-170707 reverse primer is 
24 nucleotides in length; 3 nucleotides as cozak plus a 6 nucleotide Sall site plus 
15 nucleotides which are gene specific starting prior to the  stop codon  at mRNA 
sequence position 2204 (see Table 2.2).   
 
5ug of total RNA was used as a template for RT-PCR (section 2.11.b.2) to amplify 
Lamin A/C (Figure 3.3.a). The PCR fragment was excised from the agarose gel 
extracted, purified (section 2.9) and quantified (Table 2.1). 2.5ul of purified PCR 
product (~30ng) was mixed with 1ul of salt solution, 1ul of TOPO-TA-pCR2.1 
vector (10ng/ul), and made up to 6ul with DD-water. This mixture was incubated for 
ligation and transformation (section 2.11.b.2). After transformation 5 colonies were 
selected and DNA minipreps made from them. These minipreps were digested as 
follows: 5ul of each miniprep, 3ul of 10X Buffer B, 1ul of Sfil (1u/ul) and made up to 
30ul with DD-water and then incubated at 37oC for 1 hour. Then 3ul of 10X Buffer 
D and 1ul of Sall (1u/ul) was added and incubated at 37oC for 1 more hour. After 
the gel electrophoresis, the correct band was detected in all of the 5 colonies 
(Figure 3.3.b). A large scale digestion was applied to clone # 1 as described 
above except 5ul of each enzyme and a total of 100 ul was used. After the gel 
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electrophoresis the correct band was excised, purified and quantified (Figure 
3.3.b). 
 
Vector pGBKT7 was prepared as described in section 2.11.b.3. pGBKT7 was 
digested and dephosphorylated by using Sfil , Sall and CIAP. The prepared Vector 
was then quantified. 100ng of digested Lamin A/C were mixed with 100ng of 
prepared pGBKT7 in a ratio of 3:1. This mixture was then ligated and 
transformated into E.Coli DH5α  (section 2.11.b.3). 5 transformed colonies were 
selected and plasmid minipreps made. The plasmids were then digested to double 
check for the correct orientation. ApaI and Sall were used as follows: 5ul of each 
miniprep, 3 ul of 10X Buffer A, 1ul of Apal (1u/ul) and then made up to 30ul total 
volume with DD-water then incubated at 37oC for 1 hour. After this 3ul of 10X 
Buffer D, 1ul of Sall (1u/ul) was added and incubated at 37oC for 1 more hour. All 
of the colonies were in the correct orientation (Figure 3.3.c). One of the plasmid 
was selected for DNA sequence as an alternative method to check the full open 
reading frame cloning into pGBKT7 (Appendix IV-1b). 
 
 
3.3.3 LAP2α-Gal4 DNA Binding Domain Construction. 
 
The construction of the LAP2 α-Gal4 bait vector follows the same protocol that was 
used for lamin A/C (section 3.2.2). The GenBank accession used for the design of 
primers was U09086. The full length codon sequence was required. The primers 
designed were described in section 2.11.b.1. The primers must not generate a stop 
codon when ultimately subcloned into pGBKT7 where it should be fused to the 
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Gal4 DNA-BD. Both primers have a restriction enzyme sites that will be used for 
later sub-cloning into pGBKT7. The Smal U09086 forward primer is 29 nucleotides 
in length; 4 nucleotides as cozak plus a 7 nucleotide Smal site plus 18 nucleotides 
which are gene specific from the ATG start codon at mRNA sequence position 205 
(see Table 2.2). The Sall-U09086 reverse primer is 28 nucleotides in length; 4 
nucleotides as cozak plus a 6 nucleotide Sall site plus 18 nucleotides which are 
gene specific starting prior to the stop codon at mRNA sequence position 2286 
(see Table 2.2). 
 
Preparation of RNA, RT-PCR, ligation into TOPO-TA-pCR2.1 and transformation 
into E.Coli DH5 α are all as described for lamin A/C (section 3.2.2) (Figure 3.4.a). 
Analysis of transformants were also carried out in an identical manner, except 
miniprep plasmids DNA were cut with SmaI using appropriate buffers. The correct 
fragment was detected in all cases (Figure 3.4.b). A large scale digestion of 
LAP2α clone#1 was made and ligated into prepared pGBKT7 vector as described 
in section 3.2.2 except that SmaI and SalI were used. Analysis of selected 
transformants were made by restricting miniprep plasmid DNA with NcoI, the 
correct orientation was found in all of them (Figure 3.4.c). One of the plasmid was 
selected for DNA sequence as an alternative method to check the full open reading 
frame cloning into pGBKT7 (Appendix IV-2b). 
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3.3.4 Screening of the cDNA Library with the LaminA/C-bait-construct. 
 
Before using the bait constructs in cDNA library screening, they must be tested for 
transcriptional activation and toxicity (see sections 2.11.b.4 and 2.11.b.5 
respectively). The lamin A/C bait-gene was tested for transcriptional activation. The 
colonies were white and only grew on SD/-Trp media. This means that the 
construct does not activate transcription.  However, in separate tests it did show 
toxicity. This was overcome by using the strategy described in section 2.11.b.5. 
After harvesting the lamin A/C bait gene containing cells, they and the cDNA library 
containing cells were counted by using a hemocytometer. 2 ml of cDNA library-
pGADT7 in yeast strain AH109 cells (section 2.11.c.2) and 5 ml of harvested 
lamin A/C bait-gene in yeast strain Y187 were mixed (section 2.11.d.1). After 24 
hours of incubation the mating mixture was tested for zygote formation (Figure 
3.5.b). The mating efficiency was 9.3%. 
 
After 8 days growth on selective media 1000 positive colonies were re-streaked 
onto the master plates to test for MEL1 expression and blue colony formation. 
Colony PCR was applied to these 1000 colonies by using the vector out AD LD-
insert primer set (Table 2.2) (Figure 3.6).   
 
 
3.3.5 Screening of the cDNA Library with the LAP2α-bait-construct. 
 
As described above the LAP2α-bait-gene was also tested for transcriptional 
activation and toxicity. It was found not to activate transcription but it was toxic. So, 
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the strategy described in section 2.11.b.5 was used. The cells were prepared for 
mating to cDNA library containing cells in an identical manner to that described 
above in section 3.2.4.  After 20 hours incubation the mating mixture was tested for 
zygote formation as mentioned in section 3.3.4 and (Figure 3.5.b). The mating 
efficiency was 9.3%. 
 
After 8 days growth on selective media 42 positive colonies were re-streaked onto 
the master plates to be tested for MEL1 expression and blue colony formation. 
Colony PCR was applied for these 42 colonies by using the vector out AD LD-
insert primers set (Table 2.2) (Figure 3.7).   
 
 
3.3.6 DNA sequencing and bioinformatics study. 
 
5ul of product from the colony PCR reactions for both the  1000 positive colonies 
resulting from the lamin A/C screening (section 3.2.4) and the 42 positive colonies 
resulting from the LAP2α screening (section 3.2.5) were sent to the DNA 
sequencing  facility to perform sequence analysis (section 2.12.a).  
 
Sequences data was used in a Bioinformatics study (section 2.12.b). By excluding 
small sequences off less than 200bp and poor sequence data, 11 contigs and 263 
individual sequences resulted from the lamin A/C mating with the cDNA library 
(Table 3.1). 3 contigs and 3 individual sequences resulted from LAP2α mating with 
the cDNA library (Table 3.2). One of the sequences that matched from both 
studies above was Cytochrome c Oxidase subunit II (Cox2) (Figure 4.1).
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3.4 Discussion. 
 
One of the approaches to study the function of a protein is to investigate if this 
protein works in conjunction with others or alone. Are these interactions important 
in the localization or expression of the protein? It was shown before that LAP2α 
binds to lamin A/C. Therefore, it was important to investigate novel protein binding 
to lamin A/C and/or LAP2α. The yeast 2-hybrid technique was employed for this 
study.  
 
A cDNA library was generated from total RNA purified from the epithelial layer of 
normal human colon tissue. Poly A+mRNA was purified from the total RNA this 
was followed by LD-PCR. 0.3-3 kb fraction of the cDNA was co-transformed with 
pGADT7 into AH109 yeast cells. 
 
Full length cDNA of lamin A/C and LAP2α were separately cloned into pGBKT7. 
Lamin A/C-pGBKT7 or LAP2α-pGBKT7 transformed into Y187 yeast cells were 
mated with the cDNA library transformed into AH109 yeast cells. Positive colonies 
from each mating were re-streaked onto master plates for Mel1 reporter gene 
testing and to reduce the background. Each positive colony was amplified using 
the colony-PCR technique. The PCR products were electrophoresed on 1% 
agarose gels. More than 1000 positive colonies resulted from the lamin A/C and 
cDNA library mating. Most of the PCR products were approximately 1000bp in 
size. These PCR products were sent for DNA sequencing. About 42 positive 
colonies resulted from LAP2α and cDNA library mating. The PCR products were 
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between 200bp-400bp in size. Again these PCR products were sent for DNA 
sequencing. 
 
Bioinformatics studies on the DNA sequences from lamin A/C interacting colonies 
were performed. After analysis, 11 contigs and 263 individual sequences were 
resulted. Contig 5  is assembled of 6 sequences out of 366 total sequences. Contig 
5 is 600bp in size and is identical to cytochrome c oxidase subunit II (Cox2). 
Bioinformatics studies on the DNA sequences of LAP2α interacting colonies were 
also performed. After analysis, 3 contigs and 3 individual sequences were resulted. 
Sequence 8 is 521bp in size and is also identical to cytochrome c oxidase subunit 
II (Cox2). 
 
Cox2 is a mitochondrial protein which is encoded by mtDNA. According to the 
Gene Bank (X15759) see (Appendix IV-3c), its sequence contains on poly A tail 
and rich of poly A nucleotides in the medial. This may be the target of cDNA library 
and LD-PCR generation. It localizes into the mitochondrial inner membrane in a 
complex with other proteins to form complex IV (COX) of the mitochondrial 
respiratory chain (MRC). COX is composed of thirteen subunit polypeptides, three 
of which are encoded by mtDNA while the rest are encoded by the nuclear 
genome. Cox2 is the smallest subunit found in COX. It contains on a copper centre 
that has a critical function in receiving electrons from cytchrome c (Capaldi, 1990; 
Tsukihara et al., 1996).  
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COX deficiency was linked to different diseases including Alzheimer disease (AD) 
(Ojaimi and Byrne, 2001). It was found that reduction in COX activity is associated 
with elevation in reactive oxygen species (ROS) and a reduction in ATP production 
in mitochondria from AD derived cells (Cardoso et al., 2004). LMNA mutations 
were implicated in cell stress and ROS production (Caron et al., 2007). LMNA 
mutations such as R439C and R482W were reported in FPLD2 patient and 
implicated in increasing ROS (Verstraeten et al., 2009). Because of that it was 
interesting to focus on the interaction of lamin A/C and LAP2α with Cox2.  
 
Several questions may be asked. Is this interaction real or not? If yes, does Cox2 
localize in the nucleus as well as the mitochondria, or do lamin A/C and/or LAP2α 
localize to the mitochondria as well as the nucleus? To answer these questions, 
western blot analysis following co-immunoprecipitation, immunofluorescence and 
TEM were employed. 
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3.5 Figures. 
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Figure 3.1: 
 
 
Yeast 2-Hybrid Principle: 
 
 
A) DNA- Binding Domain Construction: 
 
The bait gene should be cloned in-frame to the Gal-4 binding domain 
(BD) in plasmid pGBKT7. The construct is then transformed into yeast 
Y187 and AH109 to be tested for toxicity and transcriptional activation 
respectively. The Gal4 DNA Binding Domain of the construct protein 
binds to Gal4 upstream activating sequences (UASs) and TATA boxes of 
the AH109 genome. If it is not a transcriptional activator, the reporter 
genes (His3, Ade2, LacZ and Mel1) will not be transcribed and the 
colonies will grow on SD-Trp plates only. However, if the bait gene has 
any transcription factor function the colonies will grow in blue color on 
SD-Trp/-His3/-Ade2/-Mel1 plates. If this is the case we need to remove 
the activating domain and re-test.  
If it is inactive, a toxicity test needs to be done on the bait gene construct 
transformed into Y187. Some strains do not grow well in liquid media 
compared with the empty vector alone.  
 
 
B) cDNA Library-Activating Domain Construction:  
 
Total or polyA+ mRNA was reverse transcribed to ss cDNA by using the 
CDS III oligo(dt) primer. This primer has oligo-dt sequences and a 
sequence named CDSIII at the 5’ end. When the primer is mixed with the 
RNA it will hybridize to the 3’ end of polyA+ mRNA and generate cDNA 
sequences with GGG at the 5’ end. BD SMART III oliqonucleotide has a 
unique sequence terminating with CCC at the 3’end. When BD smart III 
is mixed with the cDNA it will generate cDNAs starting with the BD Smart 
III sequences and terminating with CDS III. Long-Distance PCR (LD-
PCR) will be used to amplify these copies of cDNA by using primers that 
match with BD Smart III and CDS III. After the LD-PCR was performed, 
the cDNA was purified on a BD chroma spin TE-400 column. The whole 
purified cDNA library was mixed with pGADT7-rec Sma l linearized 
vector and co-transformed to AH109 yeast competent cells. The yeast 
repair enzymes will restore the Sma l-linearized vector to covalently 
closed circles by recombining sequences at the ends of the cDNA library 
with the homologous sequences at the ends of the vector. The outcome 
will be on open reading frame with the activating domain of the vector 
and in the correct orientation with the cDNA. 
 
 
 
 
 
 
A) DNA-BD Construction                   B) cDNA Library construction. 
 
I- Clone Bait gene into               
     pGBKT7 vector.           I) cDNA library construction.  
    
 
      
 
       
Transformed into E. coli DH5α                                    in-vivo recombination.                                                        
 
 
 
 
 
 
                                      
Transformed into Yeast (Y187 & AH109).    Transformed into Yeast (AH109). 
            
 
 
Test for transcriptional activation and  
Toxicity. 
             
                                                                                                                              Plated onto 180X 150mm SD-Leu plates. 
                                                                                                                          Harvesting & aliquots in 2ml and freeze. 
                                                        
 
 
 
 
Count enough number of Y187 yeast    
transformed for mating.                   Count enough number of aliquots cells for mating. 
 
                                                                                                                         
 
 
   
Plated onto SD –Leu/-Trp/His/-Ade 
Figure 3.1 
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Figure 3.2:  
 
 
cDNA library generation: 
 
A) Total RNA extracted from two samples of epithelia layer of normal 
Human Colon Tissue. Sample # 2 was used for cDNA library generation. 
 
B) PCR of β-actin applied to 0.5ug of Total RNA to check for DNA 
contamination. 
 
C) LD-PCR performed on sample 2 RNA to generate the cDNA library. (S) 
cDNA generated from Poly A+ mRNA extracted from human colon 
epithelial tissue. (C) Poly A+ mRNA used as a control. (PCR-C) 3.5 Kb 
PCR fragment was used as reaction control for LD-PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
 
 
 
 
                                                               A) M       1        2 
 
 
 
 
 
                                                              B) M        1       2 
 
 
                                               C) M       C          S       PCR.C. 
 
 
Figure 3.2 
28 S; 4 Kb 
18 S;1.6 Kb 
- M, Marker 0.2-10Kb 
- C, Poly A+ mRNA 
controls. 
- S, Poly RNA Sample, 
- PCR C, LD-PCR 
controls. 
3.5 kb 
Β-actin 
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Figure 3.3: 
 
 
Lamin A-Gal4 DNA Binding Domain Bait Construction (LaminA-BD-
pGBKT7). 
 
A) Two RT-PCR reactions of 50ul each were performed from poly A+ 
mRNA. The resultant bands were excised to be used for cloning into 
TOPO-TA-pCR2.1 (Table 2.2). 
 
B) 40ul of correct clone # 1 of Lamin A+Topo (TA)-pCR2.1 digested with Sfil 
and Sall for gel extraction and purification to be used for sub-cloning into 
prepared pGBKT7. 
 
 
C) 4 correct clones were selected from sub-cloning Lamin A into pGBKT7. 
These were digested with Apal and Sfil to check for the correct 
orientation  which should give a 1.2 kb product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A)     Lamin A/C-RT PCR reactions. 
                                    1                   2 
 
 
 
B) Lamin A/C+ TOPO(TA) pCR2.1 clone # 1 
 
 
 
            
 
 
 
 
 
 
 
 
 
 
                   
 
C) Lamin A/C+pGBKT7 right orientation. 
                            1          2        3           4 
 
 
Figure 3.3 
pGBKT7     7.3 kb 
Lamin A/C  1.2kb 
Lamin A/C ~2kb 
pCR2.1      3.9 kb 
Lamin A/C 1.99kb 
         
          3’ end vector    
              seq. 
 
5’ end Gal4 DNA BD Seq. 
Lamin A/C ~2kb 
(sub-cloning sfi-sall) 
1.2 kb
Apa l  site Sal l  site 
Right Orientation 
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Figure 3.4: 
 
 
LAP2α-Gal4 Binding Domain Bait Construction (LAP2α-BD-pGBKT7): 
 
 
A) Three RT-PCR reactions of 50 ul each were performed from poly A+ 
mRNA. The resultant bands were excised to be used for cloning into 
TOPO-TA-pCR2.1 (Table 2.2). 
 
B) 40ul of correct clone # 1 of LAP2 α + Topo(TA)-pCR2.1 digested with 
Sma l and Sall for gel extraction and purification to be used for sub-
cloning into prepared pGBKT7. 
 
 
C) 5 correct clones were selected from sub-cloning LAP2α into pGBKT7. 
These were digested with Ncol to check for the correct orientation which 
should give a 1.95 kb product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A)  LAP2α-RT PCR reactions. 
                                 1            2             3 
 
 
B) LAP2α + TOPO(TA) pCR2.1 clone # 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C) LAP2α +pGBKT7 right orientation. 
                        1       2      3       4      5 
 
Figure 3.4 
         
          3’ end vector    
              seq. 
 
5’ end Gal4 DNA BD Seq. 
LAP2α ~2.1kb 
 (sub-cloning sma l-
sall) 
Nco l  site Nco l  site 
Right Orientation 
pGBKT7     7.3 kb 
1.95 kb
LAP2α      1.95 kb 
LAP2α      2.08 kb 
pCR2.1     3.9 kb 
LAP2α      2.08 kb 
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Figure 3.5: 
 
 
cDNA Library Activating Domain (AD)-pGADT7 Construction (cDNA 
library(AD)pGADT7):  
 
 
A) Purified LD-PCR product of the cDNA library was co-transformed with 
Smal linearized pGABT7-Rec into AH109 yeast competent cells and 
plated on SD/-Leu plates (~180 plates total of 150-mm size). After 5 days 
colonies appeared and were harvested (section 2.11.c.2). 
 
 
B) Zygote formation after mating one of the bait (BD)-pGBKT7 constructs in 
Y187 with cDNA (AD) pGADT7 constructs in AH109. After 20-24 hours 
incubation with gentle agitation at 50rpm, the cells were observed by 
phase-contrast microscopy at 400x power. When two yeast cells are 
matted, the parent cells will attach and form third loupe, this formation 
called (Zygote). The third loupe called daughter (Diploid) which will 
separate from the parents. After 20 hours most of the cells showed 
zygote formation (Z), after 4 more hours incubation the diploid cells were 
appeared (D). 
 
Scale bar = 10um. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                        A) 
 
 
                         
                        
                        B) 
 
 
 
 
 
 
 
 
 
Figure 3.5 
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Figure 3.6: 
 
 
Analysis of positive colonies resulting from mating the cDNA Library-AD-
pGADT7 with LaminA-BD-pGBKT7: 
 
More than 1000 positive colonies were produced from mating Lamin A/C 
and cDNA library constructs. Colony-PCR was applied to all of them 
(section 2.12.a). This figure shows part of the PCR results. We see a 
primer dimer (Red arrow 100bp) in each reaction plus many have 
indicated inserts (Black arrow 1000bp).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Colony PCR of selected positive colonies generated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 
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Figure 3.7: 
 
 
Analysis of positive clones resulting from mating the cDNA Library-AD-
pGADT7 with LAP2α-BD-pGBKT7: 
 
42 positive colonies were produced from mating LAP2α and the cDNA 
library construct. Colony-PCR was applied to all of them (section 
2.12.a). This figure shows part of the PCR results. Primer dimer (Red 
arrow 100bp) and PCR product (Black arrow 200-600bp)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colony-PCR of selected  positive colonies generated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 
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Table 3.1: 
 
 
Bioinformatics study performed on Lamin A/C interacting colony: 
 
The sequences were imported into Vector NTI software. Using the contig 
Express feature, the unreadable sequences were excluded. 366 
sequences remained out of ~1000 positive colonies sent for DNA 
sequencing. Ambiguous nucleotides (N) were corrected by using the 
chromatographs of the sequence data. 11 contigs and 263 individual 
sequences resulted from the assembly. This table shows only the blast 
results of selected contigs. Contig 5 gave the highest score to 
Cytochrome c Oxidase subunit II (Cox2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-1. Bioinformatics result of Lamin A mating to cDNA-library cells. 
 
 
 
 
 
 
 
 
 
 
Contig Blast 2.0 
Contig No. of Assembled sequences / contig Length (bp) Hit count Score  (Bit) Molecule Name Accession # Position Server
1 3 349 97 39 (77.8) Clone DKFZp686C06106 HSM807040 120-159 NCBI-Blast 
2 19 239 102 39 (77.8) Clone DKFZp686C06106 HSM807040 120-159 NCBI-Blast 
3 19 227 113 39 (77.8) Clone DKFZp686C06106 HSM807040 121-160 NCBI-Blast 
4 3 221 114 39 (77.8) Clone DKFZp686C06106 HSM807040 121-160 NCBI-Blast 
5 6 600 500 448 (888.6) Cytochrome c Oxidase II EU935845.1 152-600 NCBI-Blast 
6 2 336 93 36 (77.8) Clone DKFZp686C06106 HSM807040 118-154 NCBI-Blast 
7 5 1522 93 39 (77.8) Clone DKFZp686C06106 HSM807040 86-125 NCBI-Blast 
8 2 429 76 36 (71.8) Clone DKFZp686C06106 HSM807040 120-156 NCBI-Blast 
9 23 308 100 39 (77.8) Clone DKFZp686C06106 HSM807040 102-141 NCBI-Blast 
10 16 1634 113 41 (81.8) Clone DKFZp686C06106 HSM807040 100-141 NCBI-Blast 
11 5 1371 500 34 (67.8) Clone DKFZp686C06106 HSM807040 124-158 NCBI-Blast 
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Table 3.2: 
 
 
Bioinformatics study performed on LAP2α interacting colony: 
 
 
The sequences were imported into Vector NTI software. Using the contig 
Express feature, the unreadable sequences were excluded. 37 
sequences resulted out of ~42 positive colonies sent for DNA 
sequencing. Ambiguous nucleotides (N) were corrected using the 
chromatographs of the sequence data. This table shows the result of a 
BLAST search of 3 contigs and 3 individual sequences. Sequence 8 
(Seq8) shows a good match match to Cytochrome c Oxidase subunit II 
(Cox2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-2. Bioinformatics result of LAP2α mating to cDNA-library cells. 
 
 
 
Contig Blast 2.0 
Contig No. of Assembled sequences / contig Length (bp) Hit count Score  (Bit) Molecule Name Accession # Position Server
1 20 313 76 39 (77.8) Clone DKFZp686C06106 HSM807040 117-156 NCBI-Blast 
2 9 292 87 39 (77.8) Clone DKFZp686C06106 HSM807040 106-145 NCBI-Blast 
3 5 293 73 36 (71.8) Clone DKFZp686C06106 HSM807040 113-149 NCBI-Blast 
Seq 8  1  521 500 496 (983.7) Cytochrome c Oxidase II EU443512.1 1-496 NCBI-Blast 
Seq L34 1 832 92 303 (601.1) Mediator complex subunit 16 NM_005481.2 103-406 NCBI-Blast 
Seq L43 1 809 84 368 (730) Thyroid hormone receptor-
associated protein complex 
AF121228 118-154 NCBI-Blast 
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Chapter 4: In-Vitro conformation of the putative binding of Cox2 with Lamin 
A/C and LAP2α. 
 
 
4.1 Introduction. 
 
 
4.1.1 Lamin A/C function in health and disease. 
 
To understand the function of lamin A/C, we need to determine the interactions of 
Lamin A/C with other proteins in vivo. Over a decade of work on lamins by many 
investigators has focused on this problem.  
 
 
4.1.1.1  Lamin A/C function in health. 
 
As described in chapter 1 Lamin A/C participates with other lamins to build up the 
lamina structure underneath the inner nuclear membrane (INM)  (Moir et al., 2000; 
Hutchison, 2002; Herrmann and Foisner, 2003; Hutchison and Worman, 2004). 
These studies also showed that A-type lamins are involved in several different cell 
activities, such as the cell cycle, cell signaling and the maintenance of the size and 
shape of the nucleus.  
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4.1.1.2  Lamin A/C function in diseases. 
 
Since 1999 mutations in LMNA have been shown to cause several different 
inherited diseases affecting muscle, fat, bone, skin and nerves. In the gene 
expression hypotheses, A-type lamins are considered to be essential for the 
correct tissue-specific expression of certain genes. Thus, a pathogenic mechanism 
for certain diseases might be a change in gene expression patterns caused by 
mutations in lamin A and C (Worman and Courvalin, 2002). In the mechanical 
stress hypotheses, mutations in lamins A and C are thought to weaken the 
structural integrity of an integrated nucleocytoplasmic skeletal network (Worman 
and Courvalin, 2002). However, A-type lamin mutations were implicated in cell 
stress and reactive oxygen species (ROS) (Caron et al., 2007). Familial partial 
lipodystrophy of Dunnigan type 2 (FPLD2) was caused by mutations in LMNA. 
Belonging to these are R482W and R439C that are associated with a significant 
increase in ROS upon induction of oxidative stress by H2O2 (Verstraeten et al., 
2009).  
  
 
4.1.2 LAP2α function. 
 
LAP2α is one of the binding partners for nucleoskeletal Lamin A/C. When LAP2α 
was immunoprecipitated from nuclear fractions, lamins A/C and 
hypophosphorylated Retinoblastoma (Rb) were co-precipitated efficiently 
(Markiewicz et al., 2002). This study also showed that LAP2α bound strongly to 
pocket C and weakly to pocket B of Rb.  This study suggested that lamin A/C and 
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LAP2α complex is important in tethering Rb protein inside the nucleus. Another 
study showed the function of LAP2α on cell cycle progression and differentiation. 
Several studies have shown the involvement of LAP2α in the cell cycle and nuclear 
envelope (NE) assembly. Studies have shown that LAP2α assembled around 
chromosomes earlier than LAP2β, suggesting that it is one of the first proteins 
among the NE/nucleoskeleton components to associate with chromosomes during 
NE assembly (Foisner, 2003).  
 
When LAP2α expression is decreased it has a negative effect on the growth arrest 
response to serum starvation. When its expression is increased it delays the 
transition from G0 to S phase (Dorner et al., 2006).   
 
 
4.1.3 Mitochondrial Respiratory Chain (MRC). 
 
The mitochondrial respiratory chain (MRC) composes of five multiple subunit 
complexes embedded in the mitochondrial inner membrane (MIM). These 
complexes are; complex I (NADH dehydrogenase), II (succinate-ubiquinone 
oxidoreductase), III (ubiquinol-cytochrome oxidoreductase), IV (cytochrome c 
oxidase (COX)) and V (ATP synthase). Electron transfer in cell respiration is 
coupled with proton translocation across the mitochondrial membrane, which is a 
primary event in energy production (Belevich et al., 2006). Under physiological 
conditions, electron donations from NADH or FADH2 enter the MRC either through 
Complex I or II respectively. Variety of carriers; such as haeme-containing 
cytochrome, iron-sulfur proteins, and ubiquinone (coenzyme Q) are associated in 
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MRC structure and are implicated in transferring electrons from one complex to 
another (Kristal and Krasnikov, 2003) . 
 
Complex I is a 1 MDa complex comprising 45 polypeptides. It is the entry point for 
electrons donated from NADH into the MRC. The structure of the water soluble 
arm of complex I was studied in Thermus thermophilus which are most similar to 
the mammalian homologues and contains the FMN (Flavin Mono-Nucleotide) and 
the FeS (iron-sulfur) centers (Sazanov and Hinchliffe, 2006; Sazanov, 2007). The 
study illustrated that complex I has seven FeS centers in both the hydrophilic arms.  
They are involved in passing the electron from FMN centre through CoQ to O2 and 
to donate an electron from the FMN centre or CoQ to O2 (Sazanov, 2007). 
 
Complex II is also known as succinate dehydrogenase or succinate-ubiquinone 
oxidoreductase. Succinate-ubiquinone oxidoreductase (SQR) of Escherichia coli, is 
often referred to as homologous to Complex II. It is also the entry point of electrons 
donated from FADH2 to MRC. It comprises of two homologous integral membrane 
proteins, Succinate-quinone oxidoreductase (SQR) or succinate dehydrogenase 
(SDH) and quinol-fumarate oxidoreductase (QFR) or fumarate reductase. 
SQR/SDH is involved in the Krebs cycle and aerobic respiratory chain coupling the 
oxidation of succinate to fumarate with the reduction of quinine (Q) to quinol (QH2). 
QFR/fumarate reductase is involved in catalyzing the reverse reaction to SQR 
during anaerobic respiration. SDH is composed of four subunits two of them 
hydrophilic and two hydrophobic, hydrophilic ones are a flavoprotein (SdhA) and an 
ironsulfur (SdhB), while the hydrophobic subunits are SdhC and SdhD. The SdhAB 
are involved in catalyzing the coupling reactions of the oxidation of succinate to 
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furmarate with the reduction of quinone to quinol. SdhAB are anchored to the 
membrane by the hydrophobic subunits SdhCD (Horsefield et al., 2006). 
 
Complex III is a monomer of ~240  KDa and compose of 11 polypeptides, three 
haeme and an FeS centre, and it interacts transiently with CoQ during the Q-cycle 
at the Qi and Qo sites (Iwata et al., 1998). 
 
Complex IV, Cytochrome c Oxidase (COX) is the terminal electron acceptor 
enzyme complex of the mitochondrial respiratory chain. It is important in 
transferring electrons from reduced cytochrome c to molecular oxygen to form 
water (Capaldi, 1990). COX is a complex of thirteen subunits, three of which are 
encoded by MtDNA. The remaining subunits are encoded by nuclear DNA and 
imported into the mitochondrial matrix. It has a Y shape structure made of three 
domains. The two arms of the Y span the lipid bilayer of the inner mitochondrial 
membrane while the third arm extends outside the membrane into the 
intermembrane space (Henderson et al., 1977; Fuller et al., 1979).  
 
Complex V is also known as ATP-synthase. In mitochondria complex V is 
composed of three parts; membrane sub-complex F0 that comprises three 
polypeptide subunits through which protons flow; stator stalk that consists of four 
polypeptide subunits, which connect F0 to F1; and the peripheral catalytic sub-
complex F1 that consists of five polypeptide subunits and carries the nucleotide 
binding sites (Belogrudov et al., 1995; Weber, 2006). 
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4.1.4 ROS production by MRC. 
 
MRC is the main source of ROS production during ATP generation or 
pathogenesis. This ROS production is important in cell signaling in health and 
pathology. Studies were focused on how mitochondria produce ROS; isolated 
mitochondria were performed in the lab. Scientist noticed that ROS was produced 
from complex I, III and IV of MRC. The mechanisms of producing ROS from 
complex I were summarized into two mechanisms: when the amount of 
NADH/NAD+ is high, leading to a reduced FMN site on complex I, and when 
electrons donated to CoQ pool is associated with a high protonmotive force leading 
to RET (reverse electron transport) (Murphy, 2009).  
 
It was shown that when complex III was inhibited by antimycin, accumulation of 
large amounts of superoxide was associated. It was summarized that the amount 
of ROS produced from complex III under physiological conditions is negligible 
compared with the amount that was produced from complex I (Murphy, 2009). 
 
Cox2 is the smallest enzyme of complex IV (COX) of the mitochondrial respiratory 
chain encoded by MtDNA. COX is the terminal electron acceptor enzyme complex 
of the mitochondrial respiratory chain. It is important in transferring electrons from 
reduced cytochrome c to molecular oxygen to form water (Capaldi, 1990).  
 
Mitochondrial dysfunction was associated with Alzheimer disease (AD) and COX 
deficiency (Ojaimi and Byrne, 2001). Reduction in COX activity causes an 
elevation of reactive oxygen species (ROS) and a reduction in ATP production in 
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mitochondria from AD derived cells (Cardoso et al., 2004). Cox2 is one of the 
mitochondrial apoptotic proteins including Apaf-1 and caspase-9 (Mazzanti et al., 
2006).  
 
 
4.2 The aim of this study. 
 
As described above the function of lamin A/C and LAP2α is complex. Therefore it 
is important to look for novel protein interactions to lamin A/C and/or LAP2α. In the 
previous chapter we have shown that Cox2 is one of the putative proteins that bind 
to Lamin A/C and LAP2α. However, the yeast 2-hybrid system may result in false 
positives even with all of the controls provided. So, it is important to use alternative 
methods to confirm the interactions. Because, lamin A/C and LAP2α are nuclear 
proteins and Cox2 is a mitochondrial protein. First, western blots of cell fractions 
were done on HT29 cells to investigate the localization of these proteins. Second, 
co-immunoprecipitation on mitochondrial or nuclear fractions was also provided to 
investigate the in vivo interactions between these proteins.  
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4.3 Results. 
 
 
4.3.1 RT-PCR. 
 
In the previous chapter Cox2 was identified as a putative lamin A/C and LAP2α 
binding protein. It is important to confirm that this protein is expressed and found in 
the original cDNA library. PCR primers were designed to Cox2 (Table 2.2). RT-
PCR was performed using 1ss cDNA generated (section 2.6) from colon epithelial 
RNA (section 2.3.a) (samples 1 and 2 Figure 4.1) and by using 1ss cDNA 
generated from HT29 cell line RNA (samples 3 and 4 Figure 4.1).     
 
 
4.3.2 Western Blot. 
 
Western blots were used to investigate the expression of Lamin A/C, LAP2 α and 
Cox2 in the cytosol, mitochondrial and nuclear fractions. Protein was extracted 
(section 2.13.1) from the HT29 cell line. Protein concentration was determined as 
described in section 2.13.3. Proteins were separated using 10% SDS-PAGE 
(section 2.13.4) followed by immunobloting (section 2.13.5). Four independent 
protein extractions were blotted with Jol2 (lamin A/C antibody) which showed the 
expression of lamin A/C in both the mitochondrial and nuclear fractions but not in 
the cytosolic fraction (Figure 4.2). The same samples were blotted with LAP2α 
antibody which also showed the expression of LAP2α in the mitochondrial and 
nuclear fractions but not in the cytosolic fraction (Figure 4.3). The same samples 
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were further blotted with Cox2 antibody which showed the expression of Cox2 in 
the mitochondrial fraction but not in the cytosolic and nuclear fractions (Figure 
4.4). To show that the fractions were clear of cross contamination, two different 
antibodies were used for all of the samples. Retinoblastoma (Rb) antibody showed 
expression of Rb in the cytosolic and nuclear fractions but not in the mitochondrial 
fraction (Figure 4.5). LAP2β antibody showed expression of LAP2β in the nuclear 
fraction but not in the cytosolic and mitochondrial fractions (Figure 4.6). These 
experiments show the presence of both lamin A/C and LAP2α in mitochondria as 
well as Cox2. The controls showed us that the fractions were cleared of cross 
contamination between each other.  
 
The same blots were subjected to probe by anti-lamin B antibody that recognizes 
both lamin B1 and B2. The lamin B antibody showed expression of lamin B in the 
nuclear fraction but not in the cytosolic or mitochondrial fractions (Figure 4.7). This 
result will confirm that the cell fractions were cleared of cross contamination and 
confirm the distribution of lamin A/C and LAP2α in mitochondria and nucleus. 
 
Because of the dilution factors between the original sample of nuclear, cytosolic 
and mitochondrial fractions were 2.5 (section 2.13.5). The histograms represent 
two bars of each fraction; blue bar for the band density in the loaded sample, red 
bar for the band density in the total sample after it was multiplied by 2.5.  
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4.3.3 Co-Immunoprecipitation. 
 
Having shown interactions between Cox2 and lamin A/C and LAP2α using yeast 
2-hybrid system (Chapter 3) and that these proteins are co-located as determined 
by cell fractionation followed by immunoblotting, it was important to show direct 
protein-protein interactions using another method. The method employed here was 
co-immunoprecipitation. Because, Cox2 is a mitochondrial protein and Lamin A/C 
and LAP2α are nuclear proteins. Immunoprecipitation on protein extracts of 
mitochondrial and nuclear fractions from HT29 cell lines were performed.  Five co-
immunoprecipitations tubes were set as described in section 2.13.2.  Tubes 1 and 
2 are mitochondrial fractions; tubes 3, 4 and 5 are nuclear fractions. Tubes 2 and 3 
were precipitated using Cox2 antibody, while tubes 1 and 4 were the serum 
control. Tube 5 was precipitated by lamin A/C (Jol2) antibody. The supernatant (S) 
and immunoprecipitate (IP) of each sample was resolved using 10% SDS-PAGE. 
After transfer of proteins, the membrane was blotted with Jol2 which detected 
lamin A/C in IP fractions 2 and 5 and S fractions 1, 3, 4 and 5. This result detects 
the presence of lamin A/C in mitochondria which is precipitated by anti-Cox2 
(Figure 4.8a). The same samples were resolved again using 10% SDS-PAGE and 
after transfer of proteins, the membrane was blotted with anti-LAP2α antibody 
which detected the precipitation of LAP2α in samples 2 and 5 but not in samples 1, 
3 and 4. This again shows the interaction of LAP2α with Cox2 in sample 2 and 
lamin A/C in sample 5 (Figure 4.8-1b). The membranes were blotted by anti-Cox2 
antibody which detected Cox2 only sample 1 as expected (Figure 4.8-1c). 
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This experiment was repeated two more times on mitochondrial fraction of HT29 
cell lines as follow. Two co-immunoprecipitation tubes were set as described in 
section 2.13.2. Tube 1 was precipitated using serum, while tube 2 was using anti-
Cox2 antibody. The samples were resolved using 10% SDS-PAGE. The 
transmembranes were blotted with antibody to; lamin A/C (Jol2), LAP2α and Cox2 
respectively. Lamin A/C was detected in IP of sample 2 and S of sample 1 (Figure 
4.8 d&e). LAP2α was detected in IP of sample 2 and S of samples 1 & 2 (Figure 
4.8 f&g) and Cox2 was detected in IP of sample 2 and S of samples 1& 2 (Figure 
4.8 h&i) as well. 
 
 
4.4 Discussion. 
 
From chapter 3, it was shown that Cox2 is one of the proteins that interact with 
lamin A/C and LAP2α. Further experiments needed to be used to confirm this 
interaction and answer the questions that this initial observation raises. 
First of all, RT-PCR shows that Cox2 is expressed in the original tissue that was 
used to generate the cDNA library. Secondly, western blots of cell fractions show 
that the lamin A/C is detected in mitochondrial and nuclear fractions but not in the 
cytosolic fraction. The same samples were blotted with LAP2α antibody which also 
shows that LAP2α is detected in mitochondrial and nuclear fractions but not in the 
cytosolic fraction. By way of contrast, Cox2 was detected only in the mitochondrial 
fraction but not in the cytosolic or nuclear fractions. These blots have been 
subjected to control by probing with different antibodies that show the individual 
cell fractions are clear of cross contamination. Retinoblastoma (Rb) antibody was 
131 
 
used for this and showed that Rb is detected in cytosolic and nuclear fractions but 
not the mitochondrial fraction. LAP2β antibody was used as a second control on 
these blots. Again, LAP2β was detected in the nuclear fraction but not in the 
cytosolic and mitochondrial fractions. 
 
From above experiments, we can conclude that lamin A/C and LAP2α localize in 
the mitochondria as well as the nucleus. However, Cox2 localizes only in 
mitochondria.  
 
Does Cox2 interact with lamin A/C and/or LAP2α as it was suggested in the yeast 
2-hybrid experiments? To answer this, co-immunoprecipitation was performed on 
mitochondrial and nuclear fractions. It was shown by using Cox2 or lamin A/C 
antibodies on the mitochondrial fraction, lamin A/C, Cox2 and LAP2α were co-
precipitated. These experiments confirmed the yeast 2-hybrid result in the previous 
chapter and also the localization of lamin A/C and LAP2α in mitochondria.  
These results raise a question. Is there lamina cage structure underneath of the 
mitochondrial inner membrane like the one in the nuclear envelope? To answer 
this question, anti-lamin B antibody that recognizes both lamin B1 and B2 was 
used on all of the samples. The lamin B antibody showed expression of lamin B in 
the nuclear fraction but not in the cytosolic or mitochondrial fractions (Figure 4.7). 
This result will confirm there is no lamina structure in mitochondria and would be 
good control to show that there were no cross contamination between the cell 
fraction that used in these experiments.  
Further studies need to be performed to confirm this interaction and suggest the 
functions of lamin A/C and/or LAP2α in mitochondria. 
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4.5 Figures. 
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Figure 4.1: Cytochrome c Oxidase subunit II (COX2): 
 
 
Rt-PCR of Cox2 using cDNA generated from normal colon RNA (lanes 1&2) 
and cDNA generated from HT29 cells (lanes 3&4). 
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Figure 4.2: Western Blot of cell fractions with Lamin A/C antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with Jol2 
antibody. Double bands of Lamin A (~69KDa) and C (~65KDa) is detected in 
mitochondrial and nuclear fractions but not in cytosolic fraction. (B) Histogram 
shows the density of both bands. Data are expressed as the mean of at least 
four independent determinations. Blue bar represents the protein expression 
level per band. Red bar represents the expecting protein expression level per 
sample, after multiply the histogram mean of the band by the dilution factor 
between nuclear fraction and other fractions which are (2.5) see section 
(2.13.5).    
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Figure 4.3: Western Blot of cell fractions with LAP2α antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with 
LAP2α antibody. LAP2α is detected in mitochondrial and nuclear fractions but 
not in cytosolic fraction. (B) Histogram shows the density of the bands. Data are 
expressed as the mean of at least four independent determinations. Blue bar 
represents the protein expression level per band. Red bar represents the 
expecting protein expression level per sample, after multiply the histogram 
mean of the band by the dilution factor between nuclear fraction and other 
fractions which are (2.5) see section (2.13.5).    
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Figure 4.4: Western Blot of cell fractions labeled with Cox2 antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with 
Cox2 antibody. Cox2 is detected in mitochondrial fraction but not in nuclear and 
cytosolic fractions. (B) Histogram shows the density of the bands. Data are 
expressed as the mean of at least four independent determinations. Blue bar 
represents the protein expression level per band. Red bar represents the 
expecting protein expression level per sample, after multiply the histogram 
mean of the band by the dilution factor between nuclear fraction and other 
fractions which are (2.5) see section (2.13.5).    
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Figure 4.5: Western Blot of cell fractions with Retinoblastoma (Rb) 
antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with Rb 
antibody. Rb is detected in nuclear and cytosolic fractions but not in 
mitochondria fraction. (B) Histogram shows the density of the bands. Data are 
expressed as the mean of at least four independent determinations. Blue bar 
represents the protein expression level per band. Red bar represents the 
expecting protein expression level per sample, after multiply the histogram 
mean of the band by the dilution factor between nuclear fraction and other 
fractions which are (2.5) see section (2.13.5).     
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Figure 4.6: Western Blot of cell fractions with LAP2β antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with 
LAP2β antibody. LAP2β is detected in nuclear fraction but not in cytosolic and 
mitochondria fractions. (B) Histogram shows the density of the bands. Data are 
expressed as the mean of at least four independent determinations. Blue bar 
represents the protein expression level per band. Red bar represents the 
expecting protein expression level per sample, after multiply the histogram 
mean of the band by the dilution factor between nuclear fraction and other 
fractions which are (2.5) see section (2.13.5).    
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Figure 4.7: Western Blot of cell fractions with Lamin B antibody.  
 
 
(A) Four independent extractions from cytosol (C), mitochondrial (M) and 
nuclear (N) fractions were resolved using 10% SDS-PAGE and blotted with 
antibody to lamin B1 and B2. Lamin B is detected in nuclear fraction but not in 
cytosolic and mitochondria fractions. (B) Histogram shows the density of the 
bands. Data are expressed as the mean of at least four independent 
determinations. Blue bar represents the protein expression level per band. Red 
bar represents the expecting protein expression level per sample, after multiply 
the histogram mean of the band by the dilution factor between nuclear fraction 
and other fractions which are (2.5) see section (2.13.5).     
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Figure 4.8: Immunopreciptation (IP) of mitochondrial and nuclear 
fractions. 
 
 
Experiment # 1: Western blots of immunoprecipitation experiments on cell 
fractions. Sample 1 and 2 are the mitochondrial extract, samples 3,4 and 5 are 
nuclear extracts. Samples 2 and 3 were immunoprecipitated with anti-Cox2 
antibody. Sample 1 and 4 were immunoprecipitated with serum control. Sample 
5 was immunoprecipitated with anti-lamin A/C antibody (Jol2). 
Immunoprecipitate (IP), supernatant (S).  
(A) Samples transferred membrane probed with anti-lamin A/C antibody (Jol2). 
(B) Samples transferred membrane probed with anti-LAP2α antibody. (C) 
Samples transferred membrane probed with anti-Cox2 antibody. 
 
 
Experiment # 2 & 3: Western blots of immunoprecipitation experiments on 
mitochondrial fractions of HT29. Sample 1 was immunoprecipitated with serum 
control. Samples 2 was immunoprecipitated with anti-Cox2 antibody. 
Immunoprecipitate (IP), supernatant (S).  
(D & E) Samples transferred membrane probed with anti-lamin A/C antibody 
(Jol2). (F & G) Samples transferred membrane probed with anti-LAP2α 
antibody. (H & I) Samples transferred membrane probed with anti-Cox2 
antibody. 
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Chapter 5: Localization and functional assay of lamin A/C and LAP2α in 
mitochondria. 
 
 
5.1      Introduction: 
 
 
5.1.1 Cytochrome c Oxidase (Complex IV, COX) structure and function. 
 
Cytochrome c oxidase (COX) which is the terminal enzyme of MRC, it has a 
unique function in energy metabolism. COX is a heterooligomeric complex of 
approximately 200 KDa. It is complicated by its dual genetic origin of thirteen 
subunits (Taanman, 1997) of which the three largest which are Cox1, Cox2 and 
Cox3 are encoded by mtDNA and form the catalytic core of the enzyme. The 
remaining ten subunits such as Cox4, Cox5a, and Cox6a are encoded by nuclear 
DNA and involved in assembly and regulation of the enzyme (Kadenbach et al., 
1991). Up to date, mutations in nuclear encoded proteins such as Surf1, Sco1, 
Sco2, Cox10, Cox15 and LRPPRC have been identified in humans and implicated 
in the assembly of functional COX (Stiburek et al., 2006). Cox1 is highly 
hydrophobic protein composed of twelve transmembrane helices extended by short 
extramembrane loops. It consists Haem a, a3 and CuB that coordinates the 
catalytic site of the enzyme and constitutes the two proton translocation pathways 
(D- and K-pathway) (Wikstrom, 2000). Cox2 is the smallest enzyme of COX 
anchored to the inner membrane of mitochondria with an N-terminal α-helical 
hairpin, whereas it’s large C-terminal hydrophilic domain protrudes into the 
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intermembrane space. Cox2’s C-terminal domain is composed of ten stranded β 
barrel, coordinates the CuA center and serves as a docking site for cytochrome c 
(Capaldi, 1990; Tsukihara et al., 1996). Cox3 is highly hydrophobic protein 
spanning the inner membrane with seven transmembrane helices (Tsukihara et al., 
1996). Investigation in Rhodobacter sphaeroides aa3-type implicated Cox3 in 
maintaining rapid proton uptake through the D-pathway at physiological pH 
(Gilderson et al., 2003).  
 
The remaining 10 nuclear encoded subunits associated on the surface of the 
enzyme. Subunits Cox5a, Cox5b and Cox6b are hydrophilic extramembrane 
proteins, while the rest are hydrophobic proteins, spanning the inner membrane 
once. The small polypeptides were implicated in the stability/assembly of the 
holoenzyme (Ludwig et al., 2001). In addition to the constituent proteins, COX 
contains several metal centers like haeme a, haeme a3, CuA and CuB implicated in 
electron transfer (Taanman, 1997). It also contains cofactors like Zn2, Mg2, Ca2 and 
Na ion (Tsukihara et al., 1996). However, their function and import/insertion 
pathways remain unknown. The mechanism of coupling of electron transfer with 
proton translocation toward intermediate space was illustrated (Belevich et al., 
2006).       
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5.1.2 Synthesis and insertion of haeme moieties and copper ions in COX. 
  
The redox centers involved in electron transfer are composed of two haeme (a and 
a3) and two copper centers (CuA and CuB). This metal center has a critical function 
in COX subunit assembly and catalysis. Defects in the synthesis of the metal 
center often cause a marked reduction in fully assembled COX subunits. The low-
spin haeme a is a six-coordinate haem responsible for transfer of electrons to the 
a3-CuB centre. The high-spin haeme a3 is a five-coordinate haeme that forms a 
heterobimetallic site with CuB where the O2, CO or NO binds (Michel et al., 1998; 
Brunori et al., 2005). Both metal centers haeme a-a3 are enfolded within the 
hydrophobic interior of Cox1 (Carr and Winge, 2003). Surf1 is a 30 KDa protein 
embedded in the mitochondrial inner membrane, composed of two transmembrane 
domains and central loop region facing the intermembrane space (Yao and 
Shoubridge, 1999). Recent evidence from R.sphaeroides implicates Surf1 protein 
in inserting haeme a3 into COX (Smith et al., 2005). Copper ions are important in 
mitochondria for the formation of CuA and CuB centers associated in MRC and for 
incorporation of superoxide dismutase (Cobine et al., 2006). The small proteins 
such as Cox17 and Cox19 were implicated in copper transfer from the cytoplasm 
to mitochondria. Both of them have a copper binding site and dual localization in 
cytoplasm and mitochondria which implicated them to act as a copper shuttle 
(Beers et al., 1997; Nobrega et al., 2002). However, deletion of Cox17 or Cox19 
has no affect on the mitochondrial copper level (Cobine et al., 2004; Cobine et al., 
2006). Sco protein family was implicated in the formation of COX. Sco protein 
family composes of two proteins; Sco1 and Sco2. Sco1 is a copper-binding protein 
member which has the ability to act downstream of Cox17 to deliver CuA to Cox2 
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(Buchwald et al., 1991). Sco2 is a second member of the Sco protein family, also 
containing a copper-binding domain that are implicated in the delivery of CuA to 
Cox2 (Cobine et al., 2006). COX deficiency was identified in either Sco1 or Sco2 
deficient fibroblasts. Over-expression of the mutant Sco proteins in Sco deficient 
fibroblasts fail to rescue COX deficiency (Horng et al., 2005).  
 
 
5.1.3 Assembly of COX in mitochondrial inner membrane. 
  
The assembly of the COX holoenzyme is not fully understood. However, there is 
evidence to show that Cox2 and Cox3 are both required in the assembled 
holoenzyme COX. This suggests that any pathogenic mutation in these proteins 
will affect the assembly of COX decrease overall COX activity (Wielburski et al., 
1982; Wielburski and Nelson, 1983). The half life of the holoenzyme is thought to 
be around three days (Leary et al., 2002). Because, of rapid proteolytic 
degradation is difficult to imagine how the subassemblies of COX are formed. Two 
studies suggest that insertion of Heme a occurs on unassembled Cox1 or during 
formation of Cox1, Cox4 and Cox5 (Tsukihara et al., 1996).  Recent findings also 
suggested that insertion of haeme a within Cox1 stabilizes the binding of Cox1 to 
Cox4-Cox5a heterodimer (Stiburek et al., 2005). Investigations implicated Cox11 in 
the formation of CuB site in Cox1 (Carr et al., 2002). Formation of the CuA site in 
Cox2 is believed to be formed before the association of Cox2 with Cox1-Cox4-
Cox5a sub-complex (Williams et al., 2004; Stiburek et al., 2005). The maturation 
step in forming the COX holoenzyme is by forming a covalent bond on Cox1 
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bridging His240, one of the three histidine ligand of CuB, with conserved Tyr244 
located at the end of the proton translocation K-channel (Yoshikawa et al., 1998). 
 
 
5.1.4 COX in disease. 
 
Cox2 is one of the mitochondrial pro-apoptotic proteins including Apaf-1 and 
caspase-9 (Mazzanti et al., 2006). A putative interaction between Cox2 and 
epidermal growth factor receptor (EGFR) was confirmed in biochemical and 
immunoflurescence experiments. That interaction may play an important role in the 
regulation of apoptosis, but the exact mechanism of translocation of plasma 
membrane bound EGFR to mitochondria is not understood (Boerner et al., 2004). 
EGFR has a critical role in the regulation of cellular processes including cell 
proliferation, differentiation and survival. It’s over expression is associated with 
oncogenesis and cancer development (Biscardi et al., 2000).   
 
Evidence suggests that mitochondrial dysfunction in Alzheimer disease (AD) is 
also linked to COX deficiency (Ojaimi and Byrne, 2001). Reduction in COX activity 
causes an elevation of reactive oxygen species (ROS) and a reduction in ATP 
production in mitochondria from AD derived cells (Cardoso et al., 2004). Mutation 
in Surf1 is associated in COX deficient Leigh syndrome, a subacute necrotizing 
encephalomyopath (Shoubridge, 2001; Pecina et al., 2004). Sco2 mutation is also  
implicated in COX deficiency and associated with encephalopathy and hypertropic 
cardiomyopathy (Papadopoulou et al., 1999).  
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5.2 The aim of this study. 
 
In chapter 3 and 4, the interaction of both Lamin A/C and LAP2α with Cox2 was 
showed by yeast 2-hybrid screen and confirmed by co-immunoprecipitation. It was 
also showed that both Lamin A/C and LAP2α are localized in the mitochondria as 
well as in the nucleus. Alternative methods were necessary to confirm these 
results. Firstly, quantitative immunogold labeling of lamin A/C, LAP2α and Cox2 in 
cryo-sections from HT29 colon carcinoma cell line was suggested to investigate 
co-localization of all three proteins in mitochondria.  
 
Secondly, the cDNA library was generated from colon tissue and used in the yeast 
2-hybrid study. Most of the confirmation methods that were used were on the HT29 
cells. In this study, the phenomena of localization of lamin A in mitochondria and 
interaction with Cox2 were selected for further studies. To investigate whether this 
phenomena is specific to colon or is more general. It was suggested to use 
quantitative immunogold labeling of lamin A on different cell lines; such as 
fibroblast, fibrosarcoma and brain cancer.   
  
Thirdly, it was also important to investigate why lamin A/C or LAP2α might interact 
with Cox2 in mitochondria. In this study, lamin A was selected for further study. 
Cox2 is the smallest subunit that is encoded by mtDNA and localized in COX. COX 
deficiency was implicated in neurodegenerative diseases such as Alzheimer (AD). 
COX deficiency was also associated with ROS production and ATP reduction. 
Recently, LMNA mutations were also implicated in ROS production and oxidative 
stress. Increase mitochondrial mass were implicated in mitochondrial myopathy 
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mice. Increase in mitochondrial mass was associated with reduction in ATP 
generation and mitochondrial abnormality (Wredenberg et al., 2002). Because of 
that, different functional assays were suggested such as; ROS production, 
mitochondrial mass and expression of Cox2.  LMNA null cells were compared 
verses, Lamin B receptor null, Emerin null and fibroblast wild type.  
 
 
5.3 Results 
 
5.3.1  Immunofluorescence (Confocal). 
 
In previous chapters interactions between lamin A/C to Cox2 have been 
demonstrated. Co-immunoprecipitation confirmed the putative interaction of lamin 
A/C and/or LAP2α with Cox2. Western blot identified the expression of lamin A/C 
and LAP2α in the mitochondrial and in the nuclear fractions but not in the cytosolic 
fraction. Alternative methods are necessary to confirm this finding. 
Immunofluorescent (IF) staining was suggested. 
 
HT29 colon cancer cells were grown on cover slips and prepared for IF as 
described in section (2.18). The analysis showed the localization of lamin A and 
LAP2α in the nucleus and nothing in the mitochondria or the cytoplasm. However, 
the analysis showed the localization of Cox2 in mitochondria alone. When compare 
this result with biochemicals, it has different explanations, it may the fixation and 
permeabilization steps need more modification or the antibody cannot enter the 
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mitochondria inner membrane and matrix. However, the case in Cox2 is different, 
because the C-terminus is more accessible and localizes at the intermediate 
space. So, an alternative quantitative immunogold staining was suggested to 
confirm the biochemical’s finding. 
 
 
5.3.2 Immunogold staining. 
 
5.3.2.1 Lamin A/C.  
 
HT29 colon cancer cells were fixed and prepared for transmission electron 
microscopy (TEM). To investigate the specificity of the immunogold particles that 
distributed in mitochondria for lamin A, cryo-sections were stained with a range of 
lamin A antibodies from different sources. All of them identify lamin A (C-terminal). 
Jol2 recognizes the same epitope of lamin A/C corresponding to amino acid 464-
572 and raised in mouse (Table 5.1). Two of which recognize the same epitope of 
lamin A corresponding to amino acid residues 598-611, but one of them is raised 
in rabbit and the second one is raised in mouse (Table 5.1). The forth one 
recognizes the epitope of lamin A corresponding to amino acid 636-650 and raised 
in mouse (Table 5.1). The primary antibodies were followed by secondary 
antibodies as described in section 2.14.  Analysis of at least thirty TEM images 
(section 2.15) shows a distribution of gold particles in both mitochondria and the 
nucleus for all anti-lamin A antibodies used in this study (Figure 5.1, 5.2 & 5.3) 
except Jol2 didn’t show gold particles in mitochondria but showed in the NE (data 
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not show). This has one explanation which is the epitope that Jol2 recognizes is 
not accessible in mitochondria as in the nucleus.  
 
From the previous experiments above, all antibodies that worked gave similar 
results. However, rabbit-anti lamin A antibody was more efficient. Because of that 
this antibody was used in further experiments. The phenomena of localization of 
lamin A/C in mitochondria and its putative interaction with Cox2 were examined in 
colon tissue.  To investigate whether this phenomena is specific for colon or it is 
general. Cryo-sections of normal human fibroblast cells (NHF), fibro sarcoma cells 
(US913T) and brain cancer cells (U373) were prepared and stained with rabbit 
anti-lamin A antibody.  At least thirty images of each cell line were analyzed. In 
each cell line lamin A was detected in mitochondria and nuclei but not in the 
cytosol (Figures 5.4, 5.5 & 5.6). As a negative control sections were probed with 
secondary antibodies alone. No gold particles were detected under these 
conditions (Appendix V).  
 
As a further control for specificity to show that the antibody used in this study did 
not cross-react with unknown proteins in mitochondria which contain of the same 
epitope recognized by anti-lamin A/C. Lamin A/C-/- fibroblast were investigated 
(Muchir et al., 2003). Cryo-sections were prepared and probed with rabbit anti-
lamin A antibody as described in section 2.14. At least thirty images were 
analyzed. The results showed an absence of gold particles in mitochondria, nuclei 
and cytosol (Figures 5.7). This result suggested that the localization of anti-lamin 
A antibody specifically detected lamin A in mitochondria. 
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5.3.2.2 LAP2α.  
 
In previous chapters, similar to lamin A/C, it has shown that LAP2α interacts with 
Cox2 and is also localized in mitochondria as well as the nucleus as determined by 
western blots.  
 
HT29 cryo-sections were prepared and stained with rabbit anti-LAP2α antibody as 
before. Analysis of thirty TEM images showed that LAP2α was detected in the 
cytosol, mitochondria and nucleus. The staining of the mitochondria was more 
intense than in both the nucleus and the cytoplasm (Figure 5.8). This is could be 
because the gold particles were counted per um2 where the surface area of both 
nucleus and cytoplasm are much more compared to mitochondrial surface area. 
Whereas the image showed part of these cell compartments. Localization of 
LAP2α in cytoplasm could be a background or a third place of localization. 
 
 
5.3.2.3 Cox2.  
 
The western blots of cell fractions showed the expression of Cox2 in the 
mitochondrial fraction only. To confirm this finding cryo-section of HT29 were 
prepared and probed with mouse anti-Cox2 antibody. At least thirty TEM images 
showed that Cox2 was only detected in mitochondria (Figure 5.9). 
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5.3.2.4 B-type lamins. 
 
A long time ago, it was found that B-type lamins are specifically associated with 
inner nuclear membrane proteins and implicated in forming lamina structure. Last 
chapter, it was shown by using immunoblotting that B-type lamins are only 
expressed in the nuclear fraction. As an additional control mouse anti-lamin B 
antibody that recognizes lamin B2 was used to probe HT29 cryo-sections. TEM 
images showed that lamin B is only detected in the nucleus (Figure 5.10). 
However, the labeling was all over the nucleus which is unexpected. 
 
 
5.3.2.5 Co-localization and conclusion. 
 
TEM double labeling was suggested for further investigations. Cryo-sections of 
HT29 were subjected to double labeling with rabbit anti-lamin A antibody and 
mouse anti-Cox2 antibody. Three different cell pellets were fixed, embedded and 
sectioned. Then two groups of sections were probed by primary antibodies. Group 
1 was using 10nm and 20nm of gold particles to determine lamin A and Cox2 
respectively (Figure 5.11.1). Group 2 was using 20nm and 10nm of gold particles 
to determine lamin A and Cox2 respectively (Figure 5.11.2). Analysis of images on 
both groups demonstrated the distribution and localization of lamin A and Cox2 in 
mitochondria and lamin A alone in the nucleus. 
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Table 5.1: The selected antibodies were used in TEM. 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.3 ROS production and measurement. 
  
Further investigations were carried out to determine if lamin A has a role in 
mitochondrial function. As explained in the introduction above, Cox2 is a mtDNA 
encoded protein that is a component of COX. COX deficiency was implicated in 
different diseases. COX was also associated with ROS production and ATP 
reduction. Recent studies implicated LMNA mutations in ROS productions and 
oxidative stress (Caron et al., 2007). Because of this the link between ROS 
production in LMNA mutants with the localization of lamin A in mitochondria was 
investigated. Five different cell lines were used; NHF, Lamin A/C-/-, LBR-/+, LBR-/- 
and emerin-/-. LBR and emerin are nuclear integral membrane proteins (Ye and 
Worman, 1994; Clements et al., 2000). They have been implicated in anchoring 
Primary 
Antibodies Target hype Reference 
            
Catalog # EM 
M-Lamin A/C Lamin A/C Mouse-M In house 
            
In house 1:10 
R-Lamin A Lamin A Rabbit-R Sigma 
            
L1293 1:600 
M-Lamin A Lamin A Mouse-M Santa Cruz 
            
Sc-7292 1:10 
M-Lamin A Lamin A Mouse-M Novus 
            
NB 100-674 1:5 
R-LAP2α LAP2α Rabbit-R ImmuQuest 
            
IQ175 1:300 
 
Mt.COX2 
 
Cytochrom C 
Oxidase 
 
Mouse- M Invitrogen 
            
A6404 
1:50 
Lamin B2 
(LN43) B2 Mouse-M Abcam 
             
Ab8983 1:50 
Secondary 
Antibodies Target Type Reference 
- 
EM 
Goat anti-
mouse IgG 
Mouse primary 
antibodies 
Gold 5, 10 
or 20 nm British Biocell International 
- 
1:20 
Goat anti- 
Rabbit IgG 
Rabbit primary 
antibodies 
Gold 5, 10 
or 20 nm British Biocell International 
- 
1:20 
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lamina to the NE (Duband-Goulet et al., 1998; Haraguchi et al., 2000). Whereas, 
different studies showed that emerin null cell lines were implicated in miss-
localization of lamin A into the NE (Capanni et al., 2009). So, if the ROS are 
detected in these entire cell lines, this will implicate the miss-localization of A-type 
lamin in NE with regulating specific genes that are involved in ROS production. 
However, if the ROS level is not detected in these entire cell lines but is only 
detected in lamin null cells, this may illustrate the role of lamin A in mitochondria. 
For instant, it may implicate lamin A in the mitochondrial inner membrane structure 
or in assembling a particular protein in the MRC.  
 
Next the levels of ROS were evaluated by measuring the oxidation status of 
permeant derivative CM-H2DCFDA in these cell lines as described in section 2.16. 
The experiments were repeated at least three times. The median of the FL1 green 
fluorescence of wild-type was made 100% as basal level. Then the median of each 
cell lines including the controls were calculated based on that. Lamin A-/- cells 
showed 10 times fold induction of ROS. LBR mutant cells showed 25-35% 
induction of ROS. Whereas emerin null cell doesn’t produce ROS (Figure 5.12). 
As there is no significant increase of ROS in any of nuclear protein mutant cell 
lines except in Lamin A-/- cells. This result may implicate lamin A directly in 
mitochondrial function. 
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5.3.4 Does Lamin A/C regulate Cox2 gene expression? 
 
The question remains as to how lamin A/C is involved in ROS production. One 
study showed striking decrease in the expression of Cox2 in fibroblasts with LMNA 
mutations. This study was also able to observe low expression in Cox2 in adipose 
tissue sample (Caron et al., 2007). It was thought that Lamin A/C may regulate 
Cox2 gene expression. Thus, western blots were used to quantify the expression 
level of Cox2 in NHF, emerin-/-, LBR-/+, LBR-/- and Lamin A/C-/- cell lines. Total cell 
extracts were resolved using 10 or 12 % one dimensional SDS-PAGE and probed 
with anti-lamin A/C, β-actin and Cox2 antibodies as described in sections 2.13.1-
2.13.5. The blots showed the expression of Cox2 was even in all of the cell lines 
that were used, the blots were normalized using β-actin. This result illustrate that 
lamin A/C doesn’t regulate the expression of Cox2 (Figure 5.13). However, the 
presence of lamin A/C in mitochondria may have an important role in the assembly 
of Cox2 into the COX holoenzyme.    
 
 
5.3.5 Mitochondria mass measurement. 
 
Mitochondrial mass was implicated in mitochondrial abnormality and associated 
with reduction in ATP generation. It was also implicated in myopathy disease 
(Wredenberg et al., 2002). To answer the question of how lamin A/C is involved in 
ROS production, a second suggestion was to measure mitochondria mass in NHF, 
emerin-/-, LBR-/+, LBR-/- and Lamin A/C-/- cell lines. To monitor the mitochondrial 
mass of specific cells, fluorescent dye 10-n-nonyl-acridine orange (NAO) was 
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used. This dye binds specifically to the negatively charged cardiolipin 
(diphosphatidylglycerol) in the mitochondrial inner membrane independently of the 
membrane potential. Cell lines were stained by NAO as described in section (2.17). 
This experiment was repeated at least three times. Then the median of FL1 of wild-
type was made 100% as a basal level. The median of all cell lines were calculated 
base on that. The chart showed that mitochondrial mass was even between the 
entire cells lines used in this study under these conditions (Figure 5.14). The 
conclusion is: first Lamin A/C has no effect on the mitochondria mass. Second the 
increase of ROS in lamin null cell lines was not because of change in mitochondria 
mass between the cell lines that used in this study under this condition. 
 
 
5.4 Discussion. 
 
The previous chapters have suggested that Cox2 protein putatively interacts with 
Lamin A/C and LAP2α. This was shown in yeast 2-hybrid studies and confirmed by 
co-immunoprecipitation. It was also demonstrated that Lamin A/C and LAP2α are 
found in the mitochondria as well as the nucleus but never seen in the cytosol. 
Cox2 is localized only in the mitochondria. 
 
The localization of lamin A/C and LAP2α in mitochondria as well as the nucleus 
was also demonstrated by an alternative method. HT29 cryo-sections and TEM 
images showed the localization of lamin A/C in the matrix of mitochondria and the 
nuclear envelope. This finding was confirmed using three different antibodies 
against lamin A/C. All of them showed significant labeling of lamin A/C in the matrix 
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of mitochondria. These TEM images support my finding in the previous chapters 
that lamin A/C is located in both the mitochondria and nucleus.  
 
To demonstrate that the anti-lamin A antibody did not cross react to other protein 
localized in the mitochondria. Lamin A/C-/- fibroblasts were used to prepare cryo-
sections. All images showed that there is no lamin A gold particles in these 
sections. 
 
HT29 cryo-sections were also prepared for immunogold labeling with antibodies to 
LAP2α and Cox2. Again, as it was suggested in western blots, LAP2α is distributed 
in mitochondria and the nucleus but not in the cytosol. However, the cryo-sections 
that were stained with anti-Cox2 didn’t show significant labeling in the nucleus or 
cytosol but was significant in mitochondria. This result illustrated that LAP2α is 
presented everywhere inside the cell including mitochondria. Whereas, Cox2 is 
localized only in mitochondria. 
 
It was confirmed that B-type lamins are associated in the lamina structure at NE. 
To investigate if lamina-like structure may form in the mitochondria, western blots, 
cryo-sections of HT29 were suggested by probing with anti-lamin B antibody. 
There was no lamin B expression in either cytosol or mitochondria. Moreover, there 
was no significant gold labeling in either mitochondria or cytosol. The labeling was 
all over the nucleus which is unexpected. However this result confirms there is no 
lamina-like structure at mitochondria and supports that the fractions were used 
were cleared of cross contamination.  
 
 157 
 
The initial investigation in this study was performed using a cDNA library generated 
from normal human colon tissue and all of the confirmation experiments were 
performed on a single colon cancer derived cell line (HT29). Therefore, I need to 
investigate the possibility that this phenomenon is peculiar to colon cell. To answer 
this question, TEM experiments were performed on a range cell lines from different 
tissue. The cell lines used were normal human fibroblast (NHF), Fibro sarcoma 
(US913T) and brain cancer (U373). The data shows that lamin A/C is distributed in 
mitochondria as well as the nucleus in all cell types, indicating that this is a general 
property of lamin A/C.    
 
To demonstrate that lamin A/C has a functional role in mitochondria, ROS 
production was measured in different cell lines. ROS was significantly elevated in 
Lamin A/C-/- cell lines compared to other cell lines used in this study. This result 
demonstrates the link between the localization of lamin A/C in mitochondria with 
ROS production. 
 
The question as to how lamin A/C is involved in ROS production was addressed 
next. One suggestion was that Lamin A/C regulates Cox2 protein levels (Caron et 
al., 2007). Western blots of NHF, emerin-/-, LBR-/+, LBR-/- and Lamin A/C-/- cell lines 
showed even in the expression levels of Cox2 protein. This result illustrate that 
lamin A/C doesn’t regulate the expression of Cox2.  
 
A second possibility is that lamin A/C is involved in mitochondria division. Alteration 
in mitochondrial mass was implicated in different diseases (PD), mitochondrial 
abnormality and reduction of ATP generation (Wredenberg et al., 2002). 
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Measurement of mitochondrial mass on NHF, emerin-/-, LBR-/+, LBR-/- and Lamin 
A/C-/- cell lines was suggested. The results showed no difference in mitochondrial 
mass resulting from loss of expression of lamin A/C or other NE proteins. 
  
In summary these results indicate that lamin A/C and LAP2α are localized in the 
mitochondria and in the nuclei. The localization of A-type lamins in mitochondria 
may implicate in regulating ROS production. From the experiments above A-type 
lamins do not regulate the expression of Cox2 or affect mitochondrial mass. This 
may illustrate that A-type lamins have critical role in assembling Cox2 protein to the 
holoenzyme structure of COX. 
 
The localization and interaction of A-type lamins and LAP2α with Cox2 at 
mitochondria requires more experiments to be done. First, by generating different 
domain of GFP-Lamins or GFP-LAP2α constructs and transforms them in lamin 
A/C null or LAP2α null cell lines respectively. This will allow us to study the 
localization of these proteins in mitochondria. Secondly, in vitro overlay assay from 
those constructs may help us to define the binding entire domain on each of which 
to Cox2 recombinant protein.  
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5.5 Figures. 
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Figure 5-1: Immunogold labelling of HT29 cell lines using Rabbit anti-
Lamin A antibody (Sigma). 
 
HT29 were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-2: Immunogold labelling of HT29 cell lines using mouse anti-
Lamin A/C antibody (Santa Cruz Biotechnology, INC.). 
 
HT29 were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-3: Immunogold labelling of HT29 cell lines using mouse anti-
Lamin A antibody (Novus Biologicals). 
 
HT29 were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-4: Immunogold labelling of Normal Human Fibroblast cell lines 
using Rabbit anti-Lamin A antibody. 
 
NHF were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red, dark orange 
and blue arrows represent gold labeling of the nucleus, cytosol and 
mitochondria respectively. Secondary antibody alone was used as a negative 
control image in (Appendix V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-5: Immunogold labelling of Human Fibro-sarcoma (US913T) cell 
lines using Rabbit anti-Lamin A antibody. 
 
Fibrosarcoma were fixed, embedded and sectioned. Sections were prepared 
from at least three different blocks. The distribution of gold particles between 
cytosol, mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red, dark orange 
and blue arrows represent gold labeling of the nucleus, cytosol and 
mitochondria respectively. Secondary antibody alone was used as a negative 
control image in (Appendix V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-6: Immunogold labelling of Human Brain cancer cells (U373) 
using Rabbit anti-Lamin A antibody. 
 
Brain cancer cell were fixed, embedded and sectioned. Sections were prepared 
from at least three different blocks. The distribution of gold particles between 
cytosol, mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red, dark orange 
and blue arrows represent gold labeling of the nucleus, cytosol and 
mitochondria respectively. Secondary antibody alone was used as a negative 
control image in (Appendix V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nuclear envelope (NE), as the mean + SD (n= 30 
images, 10 images of each cell pellet). Significance was calculated using the 
Student t-test. P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-7: Immunogold labelling of Lamin A/C-/- cell lines using different 
antibodies. 
 
Lamin A/C-/- were fixed, embedded and sectioned. Sections were prepared from 
at least three different blocks. A, B, C and D represent selected images.  Red, 
and blue arrows represent gold labeling of the nucleus and mitochondria 
respectively. Secondary antibody alone was used as a negative control image 
in (Appendix V).   
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Figure 5-8: Immunogold labelling of HT29 cell lines using Rabbit anti-
LAP2 alpha antibody ( ImmuQuest). 
 
HT29 were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red, dark orange 
and blue arrows represent gold labeling of the nucleus, cytosol and 
mitochondria respectively. Secondary antibody alone was used as a negative 
control image in (Appendix V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nucleus, as the mean + SD (n= 30 images, 10 
images of each cell pellet). Significance was calculated using the Student t-test. 
P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-9: Immunogold labelling of HT29 cell lines using mouse anti-
Cox2 antibody (Invitrogen). 
 
HT29 were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red, dark orange 
and blue arrows represent gold labeling of the nucleus, cytosol and 
mitochondria respectively. Secondary antibody alone was used as a negative 
control image in (Appendix V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nucleus, as the mean + SD (n= 30 images, 10 
images of each cell pellet). Significance was calculated using the Student t-test. 
P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-10: Immunogold labelling of HT29 cell lines using mouse anti-
Lamin B antibody (Abcam). 
 
HT29 cell were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. The distribution of gold particles between cytosol, 
mitochondria and nuclei was quantified. At least ten images per cell 
compartments were analyzed. The average of the gold particles was divided by 
the average of the surface area. The density of gold labeling was evaluated by 
calculating the gold particles/um2.  
A, B, and C represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
D. Bar chart representing the value of the density of gold labeling expressed in 
the cytosol, mitochondria and nucleus, as the mean + SD (n= 30 images, 10 
images of each cell pellet). Significance was calculated using the Student t-test. 
P < 0.005. Comparing mitochondria or nucleus to cytosol. 
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Figure 5-11-1: Immunogold double labelling of HT29 cell lines using 
Rabbit anti-Lamin A antibody and mouse anti-Cox2 antibody. 
 
HT29 cell were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. 10 and 20nm of gold particles were used to 
determine lamin A and Cox2 respectively.  
A, B, C and D represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
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Figure 5-11-2: Immunogold double labelling on HT29 cell lines using 
Rabbit anti-Lamin A antibody and mouse anti-Cox2 antibody. 
 
HT29 cell were fixed, embedded and sectioned. Sections were prepared from at 
least three different blocks. 20 and 10nm of gold particles were used to 
determine lamin A and Cox2 respectively.  
A, B, C and D represent selected images from each cell pellet. Red and blue 
arrows represent gold labeling of the nucleus and mitochondria respectively. 
Secondary antibody alone was used as a negative control image in (Appendix 
V).   
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Figure 5.12: Lamin A/C functional assay in mitochondria.  
 
Reactive Oxygen Species (ROS) production was measured in terms of the 
oxidation of CM-H2DCFDA and normalized to 10,000 events/ sample. Sample 
was run in FACS-calibre by using filter 1 (green).  
A. NHF solid red was used as cell control or treated with 1% DMSO gray or 
5uM Valinomycine yellow for 12hrs as a negative control or ROS production 
positive control respectively.  
B, C, D, E. Lamin A-/- violet, LBR-/+ (Heterozygote) blue, LBR-/- (Homozygote) 
green and Emerin-/- (KK) brown, used to measure ROS production respectively.  
F. The overlays of the FACS result from all cell lines used in this study 
excluding the treatments.  
G. Bar chart representing the percentage of ROS level. The median of the FL1 
FACS data were analyzed. The cell control was made 100%, and all cell types 
were analysis based on that. The mean + SD (n= 3 individual experiments).  
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Figure 5.13: Cox2 gene expression. 
 
Western blot of cell total extracts of NHF, Emerin-/-, LBR-/+, LBR-/- and  
LaminA/C-/-  cell lines were performed. Trans-membrane probed with antibody 
to lamin A/C, β.actin and Cox2 antibodies. The expression of lamin A/C loss in 
lamin A/C-/- compare to other cell lines. The expression of Cox2 was identical in 
all cell type used in this experiment.  
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Figure 5.14: Mitochondria mass.  
 
Mitochondria mass was measured using 10-n-nonyl-acridine orange (NAO) 
followed by FACS. Samples were run in FACS-calibre and normalized to 10,000 
events/sample 
A. NHF was used as cell control without dye (NHF –NAO) solid light blue or 
NHF with die as basal level (NHF +NAO) red.  
B. NHF treated with 5uM Valinomycine (yellow) for 12hrs was used as a dye 
sensitivity and stability when mitochondrial outer membrane potential are 
changed by ROS production.  
C, D, E and F. Lamin A-/- violet, LBR-/+ (Heterozygote) blue, LBR-/- 
(Homozygote) green and Emerin-/- (KK) brown used to measure mitochondria 
mass respectively versus NHF -NAO.  
G. Bar chart representing the percentage of the mitochondria mass. The 
median of the FL1 FACS data were analyzed. The cell control was made 100%, 
and all cell types were analysis based on that. The mean + SD (n= 3 individual 
experiments). 
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Chapter 6: Discussion: 
 
Changed expression of lamin A/C has been associated with different cancers, such 
as lymphoma and leukemia  (Agrelo et al., 2005), lung cancer (Kaufmann et al., 
1991) and colon cancer which suggested that changed lamin expression in colon 
cancer could be a biological marker of malignancy (Moss et al., 1999). One study 
in colorectal cancer showed that the expression of A-type lamin in tumors leads to 
a more aggressive-form. This study also demonstrated that lamin A expression 
was associated with high cell motility, loss of cell adhesion and invasiveness (Willis 
et al., 2008). In other studies down regulated expression of lamin A was correlated 
to rapid growth within basal cell carcinomas, while down regulated expression of 
lamin C was correlated with slow growth within similar tumors. These finding 
suggest that lamin A has a negative influence on cell proliferation (Venables et al., 
2001; Tilli et al., 2003). Nucleoplasmic complexes of Lamin A/C/LAP2α interact 
with the tumor suppressor retinoblastoma (Rb) has been reported (Markiewicz et 
al., 2002). This interaction may help in regulating the expression of Rb-E2F-
dependent target genes and in cell differentiation (Dorner et al., 2006). It has also 
been reported that three different transcription regulators bind strongly to A-type 
lamins: the kruppel-like protein (MOK2), the sterol response element-binding 
protein (SREBP1) and c-Fos (Ozaki et al., 1994; Dreuillet et al., 2002; Lloyd et al., 
2002; Ivorra et al., 2006). Therefore, the aim of this research was to understand 
more about the function of Lamin A/C and LAP2α in colon epithelial cells, and their 
role in colorectal carcinoma. To achieve this, I wished to identify novel proteins that 
bind to Lamin A/C and/or LAP2α in colon tissue using a yeast 2-hybrid system.  
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Mitochondrial cytochrome c oxidase subunit II (Cox2) was the protein found to 
interact most frequently with lamin A/C and LAP2α in the yeast 2-hybrid screen. To 
confirm this finding, a second independent experimental technique was used to 
directly demonstrate the interaction between lamin A/C, LAP2α and Cox2. Co-
immunoprecipitation from mitochondrial fractions showed an in-vitro interaction 
between lamin A/C and LAP2α and Cox2. 
 
Given the different reported cellular locations of lamin A/C, LAP2α (Nucleus) and 
Cox2 (mitochondria) this result was surprising (Taanman, 1997; Dechat et al., 
1998; Hutchison, 2002). Thus, additional experiments were needed to determine if 
the proteins could co-localize in cells. Therefore, biochemical assays of cell 
fractions were performed. HT29 cells were fractionated into cytosol, mitochondrial 
and nuclear cell fractions. Lamin A/C and LAP2α were shown to be localized in the 
mitochondrial as well as the nuclear fractions but not in the cytosol. When these 
fractions were subjected to blotting with anti-LAP2β and anti-Rb antibodies, the 
results confirmed that the fractions were not cross contaminated. When the same 
blots were probed with anti-Cox2 antibody, Cox2 was only found in the 
mitochondria. These data suggest that both lamin A/C and LAP2α are localized in 
mitochondria as well as the nucleus. This finding raised a question as to whether a 
lamina-like structure exists in mitochondria. To address this question samples were 
blotted with antibody against lamin B1 and B2. Neither B-type lamin blotted was 
found in mitochondria. 
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To confirm the localization of both lamin A/C and LAP2α in mitochondria, HT29 
cells were subjected to fixation and cryo-sectioning for TEM analysis using 
immunogold labeling with different antibodies. Different anti-lamin A/C antibodies 
showed a localization of Lamin A/C in nuclei and mitochondria. Anti-LAP2α 
antibody was used, LAP2α was found in nuclei and mitochondria. The phenomena 
of localization of lamin A/C in mitochondria and its putative interaction with Cox2 
were issued in colon tissue.  To investigate whether this phenomena is specific for 
colon or colon cancer or it is general in normal tissue or different cancer. Cryo-
sections of normal human fibroblast cells (NHF), fibro sarcoma cells (US913T) and 
brain cancer cells (U373) were prepared and stained with rabbit anti-lamin A 
antibody. In each cell line lamin A was detected in mitochondria and nuclei but not 
in the cytosol. As a further control for specificity to show that the anti-lamin A 
antibody used in this study did not cross-react with unknown proteins in 
mitochondria which contain of the same epitope recognized by anti-lamin A/C. 
Lamin A/C-/- fibroblast were investigated (Muchir et al., 2003). Cryo-sections were 
prepared and probed with rabbit anti-lamin A antibody. The results showed an 
absence of gold particles in mitochondria, nuclei and cytosol. This result suggested 
that the localization of anti-lamin A antibody specifically detected lamin A in 
mitochondria. As a negative control sections were always probed with secondary 
antibodies alone. No gold particles were detected under these conditions. 
 
Most mitochondrial proteins are encoded by nuclear DNA and translated in the 
cytosol. A specific pathway exists for these proteins to enter mitochondria. Three 
characteristics are important for this import into mitochondria: (1) An N-terminal 
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mitochondrial-targeting sequence, (2) un-folded proteins are imported into 
mitochondria so all of these proteins should interact with one of the chaperone 
proteins found in the cytosol (cytosolic Hsc 70 or MSF), and (3) translocation of 
proteins to the mitochondrial matrix happens only at rare sites where the outer and 
the inner mitochondrial membrane are juxtaposed. One of these criteria was 
investigated for both lamin A/C and LAP2α by constructing a helical-wheel of the 
first 18 amino acids the amphipathic nature of the Lamin A/C and LAP2α N-
terminal domains in silico (Figure 6.1 and 6.2). The result show the possibility of 
both lamin A/C and LAP2α contain of MTS on their N-terminus. 
 
The interactions of lamin A with chaperones such as Hsp70 have been 
investigated (Willsie and Clegg, 2002). It was also suggested that chaperones such 
as Hsp25 and Hsp70 may have a role in stabilizing lamins network (Adhikari et al., 
2004). These finding in addition to the data shows in this study illustrate how lamin 
A/C may be imported into mitochondria. It was shown that lamin assembly in-vitro 
involve lateral interaction via coiled-coil associations of α-helical rod domains of 
two lamin chains to form homodimers (Stuurman et al., 1998). This raises several 
questions need to be demonstrated; how a homodimer of lamin A imported to 
mitochondria and does lamin A make a filament. To address these questions 
further investigation are required. Further studies need to investigate the 
importance of LAP2α into mitochondria.     
  
This study shows; 1) the complex of lamin A/C and LAP2α with Cox2 and 2) the  
co-localization of lamin A/C and LAP2α in mitochondria and nuclei. However, the 
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function of lamin A/C and/or LAP2α in mitochondria needs further investigation. A 
main function of mitochondria is to make a balance in utilization and releasing of 
NO, H2O2, O-2 through ATP generation and the redox system responding to the 
needs to cell proliferation, differentiation and apoptosis pathways in health and 
diseases (Huang et al., 2000; Wang et al., 2000). Since, both lamin A/C and Cox2 
have been implicated in ROS production. The measurements of ROS level in 
presence and absence of A-type lamin was suggested. Therefore, lamin A/C-/- 
(Y259X) and normal human fibroblast (NHF) cells were then used. Y259X is a 
fibroblast with a homozygous nonsense mutation in LMNA which does not express 
A-type lamins and has a slow growth rate (Muchir et al., 2003). ROS levels were 
very high compared to NHF. To investigate whether increased ROS levels are 
linked to the localization of lamin A in mitochondria. Three more cell lines were 
selected LBR-/- homozygous, LBR-/+ heterozygous, emerin null. In the study ROS 
production was always higher in the Lamin A/C-/- cells compared to other nuclear 
envelope knock out cell lines or control cells treated with 1% DMSO or 5uM 
Valinomycin. This experiment suggests that the localization of lamin A/C in 
mitochondria might be important in regulating ROS levels.  
 
Increases of ROS in LMNA null cells were raised a question as how lamin A/C is 
involved in ROS production. A recent study demonstrated that in Lamin A/C mutant 
cells prelamin A accumulated, ROS production increased and Cox2 levels 
strikingly decreased (Caron et al., 2007). In my study, it was confirmed that lamin 
A/C interacts with Cox2 and localizes in mitochondria. So, two things may explain 
the importance of this finding. The first one is to look for the expression of Cox2 
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protein in the presence or absence of lamin A/C. Therefore, NHF, LBR-/+, LBR-/-, 
emerin-/- and Lamin A/C-/- cell lines were selected for western blot experiments. 
The results showed the expression of Cox2 was even in all of the cell lines that 
were used. 
  
Mitochondrial mass has been implicated in mitochondrial abnormalities and 
associated with reduction in ATP generation. It was also implicated in myopathy 
disease (Wredenberg et al., 2002). So, the second one is to look for mitochondrial 
mass in the presence or absence lamin A/C. The same selection of cell lines was 
used. The experiments showed there was no change in mitochondrial mass in all 
the cell lines that were used in this study.  
 
From the study above, the localization of lamin A/C in the mitochondria and it is 
interaction with Cox2 was implicated in ROS production. However, lamin A/C has 
no effect on the expression level of Cox2 or on the mitochondrial mass. These 
findings may implicate lamin A/C in the assembly process of COX by anchoring 
Cox2 to the right position. It may have special role in forming the mitochondrial 
unique cristae structure which may have important role in mitochondrial functions. 
These things need further study. 
 
Mitochondria play an important role in both cell life and death. Mitochondria are 
essential for the production of ATP, through oxidative phosphorylation. 
Mitochondria regulate intracellular Ca2+ levels and generate reactive oxygen 
species (ROS). ROS function as cellular switches for signaling pathways involved 
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in cell growth, cell death, mitogenesis, angiogenesis and carcinogenesis (Desouki 
et al., 2005). Recent evidence has shown that ROS are implicated in inducing 
premature senescence through prolonged oxidative DNA-damage in bone marrow 
(BM) cells enriched for hematopoietic stem cells (HSCs) and progenitor cells 
(Zhang et al., 2007). Inhibition of one of the mitochondrial respiratory complexes 
will reduce the complex activity which increases ROS production and reduces cell 
viability.  
 
Cytochrome c oxidase (COX) also known as complex IV which is the terminal 
enzyme of MRC, has a unique function in energy metabolism. COX has a critical 
role in the consumption of molecular oxygen involved in the aerobic part of the 
energy production of the cell. Because the activity level of COX is low in cancer 
cells (Chen and Pervaiz, 2009), the cell switches to glycolysis to produce ATP 
(Marin-Hernandez et al., 2009). Reduction in COX activity causes an elevation of 
reactive oxygen species (ROS) and a reduction in ATP production in mitochondria 
from AD derived cells (Cardoso et al., 2004). COX deficiency is involved in Leigh 
syndrome and fatal and benign infantile myopathies (DiMauro et al., 1983; Rahman 
et al., 1996). Mutations in the SURF-1 gene on chromosome 9 have been identified 
in patients with Leigh syndrome. It was suggested that SURF-1 may have an 
important role in COX assembly (Tiranti et al., 1998; Zhu et al., 1998). 
Investigations have shown that by using siRNA to subunit Cox Vb of COX 
holoenzyme (MRC-complex IV) activity was low, mitochondrial ROS was high and 
cell viability reduced (Campian et al., 2007). Mutations in nuclear genes that 
encode COX proteins have been reported in Cox10, and Cox15 which are 
182 
 
associated with leukodystrophy, Leigh syndrome, sensorineural deafness and fatal 
infantile hypertrophic cardiomyopathy (Valnot et al., 2000b; Antonicka et al., 2003a; 
Antonicka et al., 2003b). 
 
Cox2 is the smallest subunit encoded by mtDNA and assembled to COX. It 
contains CuA center and serves as a docking site for cytochrome c (Capaldi, 1990; 
Tsukihara et al., 1996). Cox2 is one of the mitochondrial pro-apoptotic proteins 
including Apaf-1 and caspase-9 (Mazzanti et al., 2006). A putative interaction 
between Cox2 and epidermal growth factor receptor (EGFR) was confirmed in 
biochemical and immunoflurescence experiments. This interaction may illustrate 
the role of Cox2 in apoptosis (Boerner et al., 2004). The expression of nuclear 
encoded NADPH-oxidase 1 (Nox1) and localized in mitochondria is controlled by 
Cox2 and this control is mediated by ROS production (Desouki et al., 2005).  The 
p53 gene is commonly mutated in cancer cells. It has been shown that the 
expression of Cox2 is increased in wild-type but not in mutant p53 colon cancer 
cells. This shows that p53 regulates Cox2 expression (Yu et al., 1999). In p53-/-  
mice the  mitochondrial respiratory process are reduced because p53 modulates 
the balance between the utilization of aerobic and glycolytic pathways by regulating 
the expression of Cox2 (Matoba et al., 2006). It was suggested that p53 is involved 
in the regulation of Cox2 protein levels. 
 
There is increasing evidence that implicates mtDNA in different diseases. 
Mutations in the Co I and Co II genes, which encode Cox1 and Cox2 respectively, 
were reported diseases, such as neonatal-onset hepatic failure, encephalopathy, 
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fatal infantile hypertrophic cardiomyopathy and spinal muscular atrophy (Jaksch et 
al., 2000; Valnot et al., 2000a; Salviati et al., 2002). Missense mutations in CO II 
have been identified in a 14-years old boy with proximal myopathy and lactic 
acidosis. A thymine to adenine transversion at nucleotide position 7671 in CO II 
(T7671A) changes a methionine to lysine residue in the middle of the N-terminal 
region of Cox2. This mutation is a heteroplasmic and has a high level of mutant 
load (90%) in the skeletal muscle. This result in a dramatic decrease in Cox1 
associated with haeme a3, a reduction in cross reactivity of Cox3 and the nuclear 
encoded subunits of complex IV Vb, VIa, VIb, and VIc. This observation suggests 
that the structural associations of Cox2 and Cox1 are important in the stable 
binding of heme a3  to Cox1 (Rahman et al., 1999). A novel mutation T7587C, in 
CO II was also found in a patient with Cox deficiency. This mutation changes 
methionine to threonine with a mutant load of 67% in muscle biopsies and increase 
ROS level (Clark et al., 1999).  
 
Low levels of mitochondrial activity are associated with high cell proliferation rate 
(Nisoli et al., 2003; Navarro et al., 2005). Proliferating, embryonic and tumor cells 
are low in mitochondrial number, Nitric oxide (NO), which also results in low H2O2 
production (Simonnet et al., 2002). Colon epithelial cells show not only abnormal 
proliferation, differentiation and apoptosis processes (Bedi et al., 1995), but also is 
associated with a significantly depressed steady state mitochondrial mRNA 
(Augenlicht et al., 1991), mitochondrial enzymatic activity (Sun et al., 1981) and 
alterations in mitochondrial membrane potential (Summerhayes et al., 1982). 
However, cancer cells over expressing Bcl-2 shows an increase in COX activity, 
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oxygen consumption and mitochondrial respiration (Desouki et al., 2005; Chen and 
Pervaiz, 2007). This suggests that Bcl-2 may be able to create an environment in 
the cancer cell suited for survival by regulating mitochondrial respiration and 
keeping ROS levels under control.  
 
Lamin A/C mutations and a lack of Lamin A function have been implicated in a 
wide range of different diseases such as skeletal and cardiac muscular dystrophies 
and premature aging (Donadille et al., 2005). A lack of lamin A activity in 
cardiomyocyte nuclei results in altered nuclear shape, a distorted nuclear 
envelope, severe heterochromatin reorganization and nuclear interior remodeling 
(Fidzianska et al., 2008). A mutation in the lamin A/C gene (LMNA) has been 
reported to be the cause of dilated cardiomyopathy (DCM) (Fujimori et al., 2008). A 
subject with familial dilated cardiomyopathy has lamin A mutations E203G, E203K 
and K201R. All are associated with increased cell death and decreased lamin A 
sumoylation, which may demonstrate the importance of SUMO modification in 
normal lamin A function  (Zhang and Sarge, 2008). However, a recent study 
demonstrated that in Lamin A/C mutant cells prelamin A accumulated, ROS 
production increased and Cox2 levels strikingly decreased (Caron et al., 2007). 
Familial partial lipodystrophy of Dunnigan type 2 (FPLD2) was caused by 
mutations in LMNA. Belong of those R482W and R439C that associated with 
significant increase in ROS upon induction of oxidative stress by H2O2 (Verstraeten 
et al., 2009). These findings implicate lamin A/C in ROS production within the cell. 
This led to the link between lamin A/C and mitochondrial function as the main 
source of ROS production in cells. 
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The above evidence implicates lamin A/C in the apoptotic pathway and ROS 
productions as well as the more well known roles in nuclear structure and function. 
The new findings in this study demonstrate the localization of lamin A/C and LAP2α 
in mitochondria and their interaction to Cox2. The interaction with Cox2 may be 
helps us understand the link between lamin A/C, ROS production and the 
apoptosis pathway. It becomes obvious that A-type lamins have no effects on the 
expression level of Cox2 and on the mitochondrial mass. Missense mutation in Co 
II have been implicated in a dramatic change in COX structure, decrease Cox1 
associated with haeme a3 and reduction in cross reactivity of Cox3 (Rahman et al., 
1999). This may suggest the importance of localization of A-type lamins in 
mitochondria and it is interaction to Cox2, which may implicate A-type lamins in the 
assembling of Cox2 into COX. 
 
It was demonstrated a long time ago that Lamin A/C contains a specific chromatin 
binding site which may be important in interacting with other cellular structures 
(Glass et al., 1993). Recently, it was found that lamin A/C is required for a 
reduction of heterochromatin in viral promoters during lytic infection. This result 
shows that lamin A/C can serve as a molecular scaffold for DNA and the protein 
complexes that regulate both euchromatin and heterochromatin modification (Silva 
et al., 2008). It was also shown that disruption of lamin A/C prevents plasmid DNA 
transport through the nuclear envelope (Ondrej et al., 2008). In conclusion, it is 
important to note that lamin A/C is localized in compartments of the cell that 
contain DNA, which may link the importance of lamin A/C in regulating DNA 
structure and function. If this exists it may implicates lamin A/C in two major roles. 
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One links with the nucleus and the other to the mitochondria. The localization of 
lamin A is associated with localization of other proteins like lamin C and LAP2α. 
Further experiments need to be done to investigate more about the function of 
lamin A/C and LAP2α in mitochondria. Lamin A/C and LAP2α are implicated in 
binding to nuclear chromatin. Therefore the structure and function of mtDNA or 
mtDNA damage need to be investigated in lamin A/C-/- or LAP2α-/- cell lines. 
Because the expression of Cox2 was normal in lamin A/C-/- cells while ROS 
production was high and mitochondrial mass was similar, the localization of Cox2 
in COX holoenzyme in lamin A/C-/- cells needs to be investigated. It may also be 
interesting to look for the expression and function of the redox proteins in lamin 
A/C-/- verses wild-type. Lamins have direct role in supporting the nucleus shape, it 
will be interesting to check the shape of mitochondria in lamin A/C-/- verses wild-
type. Because it is difficult to use antibodies to identify a protein localize in the 
mitochondrial matrix, I could not demonstrate immunoflurescence of lamin A/C or 
LAP2α. To address this full length of lamin A/C and LAP2α with GFP at C-terminal 
need to be constructed and used for studying the importing and localization of A-
type lamin inside mitochondria.  
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This is the distribution of the first 18 amino acids of the lamin A/C protein sequence 
according to gene bank data accession no. NM_170707. It shows the positive 
charged amino acids (red) are distributed approximately on one side of the helical 
wheel. This may present an amphipathic helix that forms a mitochondrial targeting 
sequence (MTS).  
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This is the distribution of the first 18 amino acids of the LAP2α protein sequence 
according to gene bank data accession no. U09086. It shows the positive charged 
amino acids (red) are distributed approximately on one side of the helical wheel. 
This may present an amphipathic helix that forms a mitochondrial targeting 
sequence (MTS).  
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Appendix I: Stock Solutions. 
 
 
 
1. DEPC-DD Water 
 
     1000 ml of   Double Dionized water 
200    ul of  Diethyl Pyrocarbonate DEPC (Sigma) 
Stir over night. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
 
 
 
2. 1X PBS RNAse free. 
 
- One tablet of PBS (sigma) was dissolved in 200ml DEPC-DD 
Water. 
- Correct pH to 7.2. 
- Filtered through 0.2um syringe. 
 
  
3. 10X TAE (Tris-Acetate EDTA). 
 
48.4g   Tris-Base (Sigma)  
11.4ml   Glacial Acetic acid 
20ml   0.5M EDTA (pH 8.0) 
Made up to 1 liter with DD-water. 
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4. 50% PEG solution. 
 
167.55g  Polyethylene glycol, PEG3350 (Sigma) 
 Made up to 100 ml with DD-water. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
 
 
5. 10X TE Buffer. 
 
4.8g   Tris-Base (Sigma)  
2ml   0.5M EDTA (pH 8.0) 
90mls   DD-water 
pH adjusted to 8.0 with 1NHcl. 
Made up to 100ml with DD-water. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
 
 
6. 10X LiAc solution. 
 
1 M lithium acetate (Sigma)  
Adjust  pH to 7.5 with  acetic acid. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
 
7. PEG/LiAc solution. 
 
In the day of transformation mix this in 15 ml falcon tube. 
8mls   50% PEG. 
1ml   10X TE. 
1ml   10X LiAc. 
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8. 20 X TBST (Tris Buffer Saline Plus Tween). 
 
Tris- Base  24.2 g 
NaCl   174.4 g 
Made up to 1 liter with DD-water. 
Adjust pH to 7.4 with 1 N Hcl . 
Tween  2.5 ml/L (0.25%)  
   To make 2 X TBST: 
20 X TBST  100 ml 
Made up to 1 liter with DD-Water. 
 
9. 10 X Transfer Buffer. 
 
Tris-Base  30.2 g 
Glycine  144 g 
SDS (Solid)  0.2 g (0.02%), or 2ml of 10% SDS solution. 
Made up to 1 liter with DD-water. 
    
   To make 1 X Transfer Buffer. 
10 X Transfer Buffer 100 ml 
Methanol   200 ml 
   Made up to 1 liter with DD-water. 
 
10. 10 X Running Buffer. 
 
Tris-Base  30.2 g 
Glycine  144 g 
SDS (Solid)  10 g (1%), or 100ml of 10% SDS solution. 
Made up to 1 liter with DD-water. 
           To make 1X Running Buffer: 
10 X Running Buffer 100 ml 
Made up to 1 liter with DD-water. 
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11.  Sample Buffer. 
     2 X  4X      5 X  Final Concentration 
1 M- Tris pH 6.8   1 ml  2 ml      2.5 ml  50   mM 
DTT     0.31 g 0.62 g     0.78 g  100 mM 
SDS     0.4 g  0.8 g      1 g   2 % 
Bromphenol Blue   0.02 g 0.04 g      0.05 g  0.1% 
Glycerol    2 ml  4 ml      5 ml  10 % 
Made up to 10ml with DD-water. 
Filter through whatman paper. 
Aliquot in small volume and store at -20oc. 
 
 
12.  Hypotonic solution. 
KCL   10 mM 
HEPES-KOH  10 Mm 
pH adjusted   7.4 
MgCL2    1.5 Mm 
Triton X-100  0.1 % 
DTT*   1 mM    
Protease Inhibitor* 1 X 
    Made up to 50ml with DD-water. Store at 4oc. 
 
13.  Hypertonic solution. 
NaCl   0.5 mM 
KCL   10  mM 
HEPES-KOH  10  mM 
pH adjusted   7.4 
MgCL2    1.5 mM 
Triton X-100  0.1 % 
DTT*   1 mM  
Protease Inhibitor* 1 X 
   Made up to 50ml with DD-water. Store at 4oc. 
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14.  NP40. 
 
Tris- HCL   50  mM 
Na CL  150 mM 
NP-40  1 %  
pH adjusted to 8.0 with 1 N Hcl.  
 
   
15.  4 X Laemmli Sample Buffer (LSB). 
 
Tris-HCl pH 6.8 0.25 M  5 ml 
SDS 0.6%    0.6 g 
Sucrose 40%   4 g 
Made up to 10ml with DD-Water.  
 
 
  16 Fixation Buffers. 
 
- Double strength fixation buffer. 
8% paraformuldehyde fresh made in 0.1M PBS. 
 
- Single strength fixation buffer. 
4% paraformuldehyde fresh made in 0.1M PBS. 
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Appendix II: Medium Preparation. 
 
1.  YPDA (Yeast Peptone Dextrose Adenine): 
 
20g  Peptone (DIFCO) 
10g  Yeast Extract (DIFCO ) 
935ml                 DD-water 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Cool down the medium at 55oc water bath, then add: 
50ml  50% Glucose (BDH) 
15ml  0.2% Adenine (Sigma) 
 
 
2. YPDA Agar: 
 
20g  Peptone (DIFCO) 
10g  Yeast Extract (DIFCO) 
20g  Agar (DIFCI) 
935ml                 DD-water 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Cool down the medium at 55oc water bath, then add: 
50ml  50% Glucose (BDH) 
15ml  0.2% Adenine (Sigma) 
Pour 25ml/100mm diameter plate or 60ml/150mm diameter plate. 
 
3. SD medium (Synthetic Defined Medium): 
6.7g yeast Nitrogen Base 9 (DIFCO) 
What ever says in DO supplements amino acid (BD Bioscience) 
950ml       DD-water  
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Cool down the medium at 55oc water bath, then add: 
50ml  50% Glucose (BDH) 
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4. SD Agar: 
 
20g Agar (DIFCO) 
6.7g yeast Nitrogen Base 9 (DIFCO) 
What ever says in DO supplements amino acid (BD Bioscience) 
950ml       DD-water 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Cool down the medium at 55oc water bath, and then add: 
50ml  50% Glucose (BDH) 
Pour 25ml/100mm diameter plate or 60ml/150mm diameter plate. 
 
 
5. LB medium (Luria-Bertani Medium): 
 
25g Nutrient Broth (LAB M) 
Made up to 1 liter with DD-water 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
 
 
6. LB Agar: 
28g Nutrient Agar (LAB M) 
      Made up to 1 liter with DD-water. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Pour 25ml/100mm diameter plate or 60ml/150mm diameter plate. 
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7. S.O.C: 
20g  Peptone (DIFCO) 
5g   Yeast Extract (DIFCO) 
0.5g  Nacl2 
950ml  DD-water 
10ml  Kcl (1.8g of kcl dissolved in 100ml DD-water) 
Adjust  pH to 7.0 with 5 N NaoH.  
      Made up to 1 liter with DD-water. 
Autoclave cycle is 121oC, 15 psig (1bar) for 20 minutes. 
Cool down the media at 55oC water bath, and then add: 
20ml  Glucose (1M) 
Aliquot them in 50ml tube and keep at –20oc. 
8. SDS-Page gel preparation. 
I) Preparation of 10 ml of Resolving Gel. 
10%  12% 
DD-H20    5.3  4.9 ml 
ProSieve®  50 gel solution 2.0  2.4 ml 
1.5 M Tris- HCL, pH 8.8 2.5  2.5 ml 
10% SDS solution  100  100 ul 
10% APS*   100  100 ul 
TEMED     4.0  4.0 ul 
*Ammonium per sulfate (APS) prepared freshly just prior to use. 
II) Preparation of 5 % of Stacking Buffer. 
3 ml  5 ml 
DD-H20    2.25  3.75 ml 
ProSieve®  50 gel solution 0.5  0.3 ml 
1.5 M Tris- HCL, pH 6.8 0.4  0.65 ml 
10% SDS solution  30  50 ul 
10% APS*   30  50 ul 
TEMED     5.0  5.0 ul 
 
*Ammonium per sulfate (APS) prepared freshly just prior to use. 
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Appendix III: Competent cells preparation. 
 
1.  DH5α E. Coli chemical competent cells: 
a) 20ul of glycerol stock of DH5α was spread on new LB agar plate no 
antibiotics. 
b) Next day, one nice big colony was inoculated in 10ml LB media no 
antibiotics shaking overnight at 225-rpm and 37oC. 
c) 25ml of LB media with no antibiotics was added in each 4 of 100ml 
flasks. 250ul of overnight culture was mixed to each flask, shaking at 
225 rpm and 37oC. Every 30min the cell growth was measured by 
using spectrophotometer OD600, until it gave reading between 0.25-
0.5 OD. 
d) Cells were transferred into 2 of 50ml falcon tubes and chill on ice for 
10mins. 
e) The tubes were centrifuge at 2500rpm for 10mins at 4oC. 
f) The cell pellet was resuspended in 20ml of Buffer I and incubated on 
ice for 30mins (Resuspend the cells in 1/5 of original volume). 
g) The tubes were centrifuge at 2500rpm for 10mins at 4oC. 
h) The cell pellet was resuspended in 4mls of Buffer II and incubated on 
ice for 15mins (Resuspend the cell pellets in 1/25 of the original 
volume).  
i) The cells aliquot in 50ul/vial and freeze at –80oC. 
 
Competency Buffer I (200ml):  Competency Buffer II (200ml): 
20mls of 1M KCl     2mls of 1 M KCL 
12mls of 1M CaCL2     15mls of 1M CaCL2 
30mls of Glycerol.     30mls of Glycerol. 
1.2ml of 5 M K acetate.    4mls of 5 M K acetate. 
118ml DD-water     133ml DD-water 
PH 5.8 with 0.2M acetic acid.   PH 6.8 with 10M NaoH                
.          Made up to 200ml of DD-water.                  Made up to 200ml of DD-water.  
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2. Yeast Strain Competent cells: 
These competent cells should be freshly made on the day of the 
transformation. 
 
a) 20ul of glycerol stock of yeast strain AH109 or Y187 were spread on 
YPDA agar plate.  
b) One colony of 2mm in diameter was inoculated in 2ml of YPDA and 
vortex vigorously for 5 mins to disperse the clumps. 
c) The cell mixture was inoculated in a flask contains 50mls of YPDA 
medium. Overnight shaking at 225rpm in 30oC. Next day, the cell 
density were measured at OD600 it should >1.5. 
d) 30mls of the culture were transferred into 300ml of YPDA medium. 
The cell growth was measured at OD600 every 30mins until it gives 
OD600 0.4-0.6. 
e) The cells were spin down at 1000g for 5mins at room temperature. 
f) The supernatant were discarded and the cell pellet were resuspend 
in 5ml of 1X TE buffer. 
g) Step f was repeated. 
h) Then the cells pellet were suspended in 1.5ml of freshly prepared 
sterile 1X TE/1X LiAc (See Appendix 1). Keep these cells on ice until 
use. 
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3. Yeast Strain Transformations: 
At the day of transformation when the competent cells are ready for using 
the transformation step is as follow: 
 
a) 0.1ug of plasmid and 0.1mg of denatured herring testes carrier DNA 
was mixed in 1.5 ml sterile eppendorf tube. 
b) 100ul of the competent yeast cells (above) was added to each 
transformation tube. 
c) 600ul of sterile fresh mixture of PEG/LiAc (see appendix1) was 
added. The whole mixture was vortex well and incubated at 30oC for 
30mins with shaking at 220rpm. 
d) Then 70ul of DMSO was added and mix well by gently inversion. 
e) The tube were heat shock for 15mins in 42oC water bath. Chill on ice 
for 2mins. 
f) The it spin down for 30 seconds at 14000rpm at room temperature. 
The supernatant were discarded and the cells were resuspended in 
500ul of 1X TE. 
g) Then, 100ul were spread on each selective plate of 100mm or 200ul 
of 150mm. Incubate at 30oC incubator until the colonies will appear.  
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Appendix IV: Gene accession and DNA sequencing. 
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Appendix IV-1a: Lamin A/C gene bank. 
 
Homo sapiens lamin A/C (LMNA), transcript variant 1, mRNA. Accession no. 
NM_170707. The full length gene bank mRNA of lamin A/C that used to design 
PCR primer to generate bait construct. 
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Appendix IV-1b: Lamin A/C-pGBKT7 bait construction. 
 
The sequence of the open reading frame of lamin A/C-pGBKT7 constructs. An 
alternative method used to double check the orientation of the construct. PCR 
was performed on one of the miniprep that showed the right orientation by using 
restriction enzyme and colony PCR. The PCR was performed by using T7-
promoter PCR primer and gene specific downstream PCR primer. Then, DNA 
sequencing applied by using T7-promoter PCR primer.  As we see in the 
sequence there is no stop codon generated inside the sequence that may affect 
the fusion of Gal4-DNA Binding domain to the gene sequence. 
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Appendix IV-2a: LAP2α gene bank. 
 
Human thymopoietin alpha mRNA (LAP2α) complete cds. Accession no. 
U09086. The full length gene bank mRNA of LAP2α that used to design PCR 
primer to generate bait constructs. 
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Appendix IV-2b: LAP2α-pGBKT7 bait construction. 
 
The sequence of the open reading frame of LAP2α-pGBKT7 constructs. An 
alternative method used to double check the orientation of the construct. PCR 
was performed on one of the miniprep that showed the right orientation by using 
restriction enzyme and colony PCR. The PCR was performed by using T7-
promoter PCR primer and gene specific downstream PCR primer. Then, DNA 
sequencing applied by using T7-promoter PCR primer.  As we see in the 
sequence there is no stop codon generated inside the sequence that may affect 
the fusion of Gal4-DNA Binding domain to the gene sequence. 
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Appendix IV-3a: Conig 5 result of mating Lamin A/C-bait construct to 
cDNA-library construct cells. 
 
The sequence of contig5 resulted of bioinformatics analysis for the positive 
colonies that resulted from mating lamin A/C-bait construct cell to cDNA-library 
construct cells.  
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Appendix IV-3b: Seq8 result of mating LAP2α-bait construct to cDNA-
library construct cells. 
 
The sequence of seq8 (colony # 8) resulted of bioinformatics analysis for the 
positive colonies that resulted from mating LAP2α-bait construct cell to cDNA-
library construct cells. 
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Appendix IV-3c: Cox2 gene bank. 
 
Human mitochondrial mRNA cytochrome c oxidase subunit II (Cox2) complete 
cds. Accession no. X15759. The full length gene bank mRNA of Cox2 that 
resulted from yeast 2-hybrid screen. 
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Appendix V: TEM negative control. 
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Appendix V: TEM negative control. 
 
As a negative control, sections were prepared and stained with secondary 
antibody alone. No gold particles were detected under these conditions. It was 
run in parallel at each time to the actual experiment.  
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